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Abstract 
High performance liquid chromatography (HPLC) employing chiral stationary phases 
(CSPs) is the most popular and effective method for the separation of enantiomers. In this 
dissertation, the first chapter is an overview of chiral stationary phases for HPLC, which 
includes the structures, separation mechanisms, and applications of a variety of chiral 
stationary phases. The use of some chiral stationary phases in SFC also is discussed. 
The next three chapters present the enantiomeric separations of chiral furans, 
isochromenes, and polycycles on cyclodextrin-based chiral stationary phases. The 
performance of chiral stationary phases for the separation of these analytes was compared. 
The effect of the mobile phase compositions and structures of the analytes on the chiral 
recognitions were discussed. 
Chapter 5 through chapter 7 focuses mainly on the development and evaluation of new 
synthetic polymeric chiral stationary phases. First, the enantiomeric separation abilities of a 
new polymeric chiral stationary phase based on the monomer N,N’-(1S,2S)-1,2-
cyclohexanediyl-bis-2-propenamide was screened with 200 racemic samples. The 
enantiomeric separations obtained were optimized. The mobile phase compositions and a 
mobile phase additive (trifluoroacetic acid) were evaluated and the chiral recognition 
mechanism was discussed. The new CSP showed high sample loading capacity. Then, we 
developed two new synthetic polymeric CSPs with two other monomers, which are 
polymerible derivatives of trans-1,2-diphenylethylenediamine and trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid. The two new CSPs also showed 
enantiomeric selectivities for a variety of chiral compounds and high sample loading 
capacity. The three new synthetic polymeric CSPs are complementary to each other.  
Chapter 8 is a study on the use of the new synthetic polymeric CSPs with supercritical 
fluid eluents. The new CSPs also can separate many compounds using supercritical fluid 
chromatography (SFC). They showed high stabilities under SFC conditions. Compared with 
HPLC, SFC provides much faster separations due to the high flow rates. For some analytes, 
better enantiomeric separations were observed with SFC due to the better separation 
efficiencies. 
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Chapter 1. General introduction 
1.1. Introduction 
A molecule is chiral if it differs from its mirror image. Two molecules which are 
nonsuperimposable mirror images of one another are enantiomers. Chirality is important in 
most aspects of life. Biological systems consist of mainly of L-amino acids and D-sugars. 
Therefore, it is not unusual for there to be different biological responses to enantiomers. A 
much publicized example is the thalidomide tragedy in the last century [1]. The guidelines 
for the development of stereisomeric drugs issued by the Food and Drug Administration 
(FDA) in 1992 were due to the advent of facile methods for enantiomeric analysis, especially 
HPLC [2]. The pharmacological effect of both enantiomers of chiral drugs must be evaluated 
and the development of enantiomerically pure drugs can simplify the regulatory process. In 
2004, all the top four best-selling drugs (Lipitor, Zocor, Plavix, and Nexium) are in single 
enantiomeric forms [3]. Therefore, analysis of enantiomeric impurities and obtaining pure 
enantiomers are important for drug development and production.  
A variety of analytical technologies such as gas chromatography (GC), HPLC, 
supercritical fluid chromatography (SFC), and capillary electrophoresis (CE), have been used 
for analytical or preparative scale enantiomeric separations [4-5]. Enantioselective HPLC is 
the most popular method for enantiomeric separations in industry because of its robustness, 
reproducibility, and capability for both analytical and preparative scale chiral separations. 
Preparative scale HPLC separations are widely used for the separations of enantiomers in 
industry, particularly when other ways to obtain these species (such as asymmetric synthesis, 
fractional recrystallization of diastereomers, and enzymatic resolution) are limited [4-5]. Till 
now, more than one hundred chiral stationary phases for HPLC have been commercialized. 
The most important CSPs can be classified as three types based on their structures. They are 
macrocyclic, π-π association, and polymeric CSPs [6].  
1.2. Macrocyclic CSPs 
Macrocyclic CSPs includes three groups of chiral selectors. They are chiral crown ethers, 
cyclodextrin derivatives, and macrocyclic glycopeptides. Macrocyclic CSPs, particularly 
cyclodextrin-based CSPs, dominate enantiomeric separations in CE and GC [4-5]. They also 
are important HPLC chiral stationary phases, particularly in the reverse phase and polar 
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organic modes [4-5]. 
1.2.1. Chiral crown ether based CSPs 
Chiral crown ether based CSPs for HPLC were first introduced by Cram and co-workers 
[7-9].  Crown ether (18-crown-6 ether) modified with an optically-active binaphthyl unit was 
used as the chiral selector (Fig. 1) [10]. The cavity of 18-crown-6 ether is an optimum size 
for complexation of potassium and ammonium ions. This inclusion complexation was key for 
the retention and separation of analytes on this CSP. Therefore, this kind of CSP exclusively 
separates analytes with primary amine functional groups. Acidic mobile phase additives such 
as perchloric acid are needed for complete protonation of the primary amine analytes [11-
12]. Competing ions for complexation with crown ethers such as potassium ions need to be 
excluded from the mobile phase. Crown ether based CSPs are used in the reverse phase 
mode. This type of CSPs is not generally used for preparative separations due to the 
formation of potentially explosive organic-perchloric acid mixtures in the solvent removing 
process [13]. 
1.2.2. Cyclodextrin based CSPs 
Cyclodextrins are cyclic oligomers of α-1,4-linked D-glucose units [14]. They can be 
prepared by the treatment of starch with cyclodextrin glycosyltransferase. The cyclodextrins 
used for chiral selectors are α-,β-, and γ-cyclodextrins, which contains 6, 7, and 8 glucose 
units respectively. The shape of cyclodextrin is like a hollow, truncated cone (Fig. 2) [4]. The 
cavity is hydrophobic and the exterior rims are hydrophilic. Therefore, nonpolar molecules or 
parts of the molecules will form inclusion complexes with the hydrophobic cavity in the 
aqueous or hydro-organic solutions [15-18]. 
The first successful cyclodextrin-based CSP was introduced by Armstrong in 1984 [15]. 
β-Cyclodextrin was bonded to silica gel via an ether linkage. This CSP can separate many 
compounds and is the first CSP used in the reverse phase mode [15]. Further research lead an 
understanding of the separation mechanism [19-20]. To achieve enantiomeric separations, 
two requirements must be met. First, a relatively “tight fit” inclusion complex must be 
formed between the hydrophobic part of the analyte and the cyclodextrin cavity. Second, the 
chiral center of the analyte must be close to the rim of the cyclodextrin and interactions (such 
as hydrogen bonding, dipolar, and steric) between the analyte functional groups near the 
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chiral center of the analyte and the “mouth” of the cyclodextrin molecule must be possible. 
At least one of the interactions should be different for the two enantiomers. 
Cyclodextrins can be derivatized with various groups such as methyl, acetyl, 2-
hydroxypropyl, etc. (Fig. 3) to broaden the enantioselectivity [17, 21-24]. Each modified 
cyclodextrin based CSPs can separate different types of chiral molecules. For example, the 
cyclodextrins functionalized with aromatic groups can separate compounds with π-acid 
groups in the normal phase mode. These CSPs also can separate compounds in the reverse 
phase mode via inclusion complex mechanism.  
A new mobile phase mode, the polar organic mode, was developed by Armstrong for 
cyclodextrin based CSPs [25-30]. In the polar organic mode, acetonitrile is the major 
component of the mobile phase. Methanol is used to adjust the retention and small amounts 
of organic acids and bases are used to tune the enantioselectivity. Since the acetonitrile 
solvent molecules occupy the cavity of the cyclodextrin, the separation cannot be 
accomplished by an inclusion complexation mechanism. The analyte covers the large 
opening of the cyclodextrin toroid in a “lid” fashion (Fig. 4) [30]. The retention and 
separation are based mainly on hydrogen bonding, dipolar, and steric interactions. The 
enantiomers separated in this mode must contain two hydrogen bonding groups. Different 
types of molecules are separated in this mode as compared with the reverse phase mode. For 
analytes that can be separated in both modes, the separations in the polar organic mode are 
faster and more efficient. Subsequently, the polar organic mode has been found to be useful 
for other CSPs [31-34]. 
1.2.3. Macrocyclic glycopeptide based CSPs 
A vancomycin (Fig. 5a) based CSP for HPLC was introduced by Armstrong in 1994 [35]. 
Following this, three other macrocyclic glycopeptides also were developed as CSPs [32, 36-
38]. They are teicoplanin, teicoplanin aglycone and ristocetin A (Fig. 5b, 5c, and 5d).  Today, 
the macrocyclic glycopeptide based CSPs are considered one of the most important tools in 
enantiomeric separations due to their broad enantioselectivities [32]. Particularly, the 
teicoplanin based CSPs can separate underivatized amino acids with high enantioselectivity 
in the reverse phase mode without any mobile phase additives. This means that it is suitable 
for preparative separations since the absence of additives in the mobile phase makes recovery 
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of the product much easier [38, 39-40]. The macrocyclic glycopeptides CSPs can be used in 
all mobile phase modes including normal phase, reverse phase and polar organic modes [32]. 
Different enantioselectivities are observed in the three different mobile phase modes. In 
addition, the four macrocyclic glycopeptides CSPs are complementary to each other. If a 
partial separation is observed for an analyte on one CSP, it can be baseline separated in one 
of the other related CSPs in most cases. This property simplifies method development [32, 
41]. 
1.3. π-π association CSPs 
The first commercialized π-π association CSP was (-)-3,5-dinitrobenzoylphenylglycine 
ionically bonded to a silica support [42]. As the name indicates, π-π interactions between the 
analytes and the CSP are required for enantiomeric separations. If the CSP has a π-acid 
moiety (i.e., a π-electron deficient group such as dinitro-, or trifluoromethyl-substituted 
phenyl moiety), the analytes separated on this CSP must have a complementary π-basic 
group (i.e., with π-electron rich groups such as alkyl-substituted phenyl or a naphthyl moiety) 
and vice versa [43-46]. For analytes without π-acid or π-base groups, derivatization is 
necessary. The combination type “π-acid plus π-base” CSPs were developed and showed 
broader enantioselectivities [47-48]. The most applicable CSP of this type is Whelk-O1 CSP 
[47]. (Fig. 6) Pi-pi interactions are very important for the enantiomeric recognition on these 
CSPs. Since this interaction is more prominent in non-polar solvents, π-π association CSPs 
are always used in the normal phase mode [6]. 
1.4. Polymeric CSPs 
Polymeric chiral stationary phases play an important role in HPLC enantiomeric 
separations. Polymeric CSPs can be divided into two catagaries. One is based on natural 
polymers such as proteins and polysaccharides. Synthetic polymers constitute the other.  
1.4.1. CSPs based on natural polymers 
1.4.1.1. Protein based CSPs 
Proteins are natural chiral polymers composed of L-amino acids. They were popular 
chiral selectors for HPLC in the 1980’s due to their broad enantioselectivity [49-51]. This 
type of CSP is used in the reverse phase mode. Table 1 lists some important commercialized 
protein CSPs [4]. Protein based CSPs are not suitable for preparative separations due to two 
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reasons. First, the molar loading of the chiral selectors on the silica support is low because of 
the high molecular weight of proteins (40,000-70,000 Daltons). Secondly, just a small part of 
the protein is responsible for the enantiomeric separation. Therefore, protein CSPs are easily 
overloaded. In addition, protein-based CSPs are the most labile CSPs. Temperature, pH, and 
the composition of mobile phase can ruin the CSPs by causing irreversible changes in the 
secondary and/or tertiary structures of the proteins (which is important for 
enantioselectivity). With the development of new CSPs in the 1990s, the protein based CSPs 
decreased in importance since the enantiomeric separations achieved on these CSPs can also 
be obtained on the new CSPs. 
1.4.1.2. Polysaccharide based CSPs 
Polysaccharides such as cellulose and amylose are among the most abundant naturally 
occurring chiral polymers. Both of them are linear polymers composed of D-glucose 
moieties; however, they differ in the way the glucose units are linked. In cellulose, the 
glucose units are joined by β-1,4-glycosidic linkages, while they are connected via α-1,4-
glycosidic linkages in amylose. Native cellulose and amylose are not very effective for the 
separation of enantiomers [6]. However, when the hydroxyl groups on these carbohydrates 
are derivatized with ester or carbamate groups, good enantioselectivities are observed for a 
wide variety of compounds [52-53]. 
In the 1970s, microcrystalline triacetylcellulose were used as CSP by German scientists 
[54]. Although this CSP showed enantioselectivity for many aromatic and aliphatic chiral 
molecules, the low mechanical strength and poor efficiency limited applications on this CSP 
[55-56]. In the 1980s, Okamoto et al. advanced the polysaccharide based CSPs by coating 
ester or carbamate derivatives of polysaccharides onto macroporous 3-aminopropyl silanized 
silica gel [57-59].  These CSPs showed high efficiency, high mechanical strength, and broad 
enantioselectivity. The most important commercialized polysaccharide based CSPs are listed 
in Table 2 [4]. The 3,5-dimethylphenylcarbamate derivative of cellulose and amylose 
(Chiralcel OD and Chiralpak AD) columns are the most widely used. These CSPs are also 
suitable for preparative separations due to their high sample loading capacity [60]. 
The polysaccharide based CSPs are mainly used in the normal phase mode. Since the 
chiral selectors are coated on the support and are soluble in some normal phase solvents such 
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as chloroform, acetonitrile etc., caution must be exercised when choosing a mobile phase and 
sample solvents. The polysaccharide based CSPs used in the reverse phase mode were also 
developed. However, the CSPs used in the reverse mode cannot be used in the normal phase 
mode [61]. The configuration (three-dimensional structure) of the chiral selectors, which is 
believed to be important for enantioselectivity, will be irreversibly changed in different 
mobile phase modes.  
The stability and durability of the polysaccharide based CSPs can be improved by 
immobilization of the chiral selectors on the support. Attempts have been made in the last 
two decades by several groups [62-66]. None of them was successful due to the decrease of 
the enantioseparation ability or tedious polymerization process. Recently, the immobilized 
version of AD (IA) and OD (IB) columns were commercialized [60, 67-68]. The 
immobilized CSPs showed improved stability, durability, and solvent compatibility 
compared to the coated type CSPs. Although it was claimed that the new CSPs showed 
similar enantiomeric separation abilities to the coated types, recent research indicates that the 
enantioselectivity of the IA and IB columns are still not as broad as the coated type AD and 
OD CSPs [69]. 
1.4.2. CSPs based on synthetic polymers 
Chiral synthetic polymeric CSPs have not been nearly as successful as polysaccharide 
based CSPs. However, recent research on these CSPs also is growing due to several of their 
attractive characteristics [70-74]. First, a variety of monomers are available and they can be 
polymerized via different methods to obtain different polymers. Hence the potential variety 
of polymeric CSPs is almost unlimited. Second, chemical modifications of the CSPs are easy. 
Third, chiral selectors with the opposite absolute configurations are possible. Finally, the 
synthetic polymeric CSPs almost always show high sample loading capacity [70-74]. 
Furthermore, the covalent bonding of chiral selectors results in high stability for these CSPs. 
Four approaches have been reported for synthetic polymeric CSPs. The earliest report 
involved co-polymerization of a chiral monomer with an achiral cross-linking agent. The first 
polymeric CSPs of this type were prepared by Blaschke and coworkers [75-77]. Polymeric 
beads were prepared through copolymerization of chiral acrylamides or methacrylamides 
with ethylene diacrylate. The polymeric beads were used as CSPs and these CSPs showed 
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enantioselectivities for a few racemates. These CSPs cannot endure high pressure and were 
mainly used for preparative separations.  
Polymeric chiral selectors also can be prepared through asymmetric catalyzed 
polymerization of prochiral monomers [52, 78]. Chiral polymers with a helical secondary 
structure were prepared via asymmetric catalyzed anionic polymerization of prochiral 
monomers such as triphenylmethyl methacrylate (TrMA) and diphenyl-2-pyridylmethyl 
methacrylate (D2PymA). These “one-handed” helical polymers were bonded or coated to 
silica gel to use as CSPs. These CSPs are specialized in the separation of relatively flat, 
planer, aromatic chiral molecules. The enantioselectivity of this CSP is dependant on its 
helical secondary structure, which could be irreversible changed with solvent composition 
and temperature. 
The third approach was developed by Allenmark and coworkers. Chiral monomers with 
diallyl groups react with tetrakis(dialkylsiloxy) silane under catalysis by hydrogen 
hexachloroplatinate to form network polymeric chiral selectors. The polymeric chiral 
selectors were then covalently connected to the silical gel through the vinyl groups [79-81]. 
Two commercialized CSPs of this type are Kromasil CHI-TBB and Kromasil CHI-DMB 
CSPs [82]. The monomers of these two CSPs are based on derivatives of N, N’-diallyl-L-
tartar-diamide.  (Fig. 7) 
In the last method, chiral linear homopolymers attached to the surface of silica gel were 
created through a free radical intiated polymeric reaction of a chiral acrylamide or 
methacrylamide. Poly-acrylamide and poly-methacrylamide CSPs with phenylalanine, 1-
phenylethyl, 1-cyclohexylethyl [83], penicillin [84], and menthone or menthol [85] moieties 
were prepared. Enantiomeric separations of only a few chiral molecules were obtained on 
these CSPs.  Recently, several new polymeric CSPs based on the last approach were prepared. 
The chiral monomers are based on derivatives of trans-1,2-diaminocyclohexane (commercial 
name: P-CAP) [70-72], trans-1,2-diphenylethylenediamine (commercial name: P-CAP-DP) 
[73], and trans-9,10-dihydro-9,10-ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid [74] 
(Fig. 8.). All three of these CSPs show enantioselectivities for many chiral molecules and 
show high stability in the normal phase mode and polar organic mode. These CSPs showed 
high sample loading capacities and have the potential to be excellent preparative CSPs. 
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Finally, complementary enantioselectivities were observed on these three CSPs. Some 
analytes can only be separated on one of the columns, while for enantiomers that can be 
separated on all the three CSPs, different enantioselectivities were observed in most cases. 
1.5. Applications of CSPs on packed column SFC 
The CSPs for HPLC, particularly those CSPs that are used in the normal phase mode, can 
also be used for packed column supercritical fluid chromatography (SFC). SFC is a 
chromatographic mode, in which the mobile phase is a supercritical fluid. Carbon dioxide is 
the major mobile phase component for SFC. The polarity of supercritical CO2 is similar to 
hexane. Polar organic modifiers such as methanol, ethanol, and etc. are added to adjust 
mobile phase strength. Packed column SFC shares similar theory and hardware to normal 
phase HPLC and is compatible with most of the LC detectors such as UV, mass, ELSD, etc. 
The first enantiomeric separation by packed column SFC was reported in 1985 [86]. 
Phosphine oxide enantiomers were resolved on (R)-N-(3,5-dinitrobenzoyl)phenylglycine 
CSP. Since then, more and more attention has been paid to SFC for both analytical and 
preparative scale enantiomeric separations. This is because of its advantages which include 
lower amount of toxic organic solvent consumption, high throughput, fast method 
development, and high efficiencies [87-90]. The substitution of normal phase HPLC by SFC 
is promising. 
1.6. Summary 
Due to the extensive development of chiral stationary phases in the last three decades, 
most known enantiomers can be separated on one or more commercialized CSP columns. 
Current research on enantiomeric separations is mainly in two areas. The first area involves 
separation of newly synthesized enantiomers with existing CSPs. The other is development 
of new CSPs with advantages over existing CSPs such as higher sample loading capacity, 
separation of analytes which currently remain are difficult to separate, compatibility with 
solvents, and  etc.  In this thesis, the first three chapters (chapters 2-4) involve the use of 
cyclodextrin based CSPs for the separation of three groups of recently synthesized chiral 
molecules (i.e., racemic furans, racemic isochromens, and racemic polycycles). Chapter 5 is 
an investigation of the enantiomeric separation abilities of a newly developed synthetic 
polymeric CSP (the P-CAP CSP). The following two chapters (chapters 6 & 7) describe the 
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development and evaluation of two new synthetic polymeric CSPs for LC. Chapter 8 focuses 
on the application of the new developed synthetic polymeric CSPs for SFC. The last chapter 
(chapter 9) gives general conclusions. 
1.7 Dissertation Organization 
This dissertation begins with the overview of the research background. The following 
chapters are the finished research projects which include seven published papers with cited 
references, tables, and figures. All these projects were designed by my major professor, 
Daniel W. Armstrong, and me. I am the primary researcher and author of these papers. The 
last chapter summarizes the research results. 
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Fig. 1. Interactions between the primary amine analyte with crown ether CSP (from Ref. 
[10]). 
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Fig. 2. Structure of β-cyclodextrin (a) and the toroidal shape of a cyclodextrin molecule (b) 
(from Ref. [4]). 
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Fig. 4. The interactions between the analyte and cyclodextrin in (a) the reverse phase mode, 
and (b) the polar organic mode (from Ref. [30]). 
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Fig. 5. Structures of the macrocyclic CSPs: a) vancomycin, b) teicoplanin, c) teicoplanin 
aglycon, and d) ristocetin A (from Ref. [5]). 
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Fig. 6. Structure of  (S,S)-Whelk-O1 CSP (a) and (R,R)-Whelk-O1 CSP (b) (from Ref. [47]). 
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Fig. 7. Structures of monomers of Kromasil CHI-TBB and Kromasil CHI-DMB CSPs (from 
Ref. [83]). 
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Table 1. Proteins used as chiral selectors in HPLC Chiral Stationary Phases (Abbreviated 
from Ref. [4]) 
Proteins Molecular Weight 
Isoelectric 
point Trade Name 
BSA 66,000 4.7 
CHIRAL BSA; RESOLVOSIL 
BSA-7, BSA-7PX; USTRON 
ES-BSA 
HSA 
 69,000 4.8 CHIRAL HSA; CHIRAL -HSA 
α1-Acid glycoprotein (AGP) 41,000 2.7 CHIRAL-AGP 
Ovomucoid (OMCHI) 55,000 4.1 ULTRON ES-OVM 
Avidin (AVI) 66,000 1.0 Bioptic AV-1 
Cellobiohydrolase 1 (CBH I) 64,000 3.9 CHIRAL-CBH 
Pepsin 34,600 < 1.0 ULTRON ES-PEPSIN 
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Table 2. Important commercialized chiral stationary phases based on derivatives of cellulose 
and amylase (Abbreviated from Ref. [4]) 
Type of derivatives Derivative Trademark 
CH3
N
H
C
O
CH3  
tris(3,5-dimethylphenyl carbamate) 
AD 
Amylose Derivatives  
   
O
OR
O
ORRO
n
Silica-gel
 
 CH3
H
C
CH3
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H
CH3
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O
(S)
 
Tris(S)-α-methylbenzyl carbamate 
AS 
CH3
N
H
C
O
CH3  
Tris (3,5-dimethylphenyl carbamate) 
OD 
Cellulose Derivatives 
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n
 
 
C CH3
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Chapter 2. Separation of chiral furan derivatives by liquid 
chromatography using cyclodextrin-based chiral stationary phases 
A paper published in Journal of Chromatography A1  
Xinxin Han, Tuanli Yao, Ying Liu, Richard C. Larock, and Daniel W. Armstrong 
Abstract 
The enantiomeric separation of a set of 30 new chiral furan derivatives has been 
achieved on native and derivatized β-cyclodextrin stationary phases using high performance 
liquid chromatography (HPLC). The hydroxypropyl-β-cyclodextrin (Cyclobond RSP), the 
2,3-dimethyl-β-cyclodextrin (Cyclobond DM), and the acetyl-β-cyclodextrin (Cyclobond AC) 
stationary phases are the most effective chiral stationary phases (CSPs) for the separation of 
these racemates in the reverse phase mode. No enantioseparations have been observed on the 
native β-cyclodextrin chiral stationary phase (Cyclobond I 2000) and only a few separations 
have been attained on the S-naphthylethyl carbamate β-cyclodextrin (Cyclobond SN) and 
3,5-dimethylphenyl carbamate β-cyclodextrin (Cyclobond DMP) chiral stationary phases in 
the reverse phase mode. The polar organic and the normal phase mode on these CSPs are not 
effective for separation of these compounds. The characteristics of the analytes, including 
steric bulk, hydrogen bonding ability, and geometry, play an important role in the chiral 
recognition process. The pH affects the enantioseparation of compounds with ionizable 
groups and the addition of 0.5% methyl tert-butyl ether to the mobile phase significantly 
enhances the separation efficiency for some highly retained compounds. 
Keywords: Chiral separation; Enantioseparation; Chiral stationary phase; Cyclodextrin; 
Derivatized cyclodextrins; Chiral furan derivatives 
2.1. Introduction 
Furan derivatives are important structure units in a variety of natural products and 
pharmaceuticals [1-3]. Furanosesquiterpenes [4] are metabolites found in many marine 
invertebrates. Richardianidins [5] are isolated from the leaves of the plant Cluytia 
                                                          
1  Reprinted with permission of Journal of Chromatography A, 2005, 1063, 111-120. Copyright © 2004 
Elsevier B.V. All rights reserved. 
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richardiana and the melatonin receptor agonist drug candidate TAK-375 [6] has a chiral 
substituted furan structure. Furthermore, chiral furan derivatives are important building 
blocks in synthetic organic chemistry [7-11]. Oxidative cleavage of the furan ring under mild 
conditions allows certain furans to be converted to amino acids [12-14]. Piperidines and aza 
sugars can be obtained by the aza-Achmatowicz reaction from furan derivatives [15-17]. 
Furans also can act as dienes, and participate in [4+2] cycloaddition reactions with alkenes, 
alkynes or allenes, to form many important compounds [18-21]. 
Recently, Yao and Larock have synthesized a series of new chiral furans through the 
cyclization-cross-coupling of 2-(1-alkynyl)-2-alken-1-ones with various nucleophiles using 
auric chloride catalysis (Fig. 1) [22]. Alternatively, one can employ I2, rather than AuCl3, to 
form iodofurans [23]. The stereogenic center adjacent to the furan ring is generated by the 
attack of nucleophile on the alkene portion of the starting material. The potential of these 
compounds as drug candidates and/or useful synthetic intermediates is promising. It is well 
known that different enantiomers of a chiral compound show different biological activities 
[24]. Therefore, separation and assessment of the properties of these new chiral furans are 
necessary.  
Cyclodextrin-based chiral stationary phases (Fig. 2), due to their ability to separate 
enantiomers of many chiral compounds [25-28] and especially neutral chiral molecules with 
aromatic units [29-34], are a natural choice for the separation of these new chiral furan 
derivatives. One previous publication has described the separation of two chiral substituted 
furans (racemic 1-(2-furylethyl) prenyl ether and racemic anti-3-isopropenyl-12-methyl-13-
oxabicyclo[8.2.1]trideca-1(12), 10-dien-2-ol) using GC with a heptakis(2,3,6-tri-O-methyl)-
β-cyclodextrin column, and also by SFC and LC with a carbamoylated cellulose and amylose 
chiral stationary phases [35]. To our knowledge, no other systematic or individual 
enantioseparations of chiral furans have been reported. In this work, the enantioselectivity of 
native and derivatized cyclodextrin based chiral stationary phases for 30 new chiral 
substituted furans was evaluated in different chromatographic modes. The cyclodextrin-
based CSPs show enantioselectivity for 28 compounds and baseline separated 16 of them. 
The effects of analyte structure and the composition of the mobile phase on the 
enantioseparations are discussed. 
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2.2. Experimental 
2.2.1. Materials  
Cyclobond I 2000, DM, AC, RSP, DMP, and SN CSPs were obtained from Advanced 
Separation Technologies (Whippany, NJ, USA). All stationary phases used consisted of the 
chiral selector bonded to 5 μm spherical silica gel [27, 28]. The chiral selectors used are the 
native β-cyclodextrin and its derivatives, which are shown in Figure 2. The dimensions of the 
columns are 250 x 4.6 mm. Methanol, acetonitrile, 2-propanol, heptane, and methyl tert-
butyl ether were HPLC grade from Fisher (Fairlawn, NJ, USA). Triethylamine, and acetic 
acid were ACS certified grade from Fisher. Water was deionized and filtered through active 
charcoal and a 5 μm filter. 
2.2.2. Preparation of chiral furan derivatives 
 All chiral furan derivatives were prepared as previously reported via cyclization of 2-(1-
alkynyl)-2-alken-1-ones with various nucleophiles using auric chloride catalysis [22] or 
iodine [23]. The general procedure is as below: 
A solution of AuCl3 (30.3 mg) in acetonotrile (970mg) was prepared. To the appropriate 
2-(1-alkynyl)-2-alken-1-one (0.2 mmol) and nucleophile (1.5 equiv) in dichloromethane (1 
ml), was added the above AuCl3 solution (20mg, 1 mol %). The mixture was stirred at room 
temperature for 1 h unless otherwise specified. The solvent was removed under vacuum and 
the residue was purified by flash chromatography on silica gel. 
2.2.3. Equipment  
Chromatographic separations were carried out using a HP 1050 HPLC system with a 
UV VWD detector, an auto sampler, and computer controlled Chem-station data processing 
software. The mobile phases were degassed by ultra-sonication under vacuum for 10 
minutes. UV detection was carried out at 300 nm for most of the compounds, except 
compound 18, which was detected at 254 nm. All separations were carried out at room 
temperature (~ 23˚C). 
2.2.4. Column Evaluation 
The performance of each stationary phase was evaluated in the reverse phase mode 
using acetonitrile-water and methanol-water mobile phases. Cyclobond I 2000, AC, RSP, SN, 
and DMP CSPs were evaluated in the polar organic mode using acetonitrile and the 
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Cyclobond SN and DMP CSPs were evaluated in the normal phase mode using isopropanol-
heptane. The flow rate of the mobile phase optimized for resolving the enantiomers of each 
compound was 1.0 mL/min. 
2.2.5. Calculations 
The dead time (t0) was estimated using the peak resulting from the change in refractive 
index from the injection solvent on each CSP. The retention factor (k) was calculated using 
the equation k = (tr-t0) / t0. The enantioselectivity (α) was calculated using α = k2 / k1. The 
resolution factor (RS) was calculated using the equation RS = 2 x (tr2-tr1) / (w1+w2), where tr2 
and tr1 are the retention times of the second and first enantiomers, respectively, and w1 and 
w2 are the corresponding base peak widths. The efficiency (number of theoretical plates, N) 
was calculated using N = 16(tr/w)2. 
2.3. Results and discussion 
2.3.1. Performance of the CSPs 
All of the 30 substituted chiral furans, including 22 tetrahydrobenzofuran derivatives, 4 
furochromene derivatives, and 4 simple, multiply-substituted furans have been assessed on 
six different cyclodextrin-based CSPs in the reverse phase mode. The polar organic mode 
and normal phase mode have been utilized with five CSPs (except the Cyclobond DM CSP) 
and two aromatically derivatized cyclodextrin CSPs, respectively. The chromatographic data 
for all successful and several unsuccessful separations are given in Tables 1 and 2. Most 
compounds were eluted at the dead volume of the column in the polar organic mode under 
the weakest solvent condition (100% acetonitrile) for this separation mode and no 
enantioseparation was observed for the compounds that were retained. All analytes were 
retained in the normal phase mode with a 1:99 isopropanol-heptane mobile phase, but only 
one partial diastereomeric separation was observed for compound 5 on the Cyclobond SN 
CSP. For reverse phase LC, enantioseparations (α > 1.02) were observed for 28 compounds 
and 16 baseline separations (RS > 1.5) were achieved. The performance of each CSP in the 
reverse phase mode is summarized in Fig. 3 and Table 1. Obviously, the most effective CSPs 
for resolving these chiral substituted furans are Cyclobond DM, RSP, and AC CSPs. The 
Cyclobond DM CSP was able to separate 19 of the enantiomers with 10 baseline separations. 
Eighteen enantioselective and 5 baseline separations were observed on the Cyclobond RSP 
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column. The Cyclobond AC column also showed enantioseparations of 11 analytes and 
baseline separation of 5 of them. The remaining CSPs, Cyclobond I 2000 and the aromatic 
derivatized Cyclobond SN and DMP CSPs were either ineffective or showed 
enantioseparation for only a few of the examined chiral furans in the reverse phase mode. 
The separation data for these CSPs are summarized in Table 2. 
2.3.2. Effect of mobile phase composition 
For separations in the reverse phase mode, two organic modifiers, acetonitrile and 
methanol, were examined. In general, similar enantioseparations were observed with both 
organic modifiers. Compared to methanol, acetonitrile has greater solvent strength in the 
reverse phase mode and a higher affinity for the cyclodextrin cavity; therefore, less retention 
and enantioselectivity were found when using acetonitrile as opposed to methanol at 
equivalent volume-based mobile phase compositions.  
The effect of the pH of the buffer was also assessed. All 30 compounds were 
investigated on all of the examined CSPs with 0.1% TEAA (triethylamine/acetic acid) buffer 
solution from pH = 4 to pH = 8. No appreciable difference in selectivity or resolution was 
observed for the neutral compounds. However, a mobile phase pH effect on the 
enantioseparation of compounds 3, 7 and 14, which contain ionizable groups, was observed. 
Table 3 shows the separation data for these three compounds at different pH values. For 
example, compound 7, which has a weakly basic indole group, shows an appreciable 
decrease in retention at pH 4 on the Cyclobond DM CSP. At other pHs, the retention, 
selectivity, and resolution were similar. For compound 14 with a dimethyl aniline group, the 
reduction in retention at pH 4 was observed with both the Cyclobond RSP and AC CSPs. The 
separation data at all other pHs from 5 to 8 are quite similar. Compared to the separation 
achieved in a water/methanol mobile phase, the retention decreased, while the resolution 
increased, at all pHs. Since the enantioselectivity (α-value) is similar, the increase in 
resolution is due to the increase in efficiency. The greatest effect of pH on retention, 
selectivity, and resolution was found for compound 3, which has a carboxylic acid group 
(Fig. 4). Although good enantioselectivity was achieved with a methanol/water mobile phase, 
the efficiency was so poor that the resolution was only 0.8. When using methanol/buffer as 
the mobile phase, the retention decreased and sharper peaks with better resolution were 
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achieved. The best separation was attained at pH 5 (Fig. 4). With an increase in the pH of the 
buffer, the analyte is ionized and more hydrophilic. Thus, both the retention and resolution 
decrease.  
It has been reported that the addition of a small amount of methyl tert-butyl ether in the 
mobile phase can improve the peak shape and efficiency for some analytes with high 
enantioselectivity, but very poor efficiency, due to stationary phase mass transfer effects 
(often due to very strong inclusion in the cyclodextrin cavity) [31]. In this work, there appear 
to be two such cases. They involve the separations of compounds 14 and 15 on the 
Cyclobond DM and Cyclobond AC CSPs, respectively. These separations afforded broad, 
asymmetric peak shapes, but they retained significant peak-to-peak separations (Figs. 5a and 
5c). An appreciable decrease in retention and great increase in efficiency were observed for 
both compounds with the addition of a small amount of methyl tert-butyl ether (Figs. 5b and 
5d). For compound 14, the efficiencies (number of theoretical plates, N) for peak 1 are 1200 
and 500 using methyl tert-butyl ether as an additive versus no additive, respectively. For 
compound 15, the efficiency of peak 1 increased from 660 to 3300 with the additive in the 
mobile phase. Therefore, better efficiency and shorter separation times were achieved, 
although the enantioselectivity was similar. The methyl tert-butyl ether serves as a 
competitive binding agent for the cyclodextrin cavity, thereby displacing the analyte more 
readily and effectively than other mobile phase components.  
2.3.3. Effects due to the structure of the individual analyte 
The differences in the structures of the compounds greatly affect the enantioseparations 
of the three groups of analytes listed in Table 1 and Fig. 1. The chiral tetrahydrobenzofurans 
are the easiest to separate. The Cyclobond CSPs showed enantioselectivity for all 22 of these 
compounds and baseline separated 15 of them. These same CSPs showed moderate 
selectivity for the four furochromenes. All four compounds were separated with one 
providing a baseline separation. The four simple, multiply-substituted furans were the most 
difficult to separate with the Cyclobond CSPs. Only partial separations of two of these 
compounds were observed.  
2.3.3.1. Effect of an iodide group 
It is well known that halogen substituents have a strong affinity for the cyclodextrin 
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cavity. Therefore, an iodide substituent in the analyte may play an important role in the 
enantioseparation. For example, the separations of compounds 27 and 30 clearly show the 
effect of an iodide group in the β-position of the furan ring on the enantioseparation. 
Compound 27 cannot be separated on any Cyclobond column, but a partial separation of 
compound 30 was observed on the Cyclobond AC, RSP, and DM CSPs. A comparison of 
compounds 23 and 25 is more interesting (Fig. 6). The Cyclobond RSP column showed a 
baseline separation for compound 23, which has an iodide substituent in the β-position of the 
furan ring, while no enantioselectivity was observed on the Cyclobond DM and AC columns. 
Compound 25, which has no iodide substituent, could be only partial separated on the 
Cyclobond DM, RSP, and AC CSPs. For compounds 17 and 19, the iodide group in 
compound 19 enhanced the enantioselectivity on the Cyclobond RSP, DM and AC CSPs. 
However, for compounds 18 and 20, the enantioselectivity for compound 18 was much better 
on the Cyclobond DM CSP compared to that of compound 20. Clearly, the presence of a 
halogen substituent can either help or hurt an enantiomeric separation depending on its exact 
location. If the halogen moiety redirects inclusion complexation (by offering a more 
favorable complexation site) away from the stereogenic center and/or its substituents, it can 
hurt an enantioselective separation. Conversely, if the presence of a halogen moiety redirects 
inclusion complexation in such a way that there is enhanced interaction with the substituents 
from the stereogenic center, the enantioselective separation can be improved. 
2.3.3.2. Steric effects 
Steric repulsion plays an important role in chiral recognition for the Cyclobond DM CSP. 
The separations of compounds 6 and 15 show that an increase in steric bulk near their 
stereogenic centers improves the separation on the Cyclobond DM CSP. These two 
compounds have similar structures. The only difference is that compound 15 has a six-
membered ring fused to the furan moiety, while compound 6 has a seven-membered ring. 
The bigger ring in compound 6 produces less retention, but higher enantioselectivity (Fig. 7). 
A similar trend can be found for compounds 15, 10, and 12. With an increase in the size of 
the substitutent connected to the chiral center (from a methoxy group, to an allyloxy group to 
an isopropoxy group), a decrease in retention coupled with an enhancement in the 
enantioresolution was observed. However, too large an increase in the steric bulk around the 
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chiral center of the analyte can hinder the separation on the Cyclobond DM CSP. For 
example, compounds 13 and 5, which have much more bulky substituents attached to the 
chiral center, could not be resolved on the Cyclobond DM CSP, while they can be separated 
on the Cyclobond AC and SN CSPs, respectively.  
2.3.3.3. Effect of hydrogen bonding groups 
Hydrogen bonding interactions greatly affect separations on Cyclobond RSP and AC 
CSPs. For example, compound 3, which has a carboxylic acid group (a hydrogen bond donor 
and acceptor), shows satisfactory enantioseparation on the Cyclobond AC CSP with the 
methanol/buffer mobile phase. While compound 15, which has no carboxylic acid group, 
showed no enantioselectivity on this CSP. Another example is the separation of compounds 
14 and 11. The presence of a tertiary amine group, a much better hydrogen bond acceptor 
compared to iodine, results in compound 14 being baseline separated on the Cyclobond RSP 
and AC columns, while no enantioselectivity was observed for compound 11 on these CSPs. 
Some other compounds with hydrogen bond donor or acceptor groups, such as compounds 2, 
7, and 13, also show acceptable enantioseparation on the Cyclobond RSP or AC CSPs. 
2.3.3.4. Effect of substituent geometry 
The separations of two pairs of compounds 17, 18 and 19, 20 are also interesting. Each 
pair has similar structures. Both of them have two chiral centers, one of which is the trans 
configuration and the other is the cis configuration. The two compounds showed different 
selectivity on different cyclodextrin CSPs. For the first group, compounds 17 and 18, 
Cyclobond RSP and AC CSPs showed better selectivity for the analyte with the trans 
configuration, but the compound with the cis configuration was separated better on the 
Cyclobond DM CSP. For the second group, compounds 19 and 20, all three non-aromatic 
derivatized Cyclobond CSPs produced better enantioseparations for the compound with the 
trans configuration than the one with the cis configuration. Another interesting example of 
the effect of geometry is compound 21. It can be baseline separated on any non-aromatic 
derivatized Cyclobond CSPs due to its highly rigid fused tricyclic structure. 
2.4. Conclusions 
The Cyclobond DM, RSP, and AC CSPs have been shown to be very effective for the 
enantioselective separation of many chiral, substituted furan derivatives in the reverse phase 
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mode. The nature of the organic modifier has little effect on the enantioseparation. The pH of 
the mobile phase only affects the separation of the compounds with ionizable groups. The 
addition of 0.5 % methyl tert-butyl ether to the mobile phase enhanced the separation for 
some compounds, which had high α-values, but very poor efficiencies. The nature of the 
compounds, including the steric bulk, hydrogen bonding ability, and geometry, greatly 
affects the chiral recognition. In general, the tetrahydrobenzofurans and furochromenes are 
better separated than simple substituted furans. The normal phase and polar organic phase are 
not as effective as the reverse phase mode for the separation of these compounds.  
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Table 1. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of all chiral furans on the Cyclobond RSP, DM, and AC CSP 
# Structure CSP k1 α RS Mobile Phase (v / v) 
RSP 8.52 1.05 0.3 CH3OH/H2O = 50/50 
DM 7.59   CH3OH/H2O = 50/50 1 
O
I
Ph
I  AC 8.38   CH3OH/H2O = 50/50 
RSP 8.58 1.10 1.2 CH3OH/H2O = 45/55 
DM 7.46 1.23 1.9 CH3OH/H2O = 25/75 2 
O
I
Ph
OH  AC 4.57   CH3OH/H2O = 40/60 
RSP 3.48   CH3OH/H2O = 40/60 
DM 2.03   CH3OH/H2O = 40/60 3 
O
CO2H
Ph
OMe  AC 8.15 1.30 0.8 CH3OH/H2O = 60/40 
RSP 10.38 1.05 0.5 CH3OH/H2O = 45/55 
DM 5.13 1.13 1.2 CH3OH/H2O = 40/60 4 
O
I
Ph
O
O  AC 5.04 1.13 0.8 CH3OH/H2O = 40/60 
RSP 8.89   CH3OH/H2O = 50/50 
DM 2.12   CH3OH/H2O = 40/60 5a 
O
Ph
O
O O
O
O
O
 AC 2.55   CH3OH/H2O = 50/50 
RSP 3.35   CH3OH/H2O = 60/40 
DM 2.72 1.48 2.6 CH3OH/H2O = 40/60 6 
O
OMe
Ph
 AC 2.79   CH3OH/H2O = 50/50 
RSP 5.43 1.17 1.7 CH3OH/H2O = 60/40 
DM 3.94 1.35 1.6 CH3OH/H2O = 50/50 7 
O
N
Ph
 AC 5.52   CH3OH/H2O = 50/50 
RSP 7.14   CH3OH/H2O = 60/40 
DM 4.08 1.29 1.9 CH3OH/H2O = 40/60 8 O
OMe  AC 3.69   CH3OH/H2O = 50/50 
RSP 4.31 1.06 0.6 CH3OH/H2O = 60/40 
DM 8.75 1.10 0.4 CH3OH/H2O = 40/60 9 
O
Ph
O Ph AC 9.33   CH3OH/H2O = 50/50 
RSP 2.24   CH3OH/H2O = 60/40 
DM 2.52 1.32 2.0 CH3OH/H2O = 40/60 10 
O
Ph
O  AC 2.57   CH3OH/H2O = 50/50 
RSP 12.79   CH3OH/H2O = 50/50 
DM 6.96 1.26 1.0 CH3OH/H2O = 40/60 11 
O
Ph
O
I  AC 5.98   CH3OH/H2O = 50/50 
RSP 4.76 1.03 0.3 CH3OH/H2O = 50/50 
DM 1.57 1.34 1.7 CH3OH/H2O = 40/60 12 
O
Ph
O  AC 4.95 1.08 0.8 CH3OH/H2O = 40/60 
RSP 2.77   CH3OH/H2O = 60/40 
DM 4.06   CH3OH/H2O = 40/60 13 
O
Ph
O O AC 7.81 1.13 1.4 CH3OH/H2O = 40/60 
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Table 1. (continued) 
# Structure CSP k1 α RS Mobile Phase (v / v) 
RSP 8.97 1.37 2.9 CH3OH/H2O = 60/40 
DM 6.28   CH3OH/H2O = 50/50 14 
O
Ph
N  AC 6.94 1.36 2.4 CH3OH/H2O = 50/50 
RSP 4.40 1.03 0.3 CH3OH/H2O = 50/50 
DM 9.57 1.28 1.7 CH3OH/H2O = 40/60 15 
O
Ph
OMe AC 5.76   CH3OH/H2O = 40/60 
RSP 7.64 1.13 1.2 CH3OH/H2O = 40/60 
DM 1.66   CH3OH/H2O = 40/60 16 O
OMe
O
 AC 3.32   CH3OH/H2O = 40/60 
RSP 8.69 1.11 1.2 CH3OH/H2O = 60/40 
DM 12.60 1.10 0.6 CH3OH/H2O = 40/60 17 
O
Ph
OMe
Ph  AC 11.40 1.17 1.6 CH3OH/H2O = 40/60 
RSP 7.00   CH3OH/H2O = 60/40 
DM 6.95 1.55 3.1 CH3OH/H2O = 40/60 18 
O
Ph
OMe
Ph  AC 10.83 1.09 0.9 CH3OH/H2O = 40/60 
RSP 6.02 1.15 1.5 CH3OH/H2O = 60/40 
DM 4.50 1.27 1.2 CH3OH/H2O = 50/50 19 
O
Ph
I
OMe
Ph  AC 9.88 1.31 1.6 CH3OH/H2O = 40/60 
RSP 4.00   CH3OH/H2O = 60/40 
DM 7.37 1.22 1.0 CH3OH/H2O = 40/60 20 
O
Ph
I
OMe
Ph  AC 7.75   CH3OH/H2O = 40/60 
RSP 3.13 1.17 1.5 CH3OH/H2O = 60/40 
DM 4.64 1.34 2.8 CH3OH/H2O = 40/60 21 
O
O
 AC 5.33 1.23 2.2 CH3OH/H2O = 40/60 
RSP 10.99 1.09 1.1 CH3OH/H2O = 45/55 
DM 4.09 1.28 1.7 CH3OH/H2O = 40/60 22 
O
I
Ph
OMe  AC 6.59   CH3OH/H2O = 40/60 
RSP 14.24 1.12 1.5 CH3OH/H2O = 45/55 
DM 9.57   CH3OH/H2O = 35/65 23 
O
O
I
Ph
OMe AC 6.28   CH3OH/H2O = 40/60 
RSP 7.52   CH3OH/H2O = 50/50 
DM 8.26 1.11 0.6 CH3OH/H2O = 40/60 24 
O
O
I
Ph
OMe
Ph  AC 5.25   CH3OH/H2O = 50/50 
RSP 5.43 1.06 0.6 CH3OH/H2O = 50/50 
DM 6.99 1.15 1.2 CH3OH/H2O = 35/65 25 
O
O
Ph
OMe AC 5.59 1.04 0.3 CH3OH/H2O = 40/60 
RSP 9.05 1.11 1.1 CH3OH/H2O = 45/55 
DM 3.71   CH3OH/H2O = 40/60 26 
O
O
I
Ph
O  AC 3.04   CH3OH/H2O = 50/50 
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Table 1. (continued) 
# Structure CSP k1 α RS Mobile Phase (v / v) 
RSP 7.34   CH3OH/H2O = 50/50 
DM 4.83   CH3OH/H2O = 40/60 27 
O
I
Ph
Ph
O
Me
Me
 AC 5.84   CH3OH/H2O = 40/60 
RSP 3.43   CH3OH/H2O = 50/50 
DM 2.28   CH3OH/H2O = 50/50 28 
OPh
Ph
OMe
 AC 2.88   CH3OH/H2O = 50/50 
RSP 4.24 1.08 0.7 CH3OH/H2O = 60/40 
DM 3.86   CH3OH/H2O = 50/50 29 
OPh
Ph
O
Ph
Me
 AC 8.97   CH3OH/H2O = 50/50 
RSP 4.95 1.05 0.6 CH3OH/H2O = 50/50 
DM 5.78 1.10 0.8 CH3OH/H2O = 40/60 30 
OPh
Ph
OMe
 AC 5.71 1.11 0.7 CH3OH/H2O = 40/60 
a Separation of diastereomers 
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Table 2. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of chiral furans separated on the Cyclobond SN and DMP CSPs 
Compound # k1 α RS Mobile Phase (v / v) 
Cyclobond SN CSP 
5a 2.11 1.26 1.7 CH3OH/H2O = 60/40 
9 5.94 1.08 0.6 CH3OH/H2O = 60/40 
12 1.00 1.06 0.3 CH3OH/H2O = 60/40 
14 7.55 1.07 0.6 CH3OH/H2O = 60/40 
21 1.40 1.08 0.6 CH3OH/H2O = 60/40 
Cyclobond DMP CSP 
5a 12.54 1.02 0.3 CH3OH/H2O = 60/40 
8 3.98 1.06 0.5 CH3OH/H2O = 70/30 
14 14.36 1.03 0.4 CH3OH/H2O = 60/40 
17 10.36 1.11 1.5 CH3OH/H2O = 70/30 
a Separation of diastereomers 
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Table 3. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of compounds 3, 7, and 14 at different pHs of the mobile phase (0.1% triethylamine with 
pH adjusted by acetic acid). 
pH 4 5 6 7 8 
# CSP k1 α RS k1 α RS k1 α RS k1 α RS k1 α RS 
3 AC 1.74 1.14 1.6 2.53 1.15 2.1 1.04 1.19 1.6 0.26 1.35 1.1 0.18 1.50 1.1 
DM 3.16 1.35 2.0 3.73 1.35 2.1 3.91 1.35 2.0 3.59 1.35 2.1 3.57 1.35 2.1 
7 
RSP 4.14 1.17 1.6 4.19 1.18 1.8 4.20 1.17 1.8 3.93 1.17 1.8 4.02 1.17 1.8 
RSP 5.95 1.37 3.4 6.92 1.37 3.5 7.23 1.37 3.7 6.74 1.37 3.7 6.88 1.37 3.6 
14 
AC 3.50 1.36 2.4 5.00 1.36 2.7 5.64 1.36 2.8 5.81 1.36 3.1 5.67 1.36 3.0 
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Fig. 1. Structure 1 is a tetrahydrobenzofuran derivative. Structure 2 is a furochromene 
derivative. Structure 3 is a simple multiply-substituted furan. R1 can be various types of 
aliphatic or aromatic substituents. R2 can be an iodine or a hydrogen atom. The carbon 
marked with an asterisk is the stereogenic center. 
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Fig. 2. (a) Native β-cyclodextrin (Cyclobond I 2000). (b) Types of derivatized β-
cyclodextrins. An asterisk denotes the chiral center. Taken form Cyclobond Handbook, 6th 
Edition, 2002 with permission. 
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Fig. 3. Summary of the number of baseline and partial separations obtained on different 
CSPs. 
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a) no buffer b) pH=4 c) pH=5
d) pH=6 f) pH=8
29.79
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O
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4.03 4.32
3.76
4.04
e) pH=7
 
 
Fig. 4. The pH effect for the enantioseparation of compound 3 on the Cyclobond AC CSP. 
Mobile phase: a) CH3OH/H2O = 60/40, b) through f) were used a mobile phase of 
CH3OH/buffer = 60/40 where the buffer was 0.1% triethylamine with different 
concentrations of acetic acid to adjust the pH values indicated above. 
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Fig. 5. The effect of 0.5% methyl tert-butyl ether in the mobile phase for the separation of 
compounds 14 and 15. Chromatograms a) and b) were done using the Cyclobond DM CSP. 
Chromatograms c) and d) were done using the Cyclobond AC CSP. The mobile phase 
composition in each case was as follows: a) CH3OH/H2O = 40/60, b) CH3OH/H2O/methyl 
tert-butyl ether = 40/60/0.5, c) CH3OH/H2O = 50/50, d) CH3OH/H2O/methyl tert-butyl ether 
= 50/50/0.5. Enantioselectivity α: a) α = 1.28, b) α = 1.28, c) α = 1.36, d) α = 1.40. Number 
of theoretical plates of the first peak N1: a) N1 = 660, b) N1 = 3300, c) N1 = 500, d) N1 = 
1200. 
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Fig. 6. The iodide effect on the separation for compounds 23 and 25. Chromatograms a) and 
c) were done using the Cyclobond DM CSP. Chromatograms b) and d) were done using the 
Cyclobond RSP CSP. The mobile phase composition in each chromatogram was as follows: 
a), c) CH3OH/H2O = 35/65, b) CH3OH/H2O = 45/55, d) CH3OH/H2O = 50/50. 
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Fig. 7. Steric effect on the separation of compounds 15 and 6 on Cyclobond DM CSP. 
Mobile phase: CH3OH/H2O = 40/60. Enantioselectivity α: a) α = 1.28, b) α = 1.48. 
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Chapter 3. Separation of enantiomers of isochromene derivatives by HPLC 
using cyclodextrin-based stationary phases 
A paper published in Chromatographia1 
X. Han, Q. Zhong, D. Yue, N. Della Cà, R. C. Larock, D. W. Armstrong 
Abstract 
Twenty chiral isochromene derivatives have been chromatographed on native and 
derivatized cyclodextrin stationary phases using HPLC. The most effective CSPs for the 
enantioresolution of these analytes in the reverse phase mode are the hydroxypropyl-β-
cyclodextrin (Cyclobond RSP), the 2,3-dimethyl-β-cyclodextrin (Cyclobond DM), and the γ-
cyclodextrin (Cyclobond II) stationary phases. The α-cyclodextrin (Cyclobond III), β-
cyclodextrin (Cyclobond I), acetyl-β-cyclodextrin (Cyclobond AC), S-1-naphthylethyl 
carbamate-β-cyclodextrin (Cyclobond SN), and 3,5-dimethylphenyl carbamate-β-
cyclodextrin (Cyclobond DMP) stationary phases also show enantioselectivities for some 
analytes. No enantioresolution has been observed in the polar organic mode and only a few 
separations were found in the normal phase mode. The Cyclobond RSP CSP shows the 
highest efficiency of separation for these analytes in the reverse phase mode. The pH of the 
mobile phase and the nature of organic modifiers have little effect on the enantioresolution. 
The substituents in the isochromene ring greatly affect the chiral recognitions.  
Keywords: Column liquid chromatography, Enantioresolution, CSP, Isochromene 
derivatives, Cyclodextrin 
3.1. Introduction 
Derivatives of isochromene are found throughout in nature, particularly in fungi. A 
variety of isochromene derivatives have been isolated from Phellinus igniarius [1], 
Monascus purpureus Wentii, Penicillium sclerotiorum van Beyma, Daldinia concentrica [2], 
insect pathogenic fungus Cordyceps pseudomilitaris BCC 1620 [3], Streptomyces exfoliatus 
[4], and marine fungus Leptosphaeria obiones [5]. In addition, isochromene derivatives have 
also been found in the root bark of Fijian Ventilago vitiensis [6], and Pentas longiflora [7].  
                                                          
1 Reprinted with permission of Chromatographia, 2005, 61, 205-211. Copyright © 2005 Frider. Vieweg & 
Sohn/GWV Fachverlage GmbH. All rights reserved. 
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Isochromene analogues also possess a broad range of useful biological properties. Most 
important are their antitumor properties. Isochromene carboxamides show activity against the 
human ovarian cancer cell line SKOV3 through its interaction with DNA [8, 9]. Two 
isochromene derivatives, phelligridins C and D, display in vitro cytotoxicity against the 
A549 human lung cancer cell line, and a liver cancer line, Bel7402 [1]. In addition, 
exfoliamycin, an isochromene derivative, is a bactericide against gram-positive organisms 
[4]. Another isochromene analogue, trichoflectin, inhibits the biosynthesis of 
dihydroxynaphthalene melanin in fungi [10].  
Recently, Yue, Della Cà, and Larock have synthesized a series of substituted chiral 
isochromenes by electrophilic cyclization of acetylenic aldehydes and ketones with a variety 
of electrophiles and nucleophiles (Fig. 1) [11]. The stereogenic center is produced by the 
attack of a nucleophile on the carbonyl group of the starting material. Clearly, the potential 
of pharmaceutical and/or synthetic applications of these compounds is promising. In most 
cases, the enantiomers of chiral compounds have different pharmacological properties [12]. 
Therefore, the separation and evaluation of the properties of the enantiomers of these 
compounds are necessary. 
Cyclodextrin-based chiral stationary phases (Fig. 2), due to their high enantiomeric 
selectivities for many chiral compounds [13-19], and especially for neutral chiral molecules 
with aromatic portions [20-25], are a natural choice for the separation of chiral substituted 
isochromenes. To our knowledge, no systematic chiral separations of isochromene 
derivatives have been reported previously. In this paper, the enantioselectivity of 3 native 
and 5 derivatized cyclodextrin based chiral stationary phases for 20 chiral isochromenes are 
assessed in different chromatographic modes. The effects of the structure of the analytes and 
the composition of the mobile phase on enantiomeric separation are discussed. 
3.2. Experimental 
3.2.1. Materials  
Cyclobond I, II, III, DM, AC, RSP, DMP, and SN CSPs (Fig. 2) were obtained from 
Advanced Separation Technologies (Whippany, NJ, USA) [26]. All stationary phases used 
consist of the chiral selector bonded to 5 μm spherical silica gel. The chiral selectors used are 
the native α, β, and γ-cyclodextrins and derivatives of β-cyclodextrin. The dimensions of the 
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columns are 250 x 4.6 mm. Methanol, acetonitrile, 2-propanol, ethanol, and heptane were 
HPLC grade from Fisher (Fairlawn, NJ, USA). Triethylamine and acetic acid were ACS 
certified grade from Fisher. Water was deionized and filtered through active charcoal and a 5 
μm filter. All chiral isochromene derivatives were prepared as previously reported via 
electrophilic cyclization of acetylenic aldehydes and ketones with a variety of electrophiles 
and nucleophiles [11]. 
3.2.2. Equipment  
Chromatographic separations were carried out using a HP 1050 HPLC system with a 
UV VWD detector, an auto sampler, and computer controlled Chem-station data processing 
software (Agilent Technologies, Palo Alto, CA, USA). The mobile phases were degassed by 
ultra-sonication under vacuum for 10 min. UV detection was carried out at 300 nm for most 
of the compounds, except compounds 5 and 13, which were detected at 254 nm. All 
separations were carried out at room temperature (~ 23˚C). The flow rate of the mobile phase 
for all separations was 1.0 mL min-1. 
3.2.3. Column Evaluation 
The performance of each stationary phase was evaluated in the reverse phase mode 
using acetonitrile-water and methanol-water mobile phases. Cyclobond I, II, III, AC, RSP, 
SN, and DMP were evaluated in the polar organic mode using acetonitrile and the Cyclobond 
SN and DMP were evaluated in the normal phase mode using ethanol-heptane. Over the 
amount of 600 injections, no change in the performance of these columns was observed. 
When using a new mobile phase, ten column volumes of solution were pumped through the 
column prior to injections of the analyte. 
3.2.4.Calculations 
The dead time (t0) was estimated using the peak resulting from the change in refractive 
index from the injection solvent on each CSP. The retention factor (k) was calculated using 
the equation k = (tr-t0) / t0. The enantioselectivity (α) was calculated using α = k2 / k1. The 
resolution factor (RS) was calculated using the equation RS = 2 x (tr2-tr1) / (w1+w2), where tr2 
and tr1 are the retention times of the second and first enantiomers, respectively, and w1 and 
w2 are the corresponding base peak widths. The efficiency (number of theoretical plates, N) 
was calculated using N = 16(tr/w)2. 
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3.3. Results and Discussion 
3.3.1. Performance of the 8 CSPs in the 3 Separation Modes 
The separations of 20 chiral isochromene derivatives were evaluated on the Cyclobond 
I, II, III, DM, AC, RSP, DMP, and SN columns in the reverse phase mode. The polar organic 
mode was utilized with all Cyclobond columns except Cyclobond DM. The normal phase 
mode was used with two aromatically derivatized cyclodextrin CSPs (Cyclobond SN, and 
DMP). In the polar organic mode, most compounds were eluted at the dead volume of the 
column even with the weakest mobile phase (100% acetonitrile) for this separation mode. As 
expected, no enantiomeric separations were observed for the weakly retained compounds. In 
the reverse phase mode, observable enantioresolutions (Rs ≥ 0.3) were attained for 17 chiral 
isochromenes and 15 baseline separations (Rs ≥ 1.5) were achieved. The chromatographic 
data for the successful and unsuccessful separations in the reverse phase mode are listed in 
Tables 1 and 2. The normal phase mode did not produce as many enantiomeric separations as 
the reverse phase mode. However, the partial separation of 5 compounds and one baseline 
separation are observed with a 1:99 ethanol-heptane or 100% heptane mobile phase (Table 
3). 
The various Cyclobond columns showed widely varying selectivities for the separation of 
these chiral substituted isochromenes. The overall number of observable and baseline 
separations obtained on each CSP in the reverse phase mode is summarized in Fig. 3. 
Clearly, the most effective columns for the enantioresolution of these compounds are 
Cyclobond RSP, DM, and II (Table 1). The Cyclobond RSP was able to separate enantiomers 
of 12 isochromenes and 10 of these were baseline separations. The Cyclobond DM also 
showed enantioselectivity for 12 compounds, but only 3 baseline separations were achieved. 
Thirteen separations with 5 baseline were observed on the γ-cyclodextrin column. The other 
five CSPs, Cyclobond I, III, AC, SN, and DMP, were not as effective as the former 3 CSPs, 
but they also showed enantioselectivities for quite a few examined compounds and some 
baseline separations were obtained on these CSPs (See Table 2). 
The difference in efficiencies of the three most effective CSPs is also interesting. The 
chiral separation of compound 1 is a good example (Fig. 4). The enantioselectivity of this 
analyte is higher on the Cyclobond DM than on the Cyclobond RSP. However, the 
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enantiomeric resolution of this compound on the Cyclobond DM is not as good as on the 
Cyclobond RSP due to the poor separation efficiency (the number of theoretical plates for the 
first peak, N1, for the Cyclobond DM is 530 and 1900 for the Cyclobond RSP column). 
Although the Cyclobond RSP and II show similar enantioselectivities for compound 1, the 
resolution is much worse on the Cyclobond II, which means that the Cyclobond RSP 
produces better mass transfer and higher efficiency separations (N1 for the Cyclobond II is 
630). The enantioresolutions for compounds 2, 8, 14, 17, and 18 showed the same trends. 
Most of the time, the Cyclobond RSP produced higher efficiencies in the reverse phase mode 
than all other native or derivatized cyclodextrin-based CSPs. 
3.3.2. Effect of Mobile Phase Composition in the Reverse Phase Mode 
Two organic modifiers, acetonitrile and methanol, were examined for the separations in 
the reverse phase mode. Similar enantioselectivities, and resolutions were observed in most 
cases with the two organic modifiers. Since acetonitrile has greater solvent strength in the 
reverse phase mode and a higher affinity for the cyclodextrin cavity, less retention and 
enantiomeric resolution were observed when using acetonitrile compared to methanol at 
equivalent volume-based mobile phase compositions. 
According to our previous publications [24-25], the pH value of the mobile phase only 
influences the enantiomeric separation of compounds with ionizable groups when using 
Cyclobond columns. Therefore, in this work, the pH effect on the enantioresolutions of 
compounds 11, 12, 17, and 20, which have amine or pyridine groups, were investigated on 
all of the examined CSPs with 0.1% TEAA (triethylamine/acetic acid) buffer solution from 
pH = 4 to pH = 8. For the compounds 12 and 20 with pyridine moieties, the retention, 
enantioselectivity, efficiency, and resolution observed were almost the same as when using a 
methanol/buffer mobile phase, as opposed to using a methanol/water mobile phase. For 
compounds 11 and 17 with a dimethylaniline moiety, a decrease in retention was observed at 
pH 4, but the enantioselectivity, and efficiency were similar to those obtained with the 
methanol/water mobile phase.  
3.3.3. Effects of Substituents on the Isochromene Ring 
Steric repulsion plays an important role in chiral recognition for the Cyclobond columns, 
particularly when bulky substituents are close to the stereogenic center. A comparison of the 
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enantioresolutions of compounds 2 and 19 clearly shows that an increase in the size of the 
substituent near the stereogenic center destroys the enantioseparation. Both compounds have 
similar structures, except for the n-butyl group versus the t-butyl group connected to the 
stereogenic center. Enantiomers of compound 2 were baseline separated on the Cyclobond 
RSP and a satisfactory separation was obtained on the Cyclobond DM. However, no 
Cyclobond CSP showed any enantioselectivity for compound 19, which has a bulky t-butyl 
group. Another example of the steric effect is the separations of compounds 2 and 4. The 
larger aromatic substituent close to the chiral center resulted in compound 4 exhibiting worse 
enantioresolutions on the Cyclobond RSP and DM than compound 2. However, the 
Cyclobond II showed chiral recognition for compound 4 and showed no enantioselectivity 
for compound 2, because γ-cyclodextrin prefers to form inclusion complexes with multi-ring 
molecules. 
Substituents further removed from the stereogenic center can also affect the 
enantioresolution. For example, compounds 1 and 9 have similar structures except for the 
substituents at the 3 position of the isochromene ring. Simply changing the phenyl group to 
an n-butyl group caused compound 9 to lose enantioselectivity on all cyclodextrin-based 
CSPs. For compounds 11 and 17, the compound with a cyclohexenyl group at the 3 position 
of the isochromene ring can be baseline separated on the Cyclobond RSP and partially 
separated only on the Cyclobond DM, AC, and II. Conversely, compound 11, which has a n-
butyl substituent at the 3 position of the isochromene ring can be baseline separated only on 
the Cyclobond II and slightly separated on the Cyclobond I. Therefore, if the 3 position of 
the isochromene ring is occupied by a phenyl or cyclohexenyl substituent, the 
enantioseparation on Cyclobond CSPs is improved.  
A comparison of the separations of compounds 1 and 18 is also interesting. The two 
methoxy groups at the 6 and 7 positions of the isochromene in compound 18 increase the 
enantioselectivity on the Cyclobond RSP, maintain similar enantioselectivity on the 
Cyclobond DM, and decrease the enantioselectivity on the Cyclobond II as opposed to 
compound 1. Almost all of the Cyclobond CSPs showed enantioselectivity for compounds 12 
and 20 due to the pyridine moiety. The only difference in these two compounds is that 
compound 12 contains a phenyl group at the 3 position of the isochromene ring, while 
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compound 20 has a 4-methoxyphenyl group at the same position. The separations of these 
two compounds are similar for all cyclodextrin CSPs, except for the Cyclobond SN (which 
contains aromatic substituents). However, much better enantioresolution for compound 12 on 
the Cyclobond SN was observed. This means that π-π interaction may play a role in the chiral 
recognition for the Cyclobond SN. The electron-donating methoxy group can change the 
electron density in the phenyl ring and thus change the strength of the π-π interaction.  
The effect of a substituent in the 4 position of the isochromene ring can be observed for 
compounds 8 and 14. The iodine-substituted compound 14 shows better enantioresolution 
than compound 8 with a thiophenyl group at the same position on all Cyclobond CSPs. 
3.4. Conclusions 
Cyclodextrin-based CSPs show enantioselectivity for 17 of the 20 substituted 
isochromene compounds and baseline separate 15 of them. The Cyclobond RSP, DM, and II 
columns were most effective for the enantioresolution of the chiral isochromene derivatives 
in the reverse phase mode. The other CSPs, such as the Cyclobond AC, SN, DMP, I, and III, 
also show enantioselectivities for a few of the analytes. Weak chiral recognition was 
observed in the normal phase mode with the aromatic functionalized Cyclobond SN, and 
DMP CSPs. No enantiomeric separations were found in the polar organic mode for all the 
Cyclobond CSPs. The Cyclobond RSP CSP showed the highest efficiencies for the 
enantioresolutions of most analytes. The nature of the organic modifiers and mobile phase 
pH produce only minor effects in these enantioseparations. The substituents on the 
isochromene ring greatly affect the enantiomeric separations.  
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Table 1. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of all chiral isochromenes on the Cyclobond RSP, DM, and II CSPs in the reverse phase 
mode. 
# Structure CSP k1 α RS Mobile Phase: CH3OH/H2O (v / v) 
RSP 3.93 1.25 2.1 50/50 
DM 3.69 1.40 1.6 40/60 1 
O
OMe
Ph
S
NO2 II 3.40 1.22 1.0 40/60 
RSP 2.48 1.40 2.5 50/50 
DM 1.93 1.43 1.1 40/60 2 O
O
Ph
I  II 3.70   40/60 
RSP 7.89 1.09 1.0 50/50 
DM 4.46 1.38 1.7 40/60 3 O
Ph
I
S
 II 5.59 1.13 0.9 45/55 
RSP 4.91 1.32 1.5 50/50 
DM 3.26 1.24 0.3 45/55 4 O
O
Ph
I
I
 II 3.83 1.19 0.8 45/55 
RSP 2.42   45/55 
DM 2.06   40/60 5 
O
O
Ph
I
O
 II 7.03 1.12 1.0 30/70 
RSP 7.50 1.17 1.5 45/55 
DM 5.13 1.09 0.3 40/60 6 O
O
Ph
I
O
Ph
 II 3.34 1.19 1.0 45/55 
RSP 4.22   40/60 
DM 1.94   35/65 7 
O
OMe
Ph
Ph  II 2.77   35/65 
RSP 10.9 1.24 1.9 50/50 
DM 3.34 1.21 0.8 40/60 8 
O
OMe
S
 II 6.18 1.10 0.3 35/65 
RSP 4.23   50/50 
DM 3.31   40/60 9 
O
OMe
S
O2N  II 3.62   35/65 
RSP 2.62   40/60 
DM 2.21   30/70 10 
O
OMe
Ph
CO2Et  II 2.52 1.33 1.8 25/75 
RSP 10.3   50/50 
DM 5.05   45/55 11 
O
I
N
 II 2.32 1.33 2.7 40/60 
RSP 1.49 1.36 2.0 50/50 
DM 3.55 1.12 1.0 25/75 12 
N
O
OMe
Ph
I  II 2.80 1.24 1.6 30/70 
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Table 1. (continued) 
# Structure CSP k1 α RS Mobile Phase: CH3OH/H2O (v / v) 
RSP 5.11   45/55 
DM 2.12   35/65 13 
O
OMe
Ph
I
MeO
MeO
 II 4.58   40/60 
RSP 2.64 1.31 2.3 50/50 
DM 4.54 1.35 1.3 40/60 14 
O
OMe
I  II 5.79 1.14 1.0 45/55 
RSP 6.33 1.08 0.3 40/60 
DM 4.21 1.09 0.3 40/60 15 
O
OMe
Ph
Ph  II 3.00 1.31 2.4 35/65 
RSP 7.53   45/55 
DM 5.80   35/65 16 
O
OMe
I
O
OMe
I  II 2.30   50/50 
RSP 6.36 1.18 1.5 55/45 
DM 5.16 1.24 0.7 45/55 17 
O
I
N
 II 12.4 1.21 0.8 40/60 
RSP 4.10 1.46 3.5 45/55 
DM 1.92 1.42 1.1 40/60 18 
O
OMe
Ph
S
NO2
MeO
MeO
 II 3.94   40/60 
RSP 6.26   45/55 
DM 3.41   40/60 19 O
O
Ph
I  II 6.25   30/70 
RSP 2.18 1.32 2.0 50/50 
DM 3.08 1.18 1.5 30/70 20 
N
O
OMe
I
OMe II 5.31 1.22 2.0 25/75 
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Table 2. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of chiral isochromenes separated on the Cyclobond AC, SN, DMP, III and I CSPs in the 
reverse phase mode. 
Compound # k1 α RS Mobile Phase: CH3OH/H2O (v / v) 
Cyclobond AC CSP 
1 4.94 1.16 0.9 40/60 
3 5.92 1.14 0.8 40/60 
5 5.24 1.15 1.2 40/60 
8 4.56 1.08 0.3 40/60 
12 1.30 1.22 1.6 40/60 
14 5.91 1.14 0.7 40/60 
17 12.8 1.32 1.1 40/60 
20 1.74 1.30 1.7 40/60 
Cyclobond SN CSP 
1 6.50 1.04 0.3 50/50 
3 5.78 1.08 0.7 50/50 
5 4.12 1.26 2.0 50/50 
12 2.90 1.15 1.3 40/60 
14 5.58 1.08 0.7 50/50 
17 3.63 1.18 1.5 60/40 
20 6.98 1.08 0.8 40/60 
Cyclobond DMP CSP 
6 6.52 1.03 0.4 70/30 
7 6.56 1.04 0.6 60/40 
10 6.67 1.02 0.3 60/40 
15 7.24 1.10 1.6 70/30 
16 9.36 1.04 0.5 70/30 
Cyclobond III CSP 
10 3.19 1.14 0.5 20/80 
Cyclobond I CSP 
1 2.63 1.27 0.5 35/65 
5 4.41 1.56 2.8 35/65 
11 2.55 1.08 0.3 20/80 
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Table 2. (continued) 
Compound # k1 α RS Mobile Phase: CH3OH/H2O (v / v) 
12 4.19 1.25 1.5 20/80 
15 2.70 1.04 0.3 20/80 
20 7.06 1.23 1.5 20/80 
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Table 3. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of chiral isochromenes separated on the Cyclobond SN and DMP CSPs in the normal 
phase mode. 
Compound # k1 α RS Mobile Phase (v / v) 
Cyclobond SN CSP 
12 3.86 1.04 0.3 Heptane/Ethanol = 99/1 
Cyclobond DMP CSP 
7 1.63 1.13 1.0 Heptane 
10 2.00 1.04 0.3 Heptane/Ethanol = 99/1 
12 5.99 1.04 0.5 Heptane/Ethanol = 99/1 
15 0.66 1.24 1.6 Heptane/Ethanol = 99/1 
20 6.37 1.03 0.3 Heptane/Ethanol = 98/2 
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Fig. 1. General structure and ring numbering conventions for substituted isochromene. R1 
and R2 can be various types of aliphatic or aromatic substituents. R3 can be an iodine, a sulfur 
group or other aliphatic or aromatic groups. Position 1 is the stereogenic center. 
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Fig. 2. General structure of the Cyclobond CSPs (can have 1-3 linkages for each cyclodextrin 
molecule). R=H, Cyclobond I (β-cyclodextrin), II (γ-cyclodextrin), III (α-cyclodextrin). All 
derivatized cyclodextrin CSPs are made from β-cyclodextrin. 
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Fig. 3. Summary of the number of baseline and partial separations obtained on different CSPs 
in the reverse phase mode. 
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Fig. 4. Comparison of the efficiencies of the Cyclobond RSP (a), DM (b), and II (c) CSPs. 
The mobile phase composition in each case was as follows: a) CH3OH/H2O = 50/50, b) 
CH3OH/H2O = 40/60, c) CH3OH/H2O = 40/60. Enantioselectivity α: a) α = 1.25, b) α = 1.40, 
c) α = 1.22. Number of theoretical plates of the first peak N1: a) N1 = 1900, b) N1 = 530, c) N1 
= 630. 
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Chapter 4. Enantiomeric separation of fused polycycles by HPLC with 
cyclodextrin and macrocyclic glycopeptide chiral stationary phases 
A paper published in Separation Science & Technology1  
Xinxin Han, Qinhua Huang, Jie Ding, Richard C. Larock, and Daniel W. Armstrong 
Abstract 
The enantiomeric separation of a series of 13 new chiral polycycles have been examined 
on both cyclodextrin-based and macrocyclic glycopeptide chiral stationary phases (CSPs) 
using HPLC in the normal phase, reversed phase, and polar organic modes. The most 
effective chiral selectors for the enantiomeric separation of these analytes are the 2,3-
dimethyl-β-cyclodextrin (Cyclobond I-2000 DM) and hydroxypropyl-β-cyclodextrin 
(Cyclobond I-2000 RSP). The other Cyclobond-type and Chirobiotic (macrocyclic 
glycopeptide) CSPs only show enantioselectivity for a few of the racemic polycycles. The 
effects of mobile phase composition and analyte structure on chiral recognition and 
separation are considered. 
Keywords: Fused polycycles, Enantiomeric separation, Chiral stationary phase, Cyclodextrin, 
Macrocyclic glycopeptides 
4.1. Introduction 
Fused polycycles exist widely in the natural world. Two pentacyclic proaporphine 
alkaloids, (-)-misramine[1] and (-)-labrandine[2], have been found in the Egyptian and Turkish 
flowering plant, Roemeria hybrida, respectively. A complex fused polycycle, 
dipuupehetriol[3], has been isolated from a Verongid sponge. From the Caribbean sponge 
Smenospongia aurea, aureol and its derivatives have been obtained[4]. Esmeraldin A and B, 
derivatives of diphenazine, have been found in Streptomyces antibioticus, strain Tü 2706[5]. 
Many fused polycycles are known to possess beneficial therapeutic activities. 
Dipuupehetriol has shown selectivity against the human lung cancer cell line A549 and the 
CV-1 cell line[3]. Two analogues of aureol inhibit the growth of some gram-positive and 
gram-negative bacteria[4]. Strong antitumor activities of hexacyclic derivatives of 
                                                          
1 Reprinted with permission of Separation Science and Technology, 2005, 40, 2745-2759. Copyright © 2005 
Taylor & Francis, Inc. All rights reserved. 
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camptothecin have been reported[6]. Some other tetracyclic compounds are inhibitors of 
kynurenine-3-hydroxylase[7] and poly(ADP-ribose)polymerase[8,9]. 
Huang, Larock, and co-workers have recently prepared a set of new chiral fused 
polycycles (Fig. 1)[10], which includes 8 chromene derivatives, 2 quinoline derivatives, 2 
isochromene derivatives, and 1 polycyclic diester. These compounds are obtained through 
palladium-catalyzed alkyl to aryl palladium migration, followed by intramolecular arylation. 
Since different enantiomers of a chiral compound can have different biological properties[11], 
separation of these new chiral polycycles and evaluation of their properties are desirable. 
Cyclodextrin-based[12-23] and macrocyclic glycopeptide[24-35] chiral stationary phases (Fig. 
2) are well known for their high enantioselectivities for separation of a variety of different 
chiral molecules. In this work, the enantiomeric selectivity of 8 cyclodextrin and 4 
macrocyclic glycopeptide chiral stationary phases for 13 recently synthesized racemic fused 
polycycles have been investigated in the reversed phase, polar organic and normal phase 
modes.  
4.2. Experimental 
4.2.1. Materials 
Cyclobond I, II, III, DM, AC, RSP, DMP, SN; as well as the Chirobiotic V, R, T, and 
TAG CSPs (Fig. 2) were obtained from Advanced Separation Technologies (Whippany, NJ, 
USA). All the stationary phases consist of chiral selectors bonded to 5 μm spherical porous 
silica gel[14,15,24]. The chiral selectors are the native α-, β-, and γ-cyclodextrins, various 
derivatives of β-cyclodextrin, vancomycin, ristocetin A, teicoplanin, and teicoplanin 
aglycone (Fig. 2). The dimensions of the columns are 250 x 4.6 mm. HPLC grade methanol, 
acetonitrile, ethanol, and heptane were obtained from Fisher (Fairlawn, NJ, USA). The 
triethylamine and acetic acid used were ACS certified grade from Fisher. Water was 
deionized and filtered through active charcoal and a 5 μm filter. All chiral polycycles were 
prepared as previously reported via palladium-catalyzed alkyl to aryl migrations and 
cyclization [10]. 
4.2.2. Equipment 
Chromatographic separations were carried out using an HP 1050 HPLC system with a 
UV VWD detector, an auto sampler, and computer-controlled Chem-station data processing 
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software (Agilent Technologies, Palo Alto, CA, USA). The mobile phases were degassed by 
ultra-sonication under vacuum. UV detection was carried out at 254 nm for all of the 
compounds. All separations were carried out at room temperature (~ 23˚C) and the flow rate 
of the mobile phase was 1.0 mL min-1. 
4.2.3. Column evaluation 
The performance of all stationary phases was evaluated in the reversed phase mode using 
acetonitrile/water and methanol/water mobile phases. Cyclobond I, II, III, AC, RSP, SN, and 
DMP and all Chirobiotic CSPs were evaluated in the polar organic mode using acetonitrile as 
mobile phase. All Chirobiotic CSPs also were evaluated in the polar organic mode using 
ethanol as mobile phase. Cyclobond SN and DMP and all Chirobiotic CSPs were evaluated 
in the normal phase mode using an ethanol/heptane mobile phase. Over the course of 1000 
injections, no degradation of these columns was observed. When using a new mobile phase, 
ten column volumes of solution were pumped through the column prior to injection of the 
analytes. 
4.2.4. Calculations 
The dead time (t0) was estimated using the peak resulting from the change in refractive 
index from the injection solvent on each chiral stationary phase. The retention factor (k) was 
calculated using the equation k = (tr-t0) / t0. The enantioselectivity (α) was calculated using α 
= k2 / k1. The resolution factor (RS) was calculated using the equation RS = 2 x (tr2-tr1) / 
(w1+w2), where tr2 and tr1 are the retention times of the second and first enantiomers, 
respectively, and w1 and w2 are the corresponding base peak widths. The efficiency (number 
of theoretical plates, N) was calculated using N = 16(tr/w)2. 
4.3. Results and Discussion 
4.3.1. Performance of the chiral stationary phases 
The chromatographic parameters for successful and unsuccessful separations are given in 
Tables 1-4. For the Cyclobond CSPs, enantiomeric separations were only observed in the 
reversed phase mode. No enantiomeric separations were achieved on these CSPs in the 
normal phase mode or the polar organic mode. Chirobiotic CSPs showed enantioselectivities 
for several of these compounds in the reversed phase mode, but no enantiomeric separations 
were observed in the polar organic mode. Only separations for compounds 3 and 4 were 
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observed for Chirobiotic CSPs in the normal phase mode. For all of the CSPs, enantiomeric 
separations (Rs > 0.3) of all the 13 analytes and baseline separations for 11 of them were 
achieved. The performance of all of the CSPs is summarized in Fig. 3. Obviously, the 
Cyclobond I-2000 RSP and DM CSPs are the most effective for the enantiomeric separation 
of these chiral polycycles. Eleven enantiomeric and 8 baseline separations were obtained 
with the Cyclobond I-2000 RSP CSP alone. The Cyclobond I-2000 DM CSP was able to 
separate 12 analytes, with 5 baseline separations. The other Cyclobond and Chirobiotic CSPs 
were not as effective as the former two CSPs. Only a few analytes were resolved on these 
other CSPs. For the separation of these neutral chiral fused-ring polycycles, the Cyclobond 
CSPs are superior to the Chirobiotic CSPs. However, for compounds 3 and 4, high 
enantioselectivities and resolutions were observed on Chirobiotic T and Tag columns. 
4.3.2. Effect of mobile phase composition 
Based on studies reported in our previous publications, the pH of the reversed phase 
mobile phase has little effect on the enantiomeric separation of hydrophobic compounds that 
lack ionizable groups[21-23,35]. Two organic modifiers, acetonitrile and methanol were 
examined for separation of all of the analytes on all CSPs. In most cases, the organic 
modifiers have only small effects on the enantioselectivity, but they do affect resolution to 
some extent (Table 1). For example, Cyclobond I-2000 RSP and DM CSPs showed similar 
enantioselectivities for compound 1 when using a methanol/water or acetonitrile/water 
mobile phase. However, the enantiomeric resolution was better when using an 
acetonitrile/water mobile phase due to an increase in the efficiency (Fig. 4a and 4b). The 
theoretical plate number of the first peak, N1, is 3200, when methanol was used as the 
organic modifier, while N1 is 4300, when acetonitrile was used. Similar trends were observed 
for the separation of compounds 3-5, 7, and 9-12 on the Cyclobond I-2000 RSP column and 
compounds 4-7 on the Cyclobond I-2000 DM column. The resolution usually increases when 
using acetonitrile as the organic modifier due to an increase in the efficiency of the column. 
However, it should be noted that in a few special cases, better resolution was observed when 
methanol was used as the organic modifier, because of higher enantioselectivity. One typical 
example is the separation of compound 13 on the Cyclobond I-2000 DM CSP. Higher 
enantioselectivity, which resulted in better resolution, was observed when using a 
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methanol/water mobile phase as opposed to an acetonitrile/water mobile phase (Fig. 4c and 
4d). 
4.3.3. Effects of the structure of the analyte 
Although all analytes have similar molecular skeletons, as well as stereogenic centers, a 
small difference in the structure of these analytes away from the stereogenic center produces 
large effects on these enantiomeric separations. These effects are illustrated using the 
following examples. 
Both the Cyclobond I-2000 RSP and DM columns displayed higher enantioselectivities 
for compound 2, which has a methyl ester substituent at the 6 position, than compound 1 
without such a group, when a methanol/water mobile phase was used. Therefore, the 
resolution for compound 2 is higher than compound 1 on these two columns. Compound 2 
also can be easily separated on the Cyclobond I-2000 AC, I, Chirobiotic V, and R Columns, 
while no enantioselectivity was observed for compound 1 on these CSPs. Another example is 
the separation of compounds 11 and 12. The methylenedioxy group at the 4 and 5 positions 
of the polycycle enhanced the enantiomeric resolution. Baseline separation of compound 12 
was achieved on the Cyclobond DM CSP, while no selectivity for compound 11 was found 
on this column due to the lack of substituents. In general, Cyclobond CSPs showed higher 
enantioselectivities for the racemic polycycles with substituents than the analogous 
compounds without substituents. A substituent on any chiral compound can provide steric 
interactions that adjust the geometry of the inclusion complexation, thereby providing a more 
or less favorable enantioselective binding site. Obviously, in these specific cases, the 
substituent on the polycycle resulted in an inclusion complex that enhanced the enantiomeric 
recognition between the racemic analytes and the derivatized cyclodextrin, thereby 
improving the separations. 
Another interesting example is the separation of chromene derivatives 5-7. These three 
compounds have similar structures, except for differing substituents in the 5 position of the 
polycycle. Compound 5 has a proton, while compounds 6 and 7 have nitro and methoxy 
groups, respectively. The methoxy group has a small effect on the enantiomeric separation on 
the Cyclobond I-2000 RSP and DM CSPs. Both CSPs showed similar enantioselectivities for 
compounds 5 and 7 (Fig. 5). Conversely, the nitro group affects enantiomeric separation 
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greatly. Although Cyclobond I-2000 RSP CSP was not able to separate the enantiomers of 
compound 6, the enantiomeric separation was improved for this compound on Cyclobond I-
2000 DM CSP compared with compounds 5 and 7 (Fig. 5).  
A comparison of the separation of the structural isomers 8 and 9 is also interesting. A 
change in the position of the methylenedioxy substituent resulted in different 
enantioselectivities for these two compounds on the Cyclobond I-2000 RSP column. Using 
the same mobile phase on the Cyclobond I-2000 RSP CSP, compound 8 (with the 
methylenedioxy substituent at the 7 and 8 positions) showed lower retention, but higher 
enantioselectivity, than compound 9 (with the same group at the 8 and 9 positions). Clearly, 
the location of the same substituents on the polycycles also affected the enantiomeric 
separations of these compounds.  
Although there is no significant difference for the separations of two somewhat similar 
quinoline derivatives 3 and 4 on the Cyclobond DM and RSP CSPs, the Chirobiotic T and 
TAG CSPs showed different enantioselectivity for these two analytes. In the reversed phase 
mode, the Chirobiotic T column showed much higher enantioselectivity for compound 3 than 
compound 4 and the enantiomeric resolution of compound 3 is about 3.5 times that of 
compound 4. However, on Chirobiotic TAG column, the enantioselectivity of both 
compounds 3 and 4 increased (Fig. 6). Although higher enantioselectivity was observed for 
compound 3 on the Chirobiotic TAG than the Chirobiotic T column, the resolution was 
worse on the Chirobiotic TAG column due to the low efficiency (N1 is 1400 on Chirobiotic 
TAG CSP and 2600 on Chirobiotic T CSP). The enantiomeric resolution for compound 4 
was significantly greater on the Chirobiotic TAG column than on the Chirobiotic T column, 
because of the increase in the enantiomeric selectivity. In the normal phase mode, high 
enantiomeric resolutions of compounds 3 and 4 were observed on both Chirobiotic T and 
TAG CSPs. The Chirobiotic TAG column showed much higher enantioselectivities (more 
than twice) for these two compounds compared to the Chirobiotic T column. However, no 
great increase in separation was observed due to the poor efficiency of the Chirobiotic TAG 
column. The results in the normal phase (Table 4) indicated that the steric effect of the bulky 
sugar groups on the teicoplanin decreased the chiral recognition of these two compounds. On 
the contrary, these repulsive steric interactions of the Chirobiotic T column decreased the 
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retention and increased the efficiency greatly compared with the Chirobiotic TAG column. In 
addition, compounds 3 and 4 are the only compounds, which can be separated in normal 
phase mode on all Chirobiotic CSPs. 
4.4. Conclusions 
All of the 13 chiral fused polycycles examined were separated on Cyclobond and 
Chirobiotic CSPs and 11 of them were baseline separations. Cyclobond I-2000 DM and RSP 
CSPs are the most broadly applicable CSPs for the separation of these chiral compounds. 
Although Chirobiotic CSPs are not as effective as Cyclobond CSPs for these analytes, high 
enantioselectivities and resolutions for two analytes were observed on the Chirobiotic T and 
TAG columns in the reversed phase and normal phase modes. The reversed phase mode is 
the best mobile phase for these separations. Enantiomeric separations of only two analytes 
were observed in the normal phase mode on Chirobiotic CSPs and no enantioselectivity was 
found in the polar organic mode on any CSP. Similar enantioselectivities were found for 
analytes when either acetonitrile or methanol was used in the reversed phase mode. 
Generally, the acetonitrile/water mobile phases showed higher efficiencies than 
methanol/water mobile phases. For some special cases, the enantioselectivity in the 
methanol/water mobile phase was higher than with the acetonitrile/water mobile phase. The 
structure of the individual analytes greatly affected the enantiomeric separation. Chiral 
analytes with substituents generally were better separated than their unsubstituted parent 
compounds. 
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Table 1. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (RS) of all chiral polycycles on the Cyclobond RSP and DM CSPs in the reversed 
phase mode. 
# Structure CSP k1 α RS Mobile Phase (v / v) 
7.34 1.09 1.0 CH3OH/H2O = 35/65 RSP 
5.43 1.10 1.4 CH3CN/H2O = 20/80 
10.5 1.04 0.4 CH3OH/H2O = 30/70 
1 
O
 
DM 
9.45 1.05 0.7 CH3CN/H2O = 15/85 
5.59 1.17 1.8 CH3OH/H2O = 40/60 RSP 
6.02 1.11 1.5 CH3CN/H2O = 20/80 
6.95 1.14 1.4 CH3OH/H2O = 30/70 2 
O
O
O
 
DM 5.95 1.09 1.0 CH3CN/H2O = 15/85 
6.34 1.12 1.5 CH3OH/H2O = 40/60 RSP 7.03 1.14 1.8 CH3CN/H2O = 20/80 
9.30 1.10 1.2 CH3OH/H2O = 30/70 3 
N
SO O
CF3
 
DM 9.65 1.07 0.9 CH3CN/H2O = 15/85 
4.76 1.17 1.7 CH3OH/H2O = 50/50 RSP 
4.97 1.15 2.1 CH3CN/H2O = 25/75 
4.95 1.18 1.2 CH3OH/H2O = 35/65 
4 
N
SO O
CF3
O
 
DM 
13.7 1.13 1.4 CH3CN/H2O = 20/80 
6.55 1.10 1.3 CH3OH/H2O = 50/50 RSP 
7.46 1.10 1.5 CH3CN/H2O = 25/75 
7.70 1.08 0.5 CH3OH/H2O = 35/65 
5 
O
 
DM 
8.24 1.06 0.8 CH3CN/H2O = 25/75 
10.3 1 0 CH3OH/H2O = 50/50 RSP 
9.34 1 0 CH3CN/H2O = 25/75 
7.12 1.32 3.4 CH3OH/H2O = 50/50 
6 
OO2N
 
DM 
11.6 1.37 4.2 CH3CN/H2O = 25/75 
7.57 1.11 1.3 CH3OH/H2O = 50/50 RSP 
7.21 1.12 1.5 CH3CN/H2O = 25/75 
8.53 1.10 0.6 CH3OH/H2O = 35/65 
7 
OO
 
DM 8.29 1.10 1.3 CH3CN/H2O = 25/75 
5.48 1.23 2.5 CH3OH/H2O = 40/60 RSP 
5.00 1.24 2.6 CH3CN/H2O = 20/80 
8.81 1.18 1.8 CH3OH/H2O = 35/65 8 
O
O
O  
DM 5.82 1.13 1.5 CH3CN/H2O = 20/80 
12.8 1.03 0.3 CH3OH/H2O = 40/60 RSP 
9.80 1.05 0.6 CH3CN/H2O = 20/80 
3.82 1.18 1.9 CH3OH/H2O = 50/50 
9 
O
O O  
DM 
4.96 1.12 1.5 CH3CN/H2O = 25/75 
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Table 1. (continued) 
# Structure CSP k1 α RS Mobile Phase (v / v) 
11.6 1.13 1.5 CH3OH/H2O = 50/50 RSP 
11.6 1.14 1.8 CH3CN/H2O = 25/75 
9.04 1 0 CH3OH/H2O = 35/65 
10 
O
 
DM 
9.52 1.03 0.3 CH3CN/H2O = 25/75 
5.23 1.07 0.8 CH3OH/H2O = 35/65 RSP 
3.68 1.07 1.0 CH3CN/H2O = 20/80 
5.18 1 0 CH3OH/H2O = 35/65 
11 
O
 
DM 7.34 1 0 CH3CN/H2O = 15/85 
5.12 1.10 1.3 CH3OH/H2O = 40/60 RSP 
5.06 1.11 1.5 CH3CN/H2O = 20/80 
7.78 1.17 2.0 CH3OH/H2O = 35/65 
12 
O
O
O
 DM 5.04 1.12 1.6 CH3CN/H2O = 20/80 
2.28 1 0 CH3OH/H2O = 40/60 RSP 
3.17 1 0 CH3CN/H2O = 20/80 
5.48 1.46 4.0 CH3OH/H2O = 35/65 
13 
CO2Et
CO2Et
 
DM 
6.16 1.26 2.5 CH3CN/H2O = 20/80 
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Table 2. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (RS) of chiral polycycles separated on the Cyclobond AC, I, DMP, and II CSPs in 
the reversed phase mode. 
Compound # CSP k1 α RS Mobile Phase (v / v) 
2 AC 2.52 1.30 2.0 CH3OH/H2O = 40/60 
8 AC 5.15 1.07 0.6 CH3OH/H2O = 30/70 
10 AC 8.27 1.11 1.1 CH3OH/H2O = 40/60 
2 I 1.95 1.35 1.1 CH3OH/H2O = 30/70 
4 I 2.10 1.40 0.7 CH3OH/H2O = 40/60 
1 DMP 3.74 1.04 0.6 CH3OH/H2O = 60/40 
2 DMP 4.81 1.04 0.4 CH3OH/H2O = 60/40 
4 DMP 8.66 1.04 0.4 CH3OH/H2O = 60/40 
5 DMP 11.25 1.02 0.3 CH3OH/H2O = 60/40 
6 DMP 9.81 1.10 1.5 CH3OH/H2O = 70/30 
9 DMP 5.89 1.13 1.8 CH3OH/H2O = 60/40 
3 II 2.16 1.08 0.8 CH3OH/H2O = 30/70 
13 II 4.35 1.42 2.1 CH3OH/H2O = 30/70 
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Table 3. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(RS) of chiral polycycles separated on the Chirobiotic V, R, T, and Tag CSPs in the reversed 
phase mode. 
Compound # CSP k1 α RS Mobile Phase (v / v) 
2 V 3.04 1.20 1.7 
CH3OH/H2O = 
30/70 
4 V 6.62 1.03 0.3 
CH3OH/H2O = 
30/70 
13 V 3.42 1.08 0.5 
CH3OH/H2O = 
30/70 
2 R 6.89 1.22 1.3 
CH3OH/H2O = 
20/80 
9 R 3.81 1.14 0.9 
CH3OH/H2O = 
30/70 
11 R 2.59 1.09 0.4 
CH3OH/H2O = 
30/70 
12 R 3.40 1.08 0.5 
CH3OH/H2O = 
30/70 
3 T 6.58 1.66 4.9 
CH3OH/H2O = 
40/60 
4 T 11.9 1.13 1.4 
CH3OH/H2O = 
40/60 
3 Tag 6.39 1.86 3.6 
CH3OH/H2O = 
50/50 
4 Tag 3.44 1.87 3.4 
CH3OH/H2O = 
60/40 
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Table 4. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (RS) of chiral polycycles separated on the Chirobiotic V, R, T, and Tag CSPs in the 
normal phase mode. 
Compound # CSP k1 α RS Mobile Phase (v / v) 
3 V 8.00 1.04 0.8 HEP/EtOH = 99/1 
4 V 8.32 1.06 0.9 HEP/EtOH = 99/1 
3 R 7.40 1.04 0.6 HEP/EtOH = 99/1 
4 R 7.99 1.04 0.4 HEP/EtOH = 99/1 
3 T 4.94 1.44 3.2 HEP/EtOH = 98/2 
4 T 5.14 1.30 2.3 HEP/EtOH = 98/2 
3 Tag 2.08 3.29 3.1 HEP/EtOH = 80/20 
4 Tag 1.61 3.50 2.7 HEP/EtOH = 80/20 
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Fig. 1. General structure and ring numbering conventions for the chiral polycycles. Structure 
1 is a chromene (X = O) or quinoline (X = NSO2CF3) derivative. Structure 2 is an 
isochromene derivative. Structure 3 is a polycyclic diester. The carbon marked with an 
asterisk is the stereogenic center. 
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Fig. 2. General structure of the (a) Cyclobond and (b) Chirobiotic CSPs (there can be 1-3 
linkages for each cyclodextrin or macrocyclic glycopeptide molecule). R = H for Cyclobond 
I (β-cyclodextrin), II (γ-cyclodextrin), III (α-cyclodextrin). All derivatized cyclodextrin CSPs 
are made from β-cyclodextrin. 
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Fig. 3. Summary of the number of baseline and partial separations obtained on different 
Cyclobond and Chirobiotic CSPs. 
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Fig. 4. Chromatograms showing the difference in the separation when using two different 
organic modifiers in the reversed phase mode. Chromatograms a) and b) were obtained using 
the Cyclobond I-2000 RSP CSP. Chromatograms c) and d) were obtained using the 
Cyclobond I-2000 DM CSP. The mobile phase composition (volume ratio) in each case was 
as follows: a) and c) CH3OH/H2O = 35/65, b) and d) CH3CN/H2O = 20/80. 
Enantioselectivity: a) α = 1.09, b) α = 1.10, c) α = 1.46, d) α = 1.26. Number of theoretical 
plates of the first peak: a) N1 = 3200, b) N1 = 4300. 
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Fig. 5. The effects of different analyte substituents on the enantiomeric separation. 
Chromatograms a), b), and c) were obtained using the Cyclobond I-2000 RSP CSP. 
Chromatograms d), e), and f) were obtained using the Cyclobond I-2000 DM CSP. The 
mobile phase composition (volume ratio) in each case was as follows: a), b), c), and e) 
CH3OH/H2O = 50/50, d), f) CH3OH/H2O = 35/65. Enantioselectivity α: a) α = 1.10, c) α = 
1.11, d) α = 1.08, e) α = 1.32, f) α = 1.10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24.17
26.30
36.24 27.43
30.08
27.84
29.84 25.98
33.31
30.50
33.25
O O
O2N
a) b) c)
d) e) f)
O
O
  
84
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Comparison of the separations of compounds 3 and 4 on Chirobiotic T and TAG CSPs 
in reversed phase mode. Chromatograms a) and b) were obtained using the Chirobiotic T 
CSP. Chromatograms c) and d) were obtained using the Chirobiotic TAG CSP. The mobile 
phase composition (volume ratio) in each case was as follows: a) and b) CH3OH/H2O = 
40/60, c) CH3OH/H2O = 50/50, d) CH3OH/H2O = 60/40. Enantioselectivity α: a) α = 1.66, b) 
α = 1.13, c) α = 1.86, d) α = 1.87. Number of theoretical plates of the first peak N1: a) N1 = 
2600, c) N1 = 1400. 
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Chapter 5. Chromatographic evaluation of the poly(trans-1,2-
cyclohexanediamine acrylamide) as a chiral sationary phase for HPLC 
A paper published in Journal of Chromatography A1  
Qiqing Zhong, Xinxin Han, Lingfeng He, Thomas E. Beesley, Walter S. Trahanovsky, and 
Daniel W. Armstrong 
Abstract 
Chiral stationary phases (CSPs) based on polymeric (R,R)- or (S,S)-1,2-
diaminocyclohexane derivatives are synthesized. When bonded to 5-μm porous spherical 
silica gel, the poly (trans-1,2-cyclohexanediamine acrylamide) stationary phases (P-CAP) 
proved to be effective chiral stationary phases that could be used in the normal phase mode, 
polar organic mode and with halogenated solvent mobile phases, if desired. Since these are 
entirely synthetic CSPs, the elution order of all enantiomers can be reversed between the 
(R,R)-P-CAP and (S,S)-P-CAP columns. Because of the high loading of chiral selectors, the 
columns exhibit very high sample capacities. Thus, P-CAP columns are useful for 
preparative and semi-preparative enantiomeric separations. The application of these CSPs 
and optimization of their separations are discussed. 
Keywords: P-CAP; Synthetic polymeric chiral stationary phases; Enantiomeric separations; 
Poly (trans-1,2-cyclohexanediyl-bis acrylamide); Preparative enantiomeric separation 
5.1. Introduction  
Enantiomeric separations were thought to be difficult or impossible prior to the early 
1980s with only a few enantiomeric resolutions reported [1-4]. By the late 1990s, advances 
in the field of analytical chiral separations have made the separation of enantiomers practical 
and even routine [1,5]. Over 100 chiral stationary phases (CSPs) were commercialized 
through the 1980s and 1990s [6-8]. Based on their structure, chiral selectors can be classified 
as macrocyclic, polymeric, π–π association, ligand exchange, miscellaneous and hybrid CSPs 
[6]. Generally, polymeric CSPs, with the exception of proteins, have a high loading of chiral 
                                                          
1 Reprinted with permission of Journal of Chromatography A, 2005, 1066, 55-70. Copyright © 2004 Elsevier 
B. V. All rights reserved. 
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selector on the surface of silica gel, thus they have the potential of high sample loading 
capacity. This feature makes them suitable for preparative purposes 
Enantiomeric separations were thought to be difficult or impossible prior to the early 
1980s with only a few enantiomeric resolutions reported [1-4]. By the late 1990s, advances 
in the field of analytical chiral separations have made the separation of enantiomers practical 
and even routine [1,5]. Over 100 chiral stationary phases (CSPs) were commercialized 
through the 1980s and 1990s [6-8]. Based on their structure, chiral selectors can be classified 
as macrocyclic, polymeric, π–π association, ligand exchange, miscellaneous and hybrid CSPs 
[6]. Generally, polymeric CSPs, with the exception of proteins, have a high loading of chiral 
selector on the surface of silica gel, thus they have the potential of high sample loading 
capacity. This feature makes them suitable for preparative purposes 
In 1926, Wieland et al. reported the synthesis of trans-1,2-diaminocyclohexane (DACH) 
for the first time [9]. This diamine has C2 symmetry and its enantiomers can be resolved by 
recrystallization with d- or l-tartaric acid to give enantiomerically pure (1R,2R)- or (1S,2S)-
DACH [10-11]. In industry, trans-1,2-diaminocyclohexane can be obtained as a byproduct 
from purification of 1,6-diaminohexane, which is a starting material for the manufacture of 
Nylon 66. Thus, enantiomerically pure DACH is commercially available at relatively low 
prices. Both the pure enantiomers and derivatives of trans-DACH can serve as powerful 
stereogenic ligands in asymmetric synthesis [12-16] or as components of chiral stationary 
phases in chiral chromatographic separations [17-26]. 
Polymeric CSPs have been used extensively for enantiomeric HPLC separations. Two 
types of chiral polymers are used as CSPs. They can be classified by their origin. One group 
consists of naturally occurring polymers (such as proteins and linear carbohydrates) and their 
derivatives; the other is composed of purely synthetic polymers [27-29]. Unlike small 
molecule chiral selectors, which are usually bonded on to the surface of silica gel, chiral 
polymers can be bonded or coated on the surface of a silica gel support. Moreover, chiral 
polymers can also be crosslinked as a monolithic gel. The ability of chiral recognition by 
small molecular CSPs depends mainly on the structure of the small molecules. However, the 
mechanism of enantiomeric separation by polymeric CSPs is more complicated than that by 
small molecule CSPs because of the secondary structure of the polymers which may be 
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critical for chiral recognition [7]. Generally, it is easier to increase the loading of polymeric 
chiral selectors onto the surface of a silica gel support than it is for small molecule-based 
covalently bonded CSPs. Therefore, synthetic or semi-synthetic polymeric CSPs may have a 
greater potential for high sample loading capacity. 
The poly (trans-1,2-cyclohexanediyl-bis acrylamide) based stationary phases has been 
commercialized by Advanced Separation Technologies Inc. (Astec, Whippany, NJ) with the 
commercial name of poly-cyclic amine polymer (P-CAP). P-CAP CSP can be prepared from 
either (1R,2R)-DACH or (1S,2S)-DACH and thus (R,R)-P-CAP or (S,S)-P-CAP, respectively.  
These two chiral selectors are enantiomers. Thus, unlike most naturally occurring polymeric 
CSPs such as derivatized linear or branched carbohydrates and proteins, it is easy to obtain 
opposite selectivity CSPs using these synthetic polymeric chiral selectors. 
5.2. Experimental 
5.2.1. Materials 
Porous spherical silica gel (diameter: 5 μm; pore size: 200 Å; pore volume: 0.9 ml/g; 
specific surface area: 213 m2/g) was from Akzo Nobel, EKA Chemicals AB, Sweden. 
Acryloyl chloride and 1-methoxy-2-methyl-1-trimethylsyliloxy-1-propene were from 
Lancaster Synthesis, Inc, Pelham, NH. 3-Aminopropyltrimehoxysilane was from SILAR Lab, 
Scotia, NY. Anhydrous toluene, methylene chloride and chloroform were from Sigma-
Aldrich. 4,4′-Azo-bis-4-cyanovaleric acid was from Fluka. Phosphorus pentachloride (R,R)- 
and (S,S)-diaminocyclohexane, and diisopropylethylamine were from Alfa Aesar, Ward Hill, 
MA. Absolute ethanol was obtained from AAPER Alcohol and Chemical Co., Shelbyville, 
KY, USA. Acetonitrile, 2-propanol, n-heptane, and methylene chloride were HPLC grade 
from Fischer, Fairlawn, NJ. Triethylamine, trifluoroacetic acid and acetic acid were ACS 
certified grade from Fisher Scientific. Water was deionized and filtered through activated 
charcoal and a 5 μm filter. Most analytes used in this study were from Sigma-Aldrich. 
 5.2.2. Synthetic procedure  
The (R,R)-P-CAP and (S,S)-P-CAP columns were prepared as previously reported [30]. 
The stationary phases consisted of the chiral selector were covalently bonded to 5 μm porous 
spherical silica gel. The dimensions of the columns are 250 mm × 4.6 mm. The synthetic 
procedure is summarized below. 
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5.2.2.1. Preparation of (1R,2R)-cyclohexanediyl-bis acrylamide (DACH-ACR) 
(1R,2R)-Diaminocyclohexane (12.1 g, 105.96 mmol) and diisopropylethylamine (36.3 ml, 
210.18 mmol) were dissolved in 160 mL mixed anhydrous solvent (chloroform:toluene = 3:1 
(v/v)). Acryloyl chloride (17.3 ml, 210.18 mmol) was added dropwise into the solution at 
0 °C under nitrogen protection with stirring. The reaction was warmed up to room 
temperature for 2 h. The product was collected by filtration, washed with toluene and hexane, 
and dried at reduced pressure (0.1 mbar, 25 °C) over night to obtain 19.08 g white solid 
(yield: 81.6%).  
TLC: Merck Kieselgel 60-F254; Eluent: CH2Cl2/MeOH 90/10, Rf = 0.56. Elemental 
analysis found: C 61.78%; H 8.41%; N 12.81%. Calculated for C12H18N2O2: C 64.83%; H 
8.16%; N 12.61%. 1H NMR (400 MHz, methanol-d4): δ 8.00 (s, 2H), 6.17–6.15 (m, 4H), 
5.60 (dd, J =6.8 Hz, 5.2 Hz, 2H), 3.80–3.70 (m, 2H), 2.00–1.95 (m, 2H), 1.80–1.70 (m, 2H), 
1.40–1.30 (m, 4H). 13C NMR (methanol-d4): δ 166.7, 130.8, 125.3, 52.8, 31.9, 24.5. 
5.2.2.2. Preparation of the dichloride of 4,4’-azo-bis-4-cyanovaleric acid 
To a suspension of phosphorous pentachloride (115.1 g, 552.48 mmol) in 576 ml of 
anhydrous methylene chloride is added a suspension of 4,4′-azo-bis-4-cyanovaleric acid 
(28.8 g, 138.24 mol) in 900 ml of anhydrous methylene chloride at −5 °C under nitrogen 
protection with continuous stirring. After 1 h, the reaction mixture was warmed up to room 
temperature and kept over night, and then filtered. The precipitate was dried under reduced 
pressure (0.1 mbar, 25 °C) to obtain 24.8 g of the title compound (yield: 73.7%). 
5.2.2.3. Preparation of 3-aminopropyl silica gel (3-APSG-200) 
To anhydrous slurry of 5 μm silica gel (85.7 g) dispersed in 850 ml of anhydrous toluene 
is added 3-aminopropyltrimethoxysilane (42 ml, 180.6 mmol) at room temperature. The 
mixture was heated to reflux for 5 h and filtered afterwards. The silica gel was dried at 
105 °C over night to obtain 91.97 g 3-APSG-200 (weight gain: 7.4%). Elemental analysis 
found: C 3.22%, H 0.88%, N 0.88%. 
5.2.2.4. Functionalization of 3-aminopropyl silica gel with the dichloride of 4,4’-azo-bis-
cyanovaleric acid 
To anhydrous slurry of 3-APSG-200 (88.5 g) dispersed in 742 ml anhydrous toluene is 
added a solution of 1-methoxy-2-methyl-1-(trimethylsyliloxy)-1-propene (MMTP) (14.8 ml, 
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72.52 mmol) at −5 °C, followed by adding the solution of dichloride of 4,4′-azo-bis-4-
cyanovaleric acid (9.98 g, 36.24 mmol) in 297 ml anhydrous toluene under nitrogen 
protection with mechanical stirring. The mixture was warmed up to room temperature (25 °C) 
for 5 h. The modified silica gel was filtered, and dried at reduced pressure (0.1 mbar, 25 °C) 
to obtain 95.9 g functionalized silica gel (3-APSG-AZO-200). The percentage of weight gain 
was 8.4%. Elemental analysis found: C 7.00%, H 1.10%, N 2.26%. 
5.2.2.4. Preparation of (R,R)-P-CAP CSP 
To a solution of (1R,2R)-DACH-ACR (14.0 g) in 1380 ml anhydrous, degassed 
chloroform, is added 3-APSG-AZO-200 (82.4 g) under nitrogen protection. The mixture was 
heated at 61 °C for 5 h and then heated to reflux for 1 h. After cooling down to room 
temperature, the reaction mixture was filtered, washed with methanol and acetone, and dried 
under vacuum (0.1 mbar, 60 °C) for 4 h to obtain 91.5 g (R,R) P-CAP bonded silica gel 
(weight gain: 11.1%). Elemental analysis found: C 12.83%, H 1.98%, N 2.69%. 
5.2.3 Equipment  
Chromatographic separations were carried out using an HP 1050 HPLC system with a 
UV VWD detector, an auto sampler, and computer-controlled HP ChemStation for LC data 
processing software. The mobile phases were degassed by purging compressed pure helium 
gas for 10 min. UV detection was carried out at 210, 254 or 264 nm for most of the probe 
compounds. All separations were carried out at room temperature (~ 23˚C). 
5.2.4. Column Evaluation 
The performance of (R,R)-P-CAP and (S,S)-P-CAP CSPs was evaluated in the normal 
phase mode using n-heptane/ethanol, n-heptane/2-propanol and methylene chloride/methanol 
mobile phases; in polar organic phase mode using acetonitrile/methanol mobile phase.  
5.2.5. Calculations 
The chiral separation ability of CSPs can be quantitatively evaluated by retention factors 
(k’), selectivity factor (α), and resolution factor (RS). Those parameters are defined as 
follows: 
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in which, t1 and t2 are the retention times of enantiomers; t0 is the dead time and was 
estimated by using the peak resulting from the change in refractive index from the injection 
solvent on columns; W1 and W2 are the peak widths. To evaluate the efficiency of separation, 
the number of theoretical plates (N) is also used 
 
2
16 RtN
W
⎛ ⎞= ⎜ ⎟⎝ ⎠  (5) 
where tR is the retention time of the peak and W is the peak width. 
5.3. Results and discussion 
5.3.1 The structure of P-CAP chiral selectors 
Gasparrini and co-workers [19-20, 31] used trans-1,2-cyclohexanediamine acrylamide as 
monomer to synthesize poly-DACH-ACR, which forms a crosslinked structure. In 
synthesizing the related P-CAP chiral stationary phase, the free radical initiator was 
immobilized on the surface of silica gel before the free radical polymerization process was 
carried out [30,32]. Therefore, P-CAP is basically a linear brush-type polymer with the 
DACH-ACR units as the branches. The idealized structure of (R,R)-P-CAP CSP is shown in 
Fig. 1. The structure of (S,S)-P-CAP CSP has the opposite configuration of each stereogenic 
center of the cyclohexyl units on (R,R)-P-CAP CSP.  
5.3.2. Column performance 
A total of 62 chiral compounds were separated on the P-CAP CSPs in the normal-phase 
mode (including two different solvent systems: traditional normal phase and halogenated 
solvent mobile phase) and polar organic mode combined.  The majority of compounds were 
separated in the traditional normal-phase mode (heptane/ethanol). Table 1 shows the 
chromatographic data for 43 racemic compounds separated in the traditional normal-phase 
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mode. Of these compounds, 23 were not separated in the polar organic mode. Sixteen out of 
43 compounds were baseline separated.   
Table 2 lists the enantioseparation data obtained for the polar organic mobile phase mode 
(34 compounds). The polar organic mode is similar to the normal-phase mode. The 
difference of mobile phase composition is the normal phase contains n-heptane while the 
polar-organic phase does not. Instead, the polar-organic phase has acetonitrile as its main 
solvent. There are 16 compounds separated in polar organic phase mode only but not in the 
normal-phase mode. Twelve baseline separations were achieved in polar organic mode. 
Table 3 shows the enantioseparation data in the normal phase mode with a halogenated 
solvent (methylene chloride) and other mobile phases (10 compounds). Methanol was used 
as a modifier for these separations. For all 10 compounds separated using a methylene 
chloride based mobile phase can also be separated in either the normal phase mode (8 
compounds) or polar organic mode (5 compounds). Three compounds were enantioseparated 
in all three solvent systems (i.e. the traditional normal-phase mode, polar organic mode, and 
the normal phase mode with halogenated solvent). One baseline enantiomeric resolution of 
1,1’-bi-2-naphthol was achieved using a neat acetone mobile phase. 
Because of the covalent linkage between the polymeric chiral selector and their solid 
support (5 μm porous silica gel), no degradation in column performance was observed even 
after more than 1000 injections in each mobile phase mode. 
5.3.2.1 Retention behavior 
Typical normal-phase retention (k’) behavior of two analytes, (A) 1,1’-bi-2-naphthol and 
(B) fipronil is shown in Fig. 2. The diagrams show that the first and second eluting 
enantiomers of each analyte as plotted as the function of mobile phase composition with 
different ratio of ethanol and n-heptane. In both cases, the retention and selectivity are 
greatest when using ethanol/heptane 10/90 (v/v) as the mobile phase. No data were available 
at 100% n-heptane because the elution times are extremely long. As can be seen, retention 
decreases with increasing the concentration of ethanol.  Retention of all analytes tends to be 
minimal at ethanol concentration of ≥ 50% (by volume). However, it is interesting that even 
at 100% ethanol, the P-CAP column still gives an enantioselectivity (α) of 1.23 and 
resolution (Rs) of 1.15 for 1,1’-bi-2-naphthol. 
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Figure 3 contains plot for the retention factor '1k  of the first eluted enantiomer, selectivity 
factor α, and resolution Rs of 1,1’-bi-2-naphthol as a function of polar organic mode mobile 
phase composition. The resolution (Rs) curve has a minimum at a mobile phase composition 
of acetonitrile/methanol 30/70 (v/v). The maximum of retention factor '1k  of the first eluted 
enantiomer, selectivity factor α, and resolution Rs are all at 100% acetonitrile.   
5.3.2.2. Effects of mobile phase additives 
Additives to the mobile phase can usually improve chromatographic efficiency. 
Trifluoroacetic acid (TFA) is the most effective additive for both normal-phase mode and 
polar organic mode. Ammonium acetate sometimes can also be used in the polar organic 
mode as an additive. These additives usually shorten the retention time, decrease tailing and 
sharpen the peaks. Figure 4 shows the enantiomeric separation of (R,R)- and (S,S)-
hydrobenzoin on the (R,R)-P-CAP column with different composition of normal-phase 
solvents. The best separation (Chromatogram A) was achieved when heptane/2-
propanol/TFA 80/20/0.1 was used as the mobile phase. Without the TFA additive 
(Chromatogram B), only a partial separation can be achieved and the peaks become broader. 
Three probe molecules, including chlorthalidone, sulindac, and (±)-2,3-dibenzoyl-dl-
tartaric acid, were chosen to investigate the influence of acid additives in polar organic mode. 
The results are summarized in Table 4. Chlorthalidone (pKa = 9.4) is a weak base. The acid 
additives, acetic acid and TFA, have almost no influence on separation factor α, and a minor 
influence on the resolution (Rs). Under the same solvent system with the same volume ratio 
of acid additives, TFA increases the Rs more than acetic acid does. Sulindac (pKa = 4.7) has 
one carboxylic acid group. It could not be eluted with a mobile phase of 
CH3CN/CH3OH = 95/5, without acid additives. The compound (±)-2,3-dibenzoyl-dl-tartaric 
acid has two carboxylic acid groups. It is the strongest acid among three analytes. With the 
mobile phase of CH3CN/CH3OH = 95/5, it can only be eluted with the addition of 0.1% 
trifluoroacetic acid. The acid additives protonate acidic analytes as well as any residual 
amine groups on the stationary phase (e.g. from the 3-aminopropylsilanized silica gel). This 
minimizes a source of strong non-enantioselective association between acidic analytes and 
the CSP. The additives therefore improve the mass transfer and thus improve the efficiency. 
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Compared to acetic acid, TFA is a stronger acid and produces better separations. 
5.3.2.3. Normal phase modifier 
The choice of organic modifier in the normal phase mode (i.e. ethanol, 2-propanol, etc. in 
n-heptane) affects the efficiency, retention, and the resolution of enantiomers.  In Fig. 4, 2-
propanol is used as normal-phase modifier for Chromatogram A. While for Chromatogram 
C, ethanol is used instead of 2-propanol. A baseline separation was achieved within 15 
minutes with the mobile phase of heptane/2-propanol/TFA 80/20/0.1. But for ethanol, with 
the same mobile phase ratio (heptane/ethanol/TFA 80/20/0.1), only a partial separation (Rs = 
0.8) was achieved. When decreasing the ratio of ethanol to 10% (Chromatogram D in Fig. 4. 
Mobile phase: Heptane/ethanol/TFA 90/10/0.1), the retention time is comparable to that of 
Chromatogram A, but the separation still wasn’t baseline even with a longer retention time.  
In both cases, a TFA additive was used. Separations of some other compounds in the normal-
phase mode, such as fipronil, produced the same general trend. For these chiral stationary 
phases, 2-propanol was a better normal mobile phase modifier than ethanol. 
5.3.2.4 Effect of mobile phase flow rate 
The effect of mobile phase flow rate on enantiomeric selectivity and resolution in the 
normal-phase mode also was evaluated. Table 4 shows the chromatographic data of the 
normal-phase enantiomeric separations of fipronil on the (R,R)-P-CAP column at flow rates 
of 0.5 ml/min, 1.0 ml/min, 1.5 ml/min and 2.0 ml/min. As can be seen, flow rate has little or 
no effect on enantioselectivity, while resolution is affected. The resolution is improved from 
1.40 to 1.71 if the flow rate is dropped from 2.0 to 0.5ml/min. This is because of the mass 
transfer in the stationary phase affects efficiency at higher flow rates [33]. This is a common 
phenomenon for other CSPs. For high throughput screening, one can use higher flow rates, 
like 2.0 ml/min, and still gets reasonable resolution. 
5.3.2.5 Column efficiency in different mobile phase modes 
The normal-phase mode with two different solvent systems (heptane/IPA and methylene 
chloride/methanol) and the polar organic mode can be used on P-CAP columns. Table 5 
shows the chromatographic data for the enantiomeric separation of 1,1’-bi-2-naphthol in 
different mobile phases. As can be seen in Table 5, the halogenated mobile phase gives the 
highest efficiency (greatest N). The polar organic mode produces intermediate efficiency and 
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the traditional normal-phase separations are the least efficient among three mobile phase 
systems. 
5.3.2.6 Sample loading capacity 
P-CAP columns are polymeric CSPs. The high loading of the chiral selector on the silica 
gel provides the potential of having a high sample loading capacity. Figure 5 shows the 
chromatogram of the separation of 1,1’-bi-2-naphthol when 1μg and 1000μg racemic sample 
was injected sequentially. As can be seen, the resolution is still nearly 1.5 even given the 
heavy sample load on an analytical column. Clearly, the P-CAP CSPs are suitable for large-
scale enantiomeric separations. 
5.3.3. Reversal of elution order 
The totally synthetic chiral selectors of the (R,R)-P-CAP column and the (S,S)-P-CAP 
column have the opposite absolute configuration. Therefore, the elution order of all separable 
enantiomers will be inverted on these two columns. Figure 6 shows the inversion of elution 
order on (R,R)-P-CAP column and the (S,S)-P-CAP column under normal phase conditions.  
The (R,R)- and (S,S)-hydrobenzoin were chosen as example probe molecules. In order to 
identify the enantiomeric peaks of the probe molecules easily, the analyte sample containing 
(R,R)- and (S,S)-hydrobenzoin was prepared in the mole ratio of 2 to 1 respectively. Figure 6 
also shows that (R,R)-P-CAP CSP retains (R,R)-hydrobenzoin longer than its (S,S)-
enantiomer, and of course, the (S,S)-P-CAP CSP retains (S,S)-hydrobenzoin to a greater 
extent. 
Interestingly, the (R,R)- and (S,S)-P-CAP columns can also separate the racemic 
monomers DACH-ACR very well. Figure 7 shows the chromatographic separation of 
DACH-ACR on both (R,R)- and (S,S)-P-CAP column. As can be seen from Figure 8, the 
(R,R)-P-CAP column retains (S,S)-DACH-ACR more and the (S,S)-P-CAP column favors 
(R,R)-DACH-ACR. 
5.3.4. Interactions for chiral recognition 
The P-CAP columns do not contain any aromatic moieties. Therefore, π-π interactions 
are not expected.  Instead, the P-CAP CSPs have large numbers of amide linkages, which 
provide hydrogen bonding and dipolar interactions between these CSPs and chiral analytes.  
An examination of the compounds listed in Table 1, 2 and 3 reveals a common characteristic 
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for these compounds. Most of them contain a hydroxyl group, carboxylic group, carbonyl, 
amine, amide, urea, or fluorine group, which are capable of forming strong hydrogen bond. 
Thus, hydrogen bond interactions are believed to be the dominant associative interactions for 
chiral recognition by P-CAP CSPs [19]. 
Some chiral sulfoxides also were resolved on P-CAP columns. These sulfoxides include 
4-chlorophenyl methyl sulfoxide and 4-bromophenhyl methyl sulfoxide, etc. These chiral 
sulfoxides are known to possess a strong dipole element and the amide linkage in the P-CAP 
CSPs also is strongly dipolar. Therefore, dipole-dipole interactions also may be important for 
chiral discrimination on these CSPs.   
The cyclohexyl moiety (Fig. 1) is a restricted configurational nonpolar unit of the P-CAP 
stationary phase. It may provide solvophobic-driven attraction or steric repulsive effects.  
These are possible interactions for enantiomeric selectivity by these CSPs.   
5.4. Conclusions 
The polymeric (R,R) and (S,S) poly (trans-1,2-cyclohexanediyl-bis acrylamide) (known 
as (R,R)-P-CAP and (S,S)-P-CAP) have been used as liquid chromatographic chiral 
stationary phases. The branched polymer was bonded covalently to a 5 μm silica gel support 
and evaluated for enantiomeric separations. P-CAP CSPs can be used in the normal phase 
mode or the polar organic mode to produce enantiomeric separations of a variety of chiral 
compounds. The retention behavior, selectivity, and resolution were examined for selected 
compounds in each mobile phase mode. A total of 62 chiral compounds were enantioresolved 
on these two columns. The traditonal normal phase separation mode was the most broadly 
selective, but has the lowest efficiency. Halogenated mobile phases produced the highest 
efficiencies but separate the fewest compounds. The polar organic mode was intermediate in 
terms of both selectivity and efficiency to the two normal phase approaches. The elution 
order of enantiomers can be reversed between (R,R)- and (S,S)-P-CAP CSPs. P-CAP 
columns have great sample loading capacity and are therefore able to do large-scale 
separations. The P-CAP CSPs were chemically stable under usual separation conditions and 
not irreversibly damaged or modified when changing the mobile phase modes. 
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Table 1. Chromatographic data for the traditional normal-phase resolution of racemic 
compounds on (R,R)-P-CAP column1 
# Compounds Structure '1k  '2k  α Rs Mobile Phase2 
1 Hydrobenzoin 
OH
OH  
3.43 3.97 1.16 1.91  Heptane/IPA/TFA 80/20/0.1 
2 Warfarin 
O
OH
O
O
 
11.21 12.65 1.13 1.58 Heptane/IPA/TFA 90/10/0.1 
3 1,1'-Bi-2-Naphthol 
 
2.49 3.36 1.35 2.84 Heptane/EtOH/TFA50/50/0.1 
4 Di-6,6’-methoxy-bi-2-naphthol 
 
2.69 3.41 1.27 2.7 EtOH/Heptane 50/50 
5 Dioxibrassinin 
 
7.67 8.81 1.15 1.4 EtOH/Heptane 30/70 (v/v) 
6 Indapamide 
N
CH3
HN
O
Cl
S
O
O NH2 
7.32 7.74 1.06 0.60 Heptane/EtOH/TFA60/40/0.1 
7 
3-(α-acetonyl-4-
chlorobenzyl)-4-
hydroxy coumarin 
O O
OH
Cl
O
 
4.06 4.76 1.17 1.63 Heptane/IPA 80/20 
8 Bendroflumethia-zide 
F3C
S
N
H
NH
S
O
O
H2N
O O
CH2
 
14.5 16.34 1.12 0.80 Heptane/IPA/TFA 50/50/0.1 
                                                          
1 (R,R)-P-CAP was bonded to 5μm silica gel and the stationary phase was packed in a 250×4.6 mm (i.d.) 
stainless steel column. 
2 All samples were analyzed under the chromatographic condition: a UV detector at 254 nm, flow rate 1 
ml/min, unless otherwise noted.  All mobile phase ratios were volume to volume.  IPA: 2-propanol.  TFA: 
trifluoroacetic acid. 
OH
HO
OH
OH
H3CO
H3CO
N
H
O
HO
N
H
S
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Table 1. (continued) 
# Compounds Structure '1k  '2k  α Rs Mobile Phase 
10 
N,N'-Bis(α-
methyl 
benzyl)sulfamide 
NH S NH
CH3
O
O
CH3
 
12.3 13.50 1.10 0.90 Heptane/IPA/TFA 80/20/0.1 
11 
2,3-O-
Benzylidene-D-
threitol O
O
CH2OH
CH2OH
 
5.49 6.13 1.12 1.21  Heptane/IPA 80/20 
12 
α-carbethoxy- γ-
phenyl-γ- 
butyrolactone 
O
O
O
O
 
2.73 3.06 1.12 1.0  Heptane/IPA 80/20 
13 Chlorthalidone NH
O
HO
Cl
S
NH2
O
O
 
10.21 12.57 1.23 1.61  Heptane/EtOH/TFA 80/20/0.1 
14 
1,5-Dihydroxy-
1,2,3,4-
tetrahydro 
naphthalene 
OH
OH
 
6.78 7.22 1.06 0.81  Heptane/IPA 80/20 
15 
DL-3,4-
Dihydroxypheny
l-α-
propylacetamide NH2
OH
OH
O
 
3.84 4.59 1.20 1.64  Heptane/EtOH/TFA 50/50 
16 
4-
(Diphenylmethyl
)-2-
oxazolidinone O
NH
O
Ph
Ph
 
8.57 9.31 1.09 0.82  Heptane/IPA 80/20 
17 1,1'-Bi- (2-naphthylamine) 
NH2
NH2
 
5.80 5.95 1.03 0.7  Heptane/IPA 80/20 
18 cis-4,5-Diphenyl -2-oxazolidinone O
H
N
O
 
12.64 13.72 1.09 1.22  Heptane/IPA/TFA 90/10/0.1 
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Table 1. (continued) 
# Compounds Structure '1k  '2k  α Rs Mobile Phase 
19 
5-Ethyl-5,6-
dihydro-3,8-dinitro-
6-phenyl-6-
phenanthridinol 
N
OH
O2N NO2
 
5.43 5.75 1.06 1.05 Heptane/EtOH/TFA80/20/0.1 
20 
5-Fluoro-1-
(tetrahydro-2-
furfuryl)uracil 
N
NHO
O
O
F
 
5.04 5.39 1.07 0.65 
Heptane/EtOH/TFA
90/10/0.1 
2ml/min 
21 
DL-3-(4-
Hydroxyphenyl)lac
tic acid 
O
H
O
OH
HO  
4.57 5.76 1.26 1.54 Heptane/IPA/TFA 60/40/0.1 
22 Mandelamide 
NH2
OH
O
 
9.62 11.53 1.20 1.50 Heptane/IPA/TFA 80/20/0.1 
23 5-Methyl-5-phenyl hydantoin 
NH
NH
O
O
CH3  
8.33 9.06 1.09 0.9 Heptane/IPA 80/20 
24 
cis-4-Methyl-5-
phenyl-2-
oxazolidinone 
O
NH
H3C
O  
10.32 11.37 1.10 1.52 Heptane/IPA/TFA 80/20/0.1 
25 
N-(α-
Methylbenzyl)-
phthalamic acid 
NH
CH3 O
OHO
 
3.98 4.19 1.05 0.72 Heptane/EtOH/TFA 80/20/0.1 
26 Methyl mandelate 
O
CH3
OH
O
 
1.93 2.47 1.13 1.2 Heptane/IPA 80/20 
27 Benzyl mandelate 
 
2.07 2.21 1.07 1.0 EtOH/Heptane 10/90 
28 Mandelic acid 
 
2.04 2.19 1.07 1.0 EtOH/Heptane 10/90 
C
H
OH
C
O
OCH2
C
H
OH
COOH
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Table 1. (continued) 
# Compounds Structure '1k  '2k  α Rs Mobile Phase 
29 DL-3-Phenyllactic acid OH
OH
O
 
1.64 2.01 1.23 1.28 Heptane/EtOH/TFA 60/40/0.1 
30 1-Phenyl-1,2-ethane diol 
CH2OH
OH
 
4.68 5.25 1.12 1.60 Heptane/IPA 80/20 
31 γ-Phenyl-γ -butyrolactone 
O O  
2.82 3.00 1.06 0.92 Heptane/IPA 80/20 
32 Phenylsuccinic anhydride 
O
O
O 
2.68 3.05 1.14 1.45 Heptane/EtOH/TFA 70/30/0.1 
33 
(3a(R,S)-cis)-
3,3a,8,8a-
Tetrahydro-2H-
indeno[1,2-
d]oxazol- 2-one 
O
NH O
 
7.77 9.36 1.20 1.66 Heptane/IPA/TFA 80/20/0.1 
34 Fipronil N
N
CF3Cl
Cl
H2N
S
F3C
O
NC  
4.11 6.13 1.49 3.73 Heptane/IPA/TFA 20/80/0.1 
35 
trans-1,2-
Cyclohexanediyl-
bis acrylamide 
NH
NH
O
O  
0.78 1.02 1.31 2.7 EtOH/Heptane 10/90 
36 
trans-1-(2-Amino-
cyclohexyl)-3-(3,5-
bis-trifluoromethyl-
phenyl)-urea 
NH2
NH
NO
CF3
CF3H  
1.97 2.11 1.07 0.65 EtOH/Heptane/TFA 10/90/0.1 
37 
trans-(1,2)-
Diaminocyclohexyl 
di(4-vinyl) 
benzoylamide 
NH
NH
O
O
 
0.30 0.50 1.68 1.25 EtOH/Heptane 50/50 
38 Lorazepam 
 
3.48 5.26 1.51 4.2 EtOH/Heptane  50/50 (v/v) 
N
H
N
Cl
O
Cl
OH
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Table 1. (continued) 
# Compounds Structure '1k  '2k  α Rs Mobile Phase 
39 Oxazepam 
 
3.31 5.03 1.52 4.3 EtOH/Heptane  50/50 
40 4-chlorophenyl methyl sulfoxide S
O
Cl
 
3.81 4.09 1.07 0.78 Heptane/IPA/TFA 90/10/0.1 
41 
Methyl 4-
trifluoromethylphen
yl sulfoxide 
S
O
CF3
 
3.30 3.58 1.08 0.92 Heptane/IPA/TFA 90/10/0.1 
42 4-fluorophenyl methyl sulfoxide S
O
F
 
4.31 4.54 1.05 0.65 Heptane/IPA/TFA 90/10/0.1 
43 4-bromophenyl methyl sulfoxide S
O
Br
 
3.83 4.13 1.08 0.88 Heptane/IPA/TFA 90/10/0.1 
 
 
 
 
 
 
 
HN
N
O
OH
Cl
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Table 2. Chromatographic data for the polar organic mode resolution of racemic compounds 
on (S,S)-P-CAP column or (R,R)-P-CAP column1 
# Compounds Structure 
'
1k  '2k  α Rs Mobile Phase
2 
1 
4-Methoxy-2-
phenyl-4,5,6,7-
tetrahydro-
benzofuran-3-
carboxylic acid 
O
Ph
CO2H
OMe  
1.0 1.17 1.17 1.22 
CH3CN/CH3OH/TFA 
=99/1/0.1 
2 Sulindac 
S
O
CH3
F OH
O
 
4.03 4.62 1.15 1.85 
CH3CN/CH3OH/TFA 
=99/1/0.1 
3 Benzoin 
OHO
 
0.43 0.56 1.30 1.18 
CH3CN/CH3OH/ 
NH4OAc (10mM) 
=99/1 
4 
DL-β-Phenyllactic 
acid CO2H
HO  
3.99 4.34 1.09 0.93 
CH3CN/CH3OH/TFA 
=95/5/0.1 
1.47 1.97 1.34 3.80 
CH3CN/CH3OH/ 
NH4OAc (10mM) 
=95/5 
5 
(±)-1,1’-Bi-2-
naphthol 
OH
HO
 
1.86 2.54 1.36 3.43 
CH3CN/CH3OH/TFA 
=95/5/0.1 
6 Althiazide 
Cl
S
O
O
H2N
N
NH
S
O O
S
H
 
4.79 5.28 1.10 0.50 
CH3CN/CH3OH/ 
NH4OAc /(10mM) 
= 95/5 
7 
Benzoin methyl 
ether 
O OMe
 
0.43 0.61 1.42 1.03 CH3CN 
                                                          
1 (S,S)-P-CAP and (R,R)-P-CAP were bonded to 5μm silica gel and the stationary phase was packed in a 
250×4.6 mm (i.d.) stainless steel column. All data shown were run on SS-P-CAP column unless otherwise 
noted. 
 
2 All samples were analyzed under the chromatographic condition: a UV detector at 254nm, flow rate 1ml/min, 
unless otherwise noted.  All mobile phase ratios were volume to volume.  TEAA: triethylamino acetate.  TFA: 
trifluoroacetic acid. ACN: acetonitrile. 
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Table 2. (continued) 
# Compounds Structure 
'
1k  '2k  α Rs Mobile Phase 
8 
(±)N,N-Bis-(α-
methylbenzyl) 
sulfamide N S
N
CH3
CH3
O
O
H
H
 
0.70 0.93 1.33 1.02 CH3CN 
9 
Bendroflumethiazi
de 
F3C
S
N
H
NH
S
O
O
H2N
O O
CH2
 
4.39 4.86 1.11 0.51 
CH3CN/CH3OH 
(10mM NH4OAc) 
=95/5 
10 
3-(4-
chlorophenyl)-2-
ethyl-2,3,5,6-
tetrahydroimidazol
[2,1-b]-thiazol-3-ol Cl
N
S
N
Et
OH
 
2.34 2.59 1.11 0.94 
CH3CN/HOAc/TEA 
=100/0.25/0.05 
11 Chlothalidone 
NH
Cl
S
NH2
O
O
HO
O  
5.02 6.92 1.38 2.5 
CH3CN/CH3OH/TFA 
=90/10/0.1 
12 
p-Chloromandelic 
acid 
Cl
OH
OH
O  
7.06 8.08 1.14 1.65 
CH3CN/CH3OH/TFA 
=99/1/0.1 
13 
7-(2,3-
Dihydroxypropyl)t
heophylline 
N
N
N
N
CH3
O
CH3
O
OH
OH
 
2.23 2.44 1.09 0.72 
CH3CN/HOAc/TEA 
=100/0.25/0.05 
14 
(±)-4-
(Diphenylmethyl)-
2-oxazolidinone 
O
NH
O
Ph
Ph
 
0.61 0.74 1.21 1.06 
CH3CN/CH3OH/ 
(10mM NH4OAc) 
= 99/1 
15 
(±)-2,3-Dibenzoyl-
DL-tartaric acid 
O
O
OH
O
O
O
OH
O
 
9.26 10.15 1.10 0.94 
CH3CN/CH3OH/TFA 
=95/5/0.1 
16 
DL-p-
Hydroxymandelic 
acid HO
OH
O
OH  
9.40 10.43 1.11 0.95 
CH3CN/CH3OH/TFA 
=95/5/0.1 
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Table 2. (continued) 
# Compounds Structure 
'
1k  '2k  α Rs Mobile Phase 
17 
DL-3-(4-
hydroxyphenyl)lac
tic acid hydrate 
HO
O
OH
HO
x H2O  
3.24 3.56 1.10 1.05 
CH3CN/CH3OH/TFA 
=90/10/0.1 
18 
3-[2-
Methylphenoxy]-
1,2-propanediol 
CH3
O
OH
OH
 
1.48 1.56 1.05 0.50 
CH3CN/HOAc/TEAA 
=100/0.25/0.05 
19 DL-Mandelic acid 
OH
OH
O  
5.30 5.90 1.11 1.29 
CH3CN/CH3OH/TFA 
=99/1/0.1 
20 DL-Mandelamide 
OH
NH2
O  
1.96 2.24 1.14 1.00 
CH3CN/CH3OH/TFA 
=99/1/0.1 
21 
(±)-N-(α-
Methylbenzyl)phth
alic acid 
monoamide 
OH
O
N
O
HH3C
 
2.80 3.22 1.15 0.88 
CH3CN/CH3OH/TFA 
=99/1/0.1 
22 
(±)-Phenylsuccinic 
anhydride 
OO O  
2.42 2.90 1.20 2.62 
CH3CN/CH3OH/TFA 
=90/10/0.1 
23 
3a,4,5,6-
Tetrahydro-
succinimido[3,4-
b]acenaphthen-10-
one 
NH
O
O
O
 
1.28 1.47 1.15 0.37 
CH3CN/HOAc/TEA 
=100/0.25/0.05 
24 DL-Tropic acid 
OH
OH
O
 
4.87 5.71 1.17 1.90 
CH3CN/CH3OH/TFA 
=99/1/0.1 
25 
(3aR,S-cis)- (±)-
3,3a,8,8a-
Tetrahydro-2H-
indeno[1,2-d]-
oxazol-2-one 
O
N O
H
 
0.64 0.79 1.22 1.03 
CH3CN/HOAc/TEA 
=100/0.25/0.05 
26 
(±)-1-Phenyl-1,2-
ethanediol 
HO
OH
 
1.35 1.45 1.07 0.56 
CH3CN/HOAc/TEA 
=100/0.25/0.05 
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Table 2. (continued) 
# Compounds Structure 
'
1k  '2k  α Rs Mobile Phase 
27 
(±)-2,2,2-
Trifluoro-1-(9-
anthryl)ethanol 
CF3HO
 
0.58 0.62 1.07 0.35 
CH3CN/HOAc/TEA= 
100/0.25/0.05 
28 
1,1’-Binaphthyl-
2,2’-diyl-H 
phosphate 
 
2.00 2.35 1.17 1.4 
CH3CN/CH3OH/ 
(20mM NH4OAc) 
= 70/30 
29 Diacetyl cysteine 
 
2.61 3.39 1.30 1.5 
ACN/MeOH/ 
NH4OAc 
=80/20/0.1 (v/v/w) 
1.85 2.54 1.37 3.5 
ACN/MeOH/TFA 
=95/5/0.1  
30 
FMOC-
phenylalanine 
 1.17 1.43 1.22 2.1 
CH3CN/CH3OH/ 
(10mM NH4OAc) 
= 70/30 
31 
2-Hydroxy-3-
(Boc-amino)-3-
phenylpropionic 
acid  
2.52 3.63 1.44 2.4 
ACN/MeOH/TFA 
=95/5/0.1  
32 Lorazepam 
 
0.86 1.53 1.80 5.8 
CH3CN/CH3OH/ 
(20mM NH4OAc) 
= 70/30 
33 Oxazepam 
 
0.85 1.42 1.66 5.4 
CH3CN/CH3OH/ 
(20mM NH4OAc) 
= 70/30 
34 
trans-1,2-
Cyclohexanediyl-
bis acrylamide 
NH
NH
O
O  
0.30 0.70 2.34 4.0 
ACN/MeOH 
70/30 
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Table 3. Chromatographic data for the normal-phase mode with halogenated solvent and 
other mobile phases resolution of racemic compounds on (R,R)-P-CAP column1 
# Compounds Structure '1k  '2k  α Rs Mobile Phase2 
0.95 1.65 1.74 3.40 Acetone 
1 1,1’-Bi-2-naphthol 
OH
HO
 
1.47 2.39 1.63 3.85 CH2Cl2/MeOH =95/5 
2 Hydrobenzoin 
OH
OH
 
2.94 3.41 1.16 1.48 CH2Cl2/MeOH =99/1 
3 Indapamide 
N
CH3
HN
O
Cl
S
O
O NH2 
4.19 4.33 1.03 0.49 CH2Cl2/MeOH =95/5 
4 
3-(alpha-acetonyl-4-
chlorobenzyl)-4-
hydroxy coumarin 
 
0.77 0.83 1.08 0.68 CH2Cl2/MeOH =95/5 
5 
1,5-Dihydroxy-
1,2,3,4-tetrahydro-
naphthalene 
OH
OH  
7.03 8.17 1.16 1.84 CH2Cl2/MeOH/TFA  98/2/0.1 
6 Mephenesin H3C
O OH
OH
 
3.85 4.15 1.08 0.67 CH2Cl2/MeOH 9=8/2 
7 Mandelamide NH2
OH
O
 
3.60 4.15 1.15 1.93 CH2Cl2/MeOH 95/5 
8 5-Methyl-5-phenylhydantoin NH
NH
O
O
H3C
 
5.70 5.91 1.04 0.74 CH2Cl2/MeOH 95/5 
                                                          
1 (R,R)-P-CAP was bonded to 5μm silica gel and the stationary phase was packed in a 250×4.6 mm (i.d.) 
stainless steel column. 
 
2 All samples were analyzed under the chromatographic condition: a UV detector at 254nm, flow rate 1ml/min, 
unless otherwise noted.  All mobile phase ratios were volume to volume.  TEAA: triethylamino acetate. 
 
O O
OH
Cl
O
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Table 3. (continued) 
# Compounds Structure '1k  '2k  α Rs Mobile Phase 
9 
3a,4,5,6-
Tetrahydrosuccinimi
do[3,4-
b]acenaphthen-10-
one 
NH
O O
O
 
5.00 5.27 1.06 0.46 CH2Cl2/MeOH 99/1 
10 
(3a[R,S]-cis) -
3,3a,8,8a-Tetrahydro-
2H-indeno[1,2-
d]oxazol-2-one 
O
NH O
 
4.18 4.73 1.13 1.45 CH2Cl2/MeOH 99/1(v/v) 
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Table 4. Effect of acid additives on selectivity and resolution for the polar organic mode 
enantiomeric separations on (S,S)-P-CAP column 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure k1 α Rs Mobile Phase 
5.00 1.38 2.0 CH3CN/CH3OH = 90/10 
5.11 1.37 2.1 CH3CN/CH3OH/HOAc = 90/10/0.1 
NH
Cl
S
NH2
O
O
HO
O  
5.02 1.38 2.5 CH3CN/CH3OH/TFA = 90/10/0.1 
No elution CH3CN/CH3OH = 95/5 
2.33 1.11 1.0 CH3CN/CH3OH/HOAc= 95/5/0.1 
 
S
O
CH3
F OH
O
 
2.16 1.12 1.0 CH3CN/CH3OH/TFA = 95/5/0.1 
No elution CH3CN/CH3OH = 95/5 
No elution CH3CN/CH3OH/HOAc = 95/5/0.1 
O
O
OH
O
O
O
HO
O
 
9.26 1.10 1.0 CH3CN/CH3OH/TFA = 95/5/0.1 
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Table 5. Effect of flow rate on selectivity and resolution for the nomal-phase enantiomeric 
separations of fipronil on (R,R)-P-CAP column1 
Compound Flow rate (ml/min) 
'
1k  '2k  Selectivity (α) 
Resolution 
( SR ) 
0.5 2.35 2.87 1.22 1.71 
1.0 2.30 2.80 1.22 1.57 
1.5 2.27 2.76 1.22 1.46 
N
N
CF3Cl
Cl
H2N
S
F3C
O
NC  
2.0 2.24 2.73 1.22 1.40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
1 The mobile used to enantioseparate fipronil consisted of heptane/ethanol/TFA 80/20/0.1.  The sample was 
analyzed with a UV detector at 254nm. 
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Table 6. Efficiency comparison of enantioseparation of 1.1’-bi-2-naphthol in the traditional 
normal-phase mode, polar organic mode and the normal phase mode with halogenated 
solvent system on (R,R)-P-CAP column1 
Mobile Phase 
Enantioselectivity 
(α) 
Enantioresolution 
( SR ) 
Number of Theoretical Plates2 
(N)  
The traditonal normal-phase 
mode  (heptane/EtOH/TFA 
30/70/0.1) 
1.32 1.86 1704 
Polar organic mode 
(acetonitrile/MeOH/TFA 
95/5/0.1) 
1.36 3.43 3552 
The normal-phase with 
halogenated solvent system 
(methylene chloride/MeOH 
95/5). 
1.54 4.03 6042 
 
 
 
 
 
 
 
 
 
                                                          
1 The sample was analyzed at the flow rate of 1ml/min, with a UV detector at 254nm under room temperature 
(~23oC). 
2 Theoretical plates (N) are based on the second eluted enantiomer. 
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Silica 
Gel
Si O Si NH
O
NH
CN
O
NH
O
NH
O
NH
O
NH
O
NH
O
NH
O
NH
O
NH
O
NH
O
 
 
Fig. 1. The structure of (R,R)-P-CAP chiral stationary phase 
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(A) 1,1’-Bi-2-naphthol 
 
(B) Fipronil 
Fig. 2. Normal-phase retention behavior of the first and second eluted enantiomers of (A) 
1,1’-bi-2-naphthol, and (B) fipronil as a function of mobile phase composition.  The mobile 
phases consisted of various ratios of ethanol and heptane.  The column was a 250×4.6 mm 
(i.d) (R,R)-P-CAP CSP (5-μm silica gel support).  Flow rate: 1.0 mL/min at ambient 
temperature (~23oC).  Detection: UV at 254nm. 
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Fig. 3. Polar organic phase retention factor '1k  of the first eluted enantiomer, selectivity factor 
α, and resolution SR of 1,1’-bi-2-naphthol as a function of mobile phase composition.  The 
mobile phases consisted of various ratios of methanol and acetonitrile.  The column was a 
250×4.6 mm (i.d) (S,S)-P-CAP CSP (5-μm silica gel support).  Flow rate: 1.0 mL/min at 
ambient temperature (~23oC).  Detection: UV at 254 nm. 
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Fig. 4. Resolution of (R,R)- and (S,S)-hydrobenzoin on (R,R)-P-CAP in the normal phase: (A) 
heptane/2-propanol/trifluoroacetic acid 80/20/0.1 (v/v/v); (B) heptane/2-propanol 80/20 (v/v); 
(C) heptane/EtOH/trifluoroacetic acid 80/20/0.1 (v/v/v). (D) heptane/EtOH/trifluoroacetic 
acid 90/10/0.1 (v/v/v).  Flow rate: 1.0 mL/min; UV detection at 254 nm, T=23oC. 
 
 
 
 
 
 
(B) 
(A) 
(D) 
(C) 
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Fig. 5. Sample loading capacity test for the separation of 1,1’-bi-2-naphthol on (R,R)-P-CAP 
column.  Sample loading (A) 1000 μg; (B) 1 μg.  (R,R)-P-CAP was bonded to 5 μm silica gel 
and the stationary phase was packed in a 250×4.6 mm (i.d.) stainless steel column.  Mobile 
phase: EtOH/heptane 50/50; flow rate: 1mL/min; detection: UV at 254 nm; temperature: ~23 
oC. 
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Fig. 6. Reversal of elution order on (A) (R,R)-P-CAP and (B) (S,S)-P-CAP columns under 
the normal phase.  Peak 1 is (R,R)-hydrobenzoin and Peak 2 is (S,S)-hydrobenzoin with the 
mole ratio of (R,R):(S,S) = 2:1.  Mobile phase: heptane/2-propanol/TFA 80/20/0.1 (v/v/v); 
flow rate: 1 mL/min; UV detection at 254nm; T=23 oC. 
 
 
 
 
 
 
 
 
(B) 
(A) 
1 
2 
2 
1 
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(A) (R,R)-P-CAP 
 
 
 
 
 
 
 
 
(B) (S,S)-P-CAP 
Fig. 7. Reverse elution order on (A) (R,R)-P-CAP and (B) (S,S)-P-CAP CSPs under polar 
organic phase.  Samples are racemic mixture of (R,R) and (S,S) DACH-ACR.  Mobile phase: 
CH3CN/MeOH 97/3(v/v).  Flow Rate: 1.0 mL/min.  Detection: UV at 254 nm.  Temperature: 
23 °C. 
 
 4.392
6.12
(R,R)
(S,S) 
 4.416
(R,R)
 3.935 
4.939 
 4.949 
(S,S) (R,R) (R,R) 
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Chapter 6. Synthesis and evaluation of a synthetic polymeric chiral 
stationary phase for HPLC based on the N, N’-[(1R,2R)-1,2-diphenyl-1,2-
ethanediyl]bis-2-propenamide monomer 
A paper published in Chromatographia1  
X. Han, L. He, Q. Zhong, T. E. Beesley, D. W. Armstrong 
Abstract 
A synthetic polymeric chiral stationary phase for liquid chromatography based on N,N’-
[(1R,2R)-1,2-diphenyl-1,2-ethanediyl]bis-2-propenamide monomer was prepared via a 
simple solution initiated radical polymerization. This stable chiral stationary phase showed 
enantioselectivities for a large number of racemates in polar organic and normal phase modes 
and high sample loading ability. However, none of the generated data has been optimized in 
terms of column performance. Different enantioselectivities were observed on this new chiral 
stationary phase compared with the commercial polymeric chiral stationary phase based on 
N-(2-acryloylamino-(1R,2R)-cyclohexyl)-acrylamine monomer. Consequently, these two 
chiral stationary phases are considered complementary to one another. Furthermore they 
utilize the same mobile phase and optimization procedures. This polymeric chiral stationary 
phase appears to be useful for preparative separation since high amount of analyte can be 
injected without loosing enantioselectivity. 
Keywords: Column liquid chromatography, Chiral stationary phase (CSP), Poly-DPEDA, 
Enantioselectivity 
6.1. Introduction 
In the past two decades, research on chiral stationary phase for HPLC has advanced 
greatly [1-4]. Currently, more than 100 chiral stationary phases (CSPs) have been 
commercialized [2]. Of all the chiral stationary phases, polymeric ones (except for those 
based on proteins) appear to be the most suitable for preparative separations due to their 
potential for high sample loading. There are two classes of polymeric stationary phases. One 
of them uses natural polymers such as polysaccharide derivatives and proteins as chiral 
                                                          
1 Reprinted with permission of Chromatographia, 2006, 63, 13-23. Copyright © 2006 Frider. Vieweg & 
Sohn/GWV Fachverlage GmbH. All rights reserved. 
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selectors. The other group employs synthetic polymers such as polyamides, vinyl polymers, 
polyurethanes, and polyacetylene as chiral selectors [4]. Cellulose and amylose carbamate 
CSPs have been widely used for the preparative and analytical separations of racemates due 
to their broad enantiomeric selectivity as well as their high sample loading capacity [4-5]. 
Until recently, research on synthetic polymeric CSPs has not produced anything of 
comparable success [4]. However, the attractive characteristics of synthetic polymeric CSPs 
remain in the richness of the chemical structures of potential chiral selectors, the ease of 
chemical modification of the chiral selectors, and the possibility of obtaining polymeric CSPs 
with opposite absolute configuration. In addition, the covalent bonding of the chiral polymers 
to the supporting material increases the stability of these CSPs and they are amenable for 
preparative separations. 
By copolymerization of chiral acrylamides with ethylene diacrylate as cross-linking 
agent, Blaschke and his co-workers prepared polymeric beads as CSPs [6-8]. These CSPs 
were not stable to high pressure and were only used for preparative purposes. This problem 
was circumvented through copolymerization of chiral acrylamide with methacryloyl silica 
gel [9]. Using a similar method, Lange and co-workers made another group of polymeric 
CSPs with monomers, which had amino acid and (-)-menthone or (+)-menthol units [10]. 
Few enantiomeric separations were reported on these polymeric CSPs [6-10]. Okamoto 
prepared a chiral polymer with a helical secondary structure, which was formed from a 
nonchiral monomer TrMA (triphenylmethyl methacrylate) via the asymmetric catalyzed 
anionic polymerization [11]. This polymer can be either coated [4,11] or bonded [4] to silica 
gel as CSP for HPLC. These CSPs showed enantiomeric selectivities for a number of 
racemates [4]. Saigo and his coworkers made a chiral polymer through the reaction of (-)-
1,2-diphenylethylenediamine and diacid chlorides at low temperature and coated this 
polymer on silica gel to obtain a chiral stationary phase [12]. However, marginal separations 
of very few racemates were reported. 
Recently, a new synthetic polymeric chiral stationary phase was developed by 
Gasparrini and co-workers and commercialized as the P-CAP column by Advanced 
Separation Technologies Inc [13-15]. More than 60 separations of racemates with various 
structures were reported on this CSP. The P-CAP CSP also showed high stability, high 
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sample loading and the ability to be used in multiple mobile phase types. Since the P-CAP 
CSP has no aromatic units, a polymeric CSP with such groups will show different 
enantioselectivities and thus be a complementary CSP. Trans-1,2-diphenylethylenediamine 
(DPEDA), a molecule with two phenyl units, has been used successfully in π-complex brush-
type CSPs [16-18]. While it has been suggested that DPEDA can be used as the basis for a 
polymeric CSP [15], it has not yet been demonstrated to our knowledge. In this paper, a 
synthetic polymeric chiral stationary phase based on the N,N’-[(1R,2R)-1,2-diphenyl-1,2-
ethanediyl]bis-2-propenamide is reported. Synthesis, chromatographic properties, 
complementarity of the normal phase and polar organic modes, and a comparison with the 
related P-CAP CSP are presented and discussed. 
6.2. Experimental 
6.2.1. Materials 
Spherical silica gel (particle diameter: 5 μm, pore size: 200 Å, surface area: 213 m2/g) 
was purchased from Akzo Nobel, EKA Chemicals AB, Bohus, Sweden. Acryloyl chloride, 
(1R,2R)-(+)-diphenylethylenediamine, 3-(trimethoxysilyl)propyl methacrylate, 
diisopropylethylamine, 2,2’-azobis(isobutyronitrile) (AIBN), anhydrous toluene, chloroform, 
acetone, and trifluoroacetic acid (TFA) were purchased from Aldrich. HPLC grade methanol, 
ethanol, acetonitrile, 2-propanol, hexane, and n-heptane were purchased from Fisher, 
Fairlawn, NJ. 
6.2.2. Synthesis 
Preparation of N,N’-[(1R,2R)-1,2-diphenyl-1,2-ethanediyl]bis-2-propenamide (DPEDA-
ACR) (1) 
(1R,2R)-(+)-diphenylethylenediamine (1.0g, 4.71mmol) and triethylamine (1.4 mL, 
10.95 mmol) were dissolved in 20 mL anhydrous chloroform. Anhydrous chloroform (10 
mL) solution of acryloyl chloride (0.8 ml, 9.85 mmol) was added dropwise into the above 
solution at 0 ºC under stirring and the reaction was kept at 0 ºC for 12 h. The precipitate was 
collected by filtration, washed with chloroform (3 x 10 mL) to get white solid 0.74 g. The 
filtrate was dried and the solid was crystallized with chloroform/ether. The precipitate was 
collected and dissolved in acetone. The acetone solution was filtered through a silica gel 
column to obtain 0.45 g white solid. The combined product was dried under vacuum at 25 ºC 
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over night to obtain 1.13 g white solid (yield: 75%). 1H NMR (300 MHz, DMSO-d6): δ 8.74 
(d, J = 8.4 Hz, 2H), 7.18-7.07 (m, 10H), 6.25 (dd, J1 = 17.1 Hz, J2 = 10.2 Hz, 2H), 6.02 (dd, 
J1 = 17.1 Hz, J2 = 2.1 Hz, 2H), 5.57 (dd, J1 = 10.2 Hz, J2 = 2.1 Hz, 2H), 5.25 (dd, J1 = 8.4 
Hz, J2 = 6.6 Hz, 1H), 5.22 (dd, J1 = 8.4 Hz, J2 = 6.6 Hz, 1H). 13C NMR (75 MHz, DMSO-d6) 
Preparation of methacryl silica gel 
Silica gel (8 g) and anhydrous toluene (180 mL) were added into a 500 mL round bottom 
flask with a Dean-Stark trap and a condenser. After removing 25 mL of distillate under 
reflux, the mixture was cooled down to the room temperature. 3-(trimethoxysilyl)propyl 
methacrylate (2 mL, 8.42 mmol) was added into the reaction medium and the reaction 
medium was refluxed for 4 h. The modified silic gel was collected by filtration, washed with 
100 mL acetone, methanol, acetone, respectively. The methacryl silica gel was dried under 
vacuum at 25 ºC overnight and screened with 53 μm sieve and bottle to obtain 8.3 g. Loading: 
3.8%. Elemental Analysis: C, 2.20%; H, 0.53%. 
Preparation of poly-DPEDA CSP 
Methacryl silica gel (3.41 g) was suspended in 70 mL anhydrous toluene in 250 mL 3-
neck flask with a Dean-Stark trap and a condenser. After removing 10 mL of distillate, the 
reaction mixture was cooled down to room temperature and saturated with nitrogen. 
DPEDA-ACR (0.707g, 2.207 mmol) and AIBN (22 mg, 0.134 mmol) were put into the 
suspension under nitrogen protection. The suspension was kept at 80 ºC for 4 h and refluxed 
for 1 h. The CSP was collected by filtration, washed with 100 mL of ethanol, acetone, 
methanol, and chloroform respectively. The CSP was dried under vacuum at 50 ºC over night 
and screened with 53 μm sieve and bottle to obtain 3.82 g. Loading: 12%. Elemental 
Analysis: C, 10.49%; H, 1.36%; N, 1.03%. The CSP was packed into a 250 mm x 4.6 mm (i. 
d.) stainless steel column. 
6.2.3. Equipment  
Chromatographic separations were carried out using a HP 1050 HPLC system with an 
auto sampler, a UV VWD detector, and computer controlled Chem-station data processing 
software (Agilent Technologies, Palo Alto, CA, USA). The mobile phases were degassed 
under helium for 10 min. UV detection was carried out at 254 nm for all analytes. All 
separations were carried out at room temperature (~ 23˚C) and the flow rate of the mobile 
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phase for all separations was 1.0 mL min-1. 
6.2.4. Column Evaluation 
The performance of poly-DPEDA chiral stationary phase was evaluated in the polar 
organic mode using acetonitrile/methanol and in the normal phase mode using 2-
propanol/heptane, ethanol/heptane, or ethanol/hexane mobile phase. Before using a new 
mobile phase, ten column volumes of new mobile phase were pumped through the column 
prior to the injection of the analyte. 
6.2.5. Calculations 
The dead time (t0) was estimated using the peak resulting from the change in refractive 
index from the injection solvent on the poly-DPEDA CSP. The retention factor (k) was 
calculated using the equation k = (tr-t0) / t0. The enantioselectivity (α) was calculated using α 
= k2 / k1. The resolution factor (RS) was calculated using the equation RS = 2 x (tr2-tr1) / 
(w1+w2), where tr2 and tr1 are the retention times of the second and first enantiomers, 
respectively, and w1 and w2 are the corresponding base peak widths. The efficiency (number 
of theoretical plates, N) was calculated using N = 16(tr/w)2. 
6.3. Results and Discussion 
6.3.1. Preparation of poly-DPEDA CSP 
The procedure of preparation of the new CSP is shown in Fig. 1 (see Experimental). The 
optically active polymers were grafted to the surface of the modified silica gel through 
reaction with the acryloyl group on the surface of the support. Unattached polymers in the 
solution can be removed by washing the CSP with various solvents. A 12% loading of the 
chiral selector was obtained. 
6.3.2. Chromatographic performance of poly-DPEDA CSP 
Two mobile phase modes were evaluated on this new polymeric chiral stationary phase. 
The normal phase mode is composed of nonpolar solvents such as heptane or hexane and 
polar modifiers such as ethanol or isopropanol. The polar organic mode is composed of 
acetonitrile and methanol, typically with a small amount of trifluoroacetic acid. Tables 1 and 
2 list the enantiomeric separations observed on this CSP in the normal phase mode and polar 
organic mode, respectively. It should be noted that these results were obtained on a column 
in which the packing has not been optimized. Such optimization would be expected to 
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produce even more efficient separations, which would further improve resolution. In the 
normal phase mode, enantiomeric separations of 42 racemic compounds were observed and 
13 of them are baseline separations. Thirty-four racemic analytes were separated in the polar 
organic mode and 15 baseline separations were obtained. Combined the two mobile phase 
modes, 56 chiral compounds were separated and 25 baseline separations were achieved (Fig. 
2). 
Since the polymeric chiral selector was covalently grafted to the solid support (silica 
gel), the new polymeric CSP shows high stability. No degradation of stationary phase or 
change in the enantiomeric separation performance was observed after more than 1000 
injections and several mobile phase mode changes. 
6.3.3. Complementary nature of the two mobile phase modes 
The polar organic mode and nomal phase mode are complementary to one another for 
the poly-DPEDA chiral stationary phase. Fourteen of the racemic analytes separated in the 
polar organic mode cannot be separated in the normal phase mode. Similarly, 22 racemic 
compounds can only be separated in the normal phase mode. For compounds that can be 
separated in both the polar organic mode and normal phase mode, different 
enantioselectivities and resolutions were observed. For example, compound 17 can be 
baseline separated in the polar organic mode, while in the normal phase mode, only a partial 
separation was obtained (Fig. 3). Part of the contribution to the better separation in the polar 
organic mode for compound 17 was the increase in the enantioselectivity (α = 1.50 vs. α = 
1.41), while the most contribution is from the increase in efficiency (theoretical plate number 
of the first peak (N1) in the polar organic mode is 2500, while N1 is just 310 in the normal 
phase mode). On the contrary, for analyte 3, a better separation was observed in the normal 
phase mode, although higher enantioselectivities were obtained in the polar organic mode 
(Table 1 and 2). The reason is that the retention of compound 3 is so low in the polar organic 
mode even under the weakest mobile phase condition (100% acetonitrile) that there is not 
enough retention for a satisfactory enantiomeric separation to be achieved. 
6.3.4. Comparison with the P-CAP CSP 
The poly-DPEDA column showed different enantioselectivities as opposed to the P-
CAP column (i.e., the comparable polymeric column that utilized the trans-1,2-
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diaminocyclohexane chiral selectors) in both mobile phase modes. For the 42 separated 
racemates found in the normal phase mode on the poly-DPEDA column, 19 racemates can 
only be separated on the poly-DPEDA column, but not on the P-CAP column. Different 
selectivities were also observed for the analytes that can be separated on both CSPs. For 
example, compound 19 can be baseline separated on the poly-DPEDA CSP, while just a 
slightly split peak can be obtained for the same compound on the P-CAP column (Fig. 4a, 
4b). In the polar organic mode, 18 of the separated analytes in this work have not been 
reported on the P-CAP CSP. Conversely, a much better enantiomeric selectivity was 
observed on the P-CAP column for compound 4 (Fig. 4c, 4d). Combining the two mobile 
phase modes, 20 new separations of racemates were obtained on this column compared with 
the analogous P-CAP column. In this respect, these two CSPs appear to be complementary to 
each other. 
6.3.5. Sample loading study 
 The poly-DPEDA chiral stationary phase showed high sample loading capacity. For the 
enantiomeric separations of fipronil (compound 35), excellent separation of 7.5 μg of analyte 
(Fig. 5a) and satisfactory separation of 500 μg of racemate (Fig. 5b) were obtained on an 
analytical column. Another example is the separation of fuoroin (compound 19). Almost 
baseline separation was achieved for 1000 μg analyte on the same column (Fig. 5d). Thus, 
this column has the potential to be a good preparative LC column, which is one of the 
strengths of this class of CSPs. 
6.4. Conclusions 
A simple solution initiated radical polymeric reaction was used to produce a new 
polymeric chiral stationary phase based on N,N’-[(1R,2R)-1,2-diphenyl-1,2-ethanediyl] bis-
2-propenamide. This CSP showed high sample loading capacity and enantioselctivities for a 
large variety of racemic compounds. The CSP can be used in the polar organic and normal 
phase modes with no degradation of stationary phase observed. Different enantiomeric 
selectivities and resolutions were obtained on this new CSP for the polar organic mode and 
normal phase mode. The new poly-DPEDA column showed different enantiomeric 
selectivities as opposed with the commercialized P-CAP column, thus it is complementary to 
the P-CAP column. High loading capacity is possible on this new CSP. 
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Table 1. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(Rs) of separated racemates on the poly-DPEDA column in the normal phase mode 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
1 O-Acetyl-mandelic acid 
O
OH
O
O
 
1.43 1.16 1.0 HEP/IPA/TFA = 80/20/0.1 
2 Atrolactic acid 
OH
OH
O
 
3.03 1.17 1.2 HEP/IPA/TFA = 80/20/0.1 
3 
Benzyl-6-oxo-2,3- 
diphenyl-4-morpholine 
carboxylate 
O
O
N
O
Ph
Ph
O  
4.19 1.38 1.5 HEP/IPA = 80/20 
4 1, 1’-Bi-2-naphthol OHHO
 
6.39 1.24 1.0 HEP/IPA = 80/20 
5 1-Benzocyclobutene- carbonitrile 
CN
 
2.36 1.05 0.4 HEP/IPA = 98/2 
6 3-(benzyloxycarbonyl)-4-oxazolidinecarboxylic acid 
O
O
N
O
COOH
 
2.83 1.17 0.7 HEP/IPA = 80/20 
7 
6-(4-Chlorophenyl)-4,5- 
dihydro-2-(2-hydroxybutyl)- 
3(2H)-pyridazinone 
N
NO
OH
Cl 
2.87 1.23 1.1 HEP/IPA = 80/20 
8 2-[3-Chlorophenoxy]- propionamide 
Cl
O
CONH2
CH3
 
2.48 1.19 1.5 HEP/IPA = 80/20 
9 p-Chloromandelic acid 
Cl
OH
OH
O  
4.85 1.11 0.7 HEP/IPA/TFA = 80/20/0.1 
10 α-Ethoxycarbonyl-γ- phenyl-γ-butyrolactone 
OPh O
O
OEt
 
2.56 1.35 1.5 HEP/IPA = 80/20 
11 1,5-dihydroxy-1,2,3,4- tetrahydronaphthalene 
OH
OH
 
2.68 1.21 1.5 HEP/IPA = 80/20 
12 N-(3,5-Dinitrobenzoyl)- phenylglycine 
O2N
O2N
O
NH
OH
O
Ph  
11.4 1.32 0.8 HEP/IPA/TFA = 70/30/0.1 
13 
2,3-dihydroxy-N, N'- 
bis(phenylmethyl)- 
butanediamide 
Ph N
N Ph
O
OH
OH
O
H
H
 
4.47 2.28 1.7 HEP/IPA/TFA = 70/30/0.1 
14 cis-4,5-Diphenyl-2- oxazolidinone 
O
NH
Ph
Ph O 
7.97 1.07 0.3 HEP/IPA = 80/20 
15 1,5-Dimethyl-4-phenyl-2- imidazolidinone N
NH
Ph
Me O
Me  
4.18 1.16 1.2 HEP/IPA/TFA = 80/20/0.1 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
16 2,3-Dibenzoyl- tartaric acid 
O
O
OH
O
O
OH
O
O  
4.69 1.11 0.3 HEP/IPA/TFA = 80/20/0.1 
17 N-(3,5-Dinitrobenzoyl)- leucine 
O2N
O2N
O
NH
OH
O
 
4.35 1.41 1.3 HEP/IPA/TFA = 70/30/0.1 
18 5,5-Dimethyl-4-phenyl-2- oxazolidinone 
O NH
Ph
O
 
4.72 1.09 0.4 HEP/IPA/TFA = 80/20/0.1 
19 Furoin O
OH
O
O  
5.29 1.69 3.7 HEP/IPA/TFA = 80/20/0.1 
20 Ftorafur N
NH
O
F
O
O
 
11.8 1.08 0.3 HEP/IPA/TFA = 70/30/0.1 
21 3-(4-Hydroxyphenyl)- lactic acid 
HO
COOH
HO  
9.12 1.17 0.8 HEP/IPA/TFA = 70/30/0.1 
22 5-Methyl-5-phenyl- hydantoin 
NH
HN
O
O
 
7.76 1.16 0.7 HEP/IPA = 70/30 
23 Mandelamide NH2
O
OH  
5.11 1.07 0.4 HEP/IPA = 70/30 
24 Mephenesin 
O
OH
OH
 
2.23 1.07 0.4 HEP/IPA = 80/20 
25 Hydrobenzoin 
OH
HO  
1.02 1.26 1.5 HEP/IPA = 70/30 
26 Sulindac 
S
O
CH3
F OH
O
 
2.93 1.10 1.0 HEP/IPA = 70/30 
27 
cis-3,3a,8,8a- 
Tetrahydro-2H-indeno[1,2-
d]oxazol-2-one 
NH
O O
 
5.03 1.31 1.3 HEP/IPA = 70/30 
28 1,2,3,4-Tetrahydro-1- naphthol 
OH
 
1.25 1.05 0.5 HEP/EtOH = 95/5 
29 1-(9-Anthryl)-2,2,2- trifluoroethanol 
CF3HO
 
3.53 1.06 0.9 HEP/EtOH = 95/5 
30 
Dihydro-5- 
[(triphenylmethoxy)methyl]-
2(3H)-Furanone O
OO
Ph3C  
3.81 1.17 1.5 HEP/EtOH = 95/5 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
31 5-(α-phenethyl)- semioxamazide 
N
O
NHNH2
O
H
 
5.18 1.11 0.8 HEP/EtOH = 70/30 
32 Omeprazole 
N
NH
S
O
N
O
O
 
1.90 1.14 0.9 HEP/EtOH = 70/30 
33 Lactamide 
OH
O
NH2
 
5.94 1.08 1.1 HEP/EtOH = 90/10 
34 Benzoin 
O
OH  
1.93 1.25 1.9 HEX/EtOH = 90/10 
35 Fipronil 
CF3Cl
Cl
N
N
H2N
NC
S
F3C
O
 
3.72 1.46 2.1 HEP/IPA = 90/10 
36 Mandelic acid 
OH
OH
O  
1.73 1.22 1.5 HEX/EtOH = 90/10 
37 Methyl mandelate 
OH
OMe
O  
1.68 1.21 1.5 HEX/EtOH = 90/10 
38 Mandelic benzylate 
OH
OCH2Ph
O  
1.69 1.21 1.5 HEX/EtOH = 90/10 
39 β-Phenyllactic acid COOH
HO  
1.13 1.36 1.3 HEX/EtOH = 90/10 
40 Phensuximide 
N
Me
OO
Ph  
2.32 1.10 1.2 HEX/EtOH = 90/10 
41 Methyl phenylsulfoxide S
O
 
3.15 1.03 0.7 HEX/EtOH = 90/10 
42 5-(4-methylphenyl)-5- phenyl-hydantoin N
NO
O
Ph MeH
H  
5.60 1.08 0.8 HEX/EtOH = 70/30 
 
a HEP: n-heptane, HEX: hexane, IPA: 2-propanol, EtOH: ethanol, TFA: trifluoroacetic acid.  
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Table 2. Retention factor of the first peak (k1), enantioselectivity (α), and enantioresolution 
(Rs) of separated racemates on the poly-DPEDA column in the polar organic mode 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
2 Atrolactic acid 
OH
OH
O
 
1.34 1.15 0.8 ACN/MeOH/TFA = 99/1/0.1 
3 Benzyl-6-oxo-2, 3-diphenyl-4-morpholine carboxylate 
O
O
N
O
Ph
Ph
O  
0.07 1.57 0.4 ACN/TFA =100/0.1 
4 1, 1’-Bi-2-naphthol OHHO
 
0.61 1.11 0.5 ACN/TFA =100/0.1 
6 3-(benzyloxycarbonyl)-4- oxazolidinecarboxylic acid 
O
O
N
O
COOH
 
0.59 1.25 1.5 ACN/TFA =100/0.1 
8 2-[3-Chlorophenoxy]- propionamide 
Cl
O
CONH2
CH3
 
0.48 1.27 1.5 ACN 
11 1,5-dihydroxy-1,2,3,4- tetrahydronaphthalene 
OH
OH
 
0.56 1.12 0.4 ACN/MeOH/TFA = 99/1/0.1 
12 N-(3,5-Dinitrobenzoyl)- phenylglycine 
O2N
O2N
O
NH
OH
O
Ph  
1.34 1.52 2.0 ACN/MeOH/TFA =99/1/0.1 
13 
2,3-dihydroxy-N, N'- 
bis(phenylmethyl)- 
butanediamide 
Ph N
N Ph
O
OH
OH
O
H
H
 
1.20 1.69 2.7 ACN/MeOH/TFA =99/1/0.1 
14 cis-4,5-Diphenyl-2- oxazolidinone 
O
NH
Ph
Ph O 
0.48 1.12 0.6 ACN/TFA =100/0.1 
15 1,5-Dimethyl-4-phenyl-2- imidazolidinone N
NH
Ph
Me O
Me  
1.72 1.13 1.2 ACN/MeOH/TFA =99/1/0.1 
17 N-(3,5-Dinitrobenzoyl)- leucine 
O2N
O2N
O
NH
OH
O
 
1.24 1.50 2.8 ACN/TFA=100/0.1 
18 5,5-Dimethyl-4-phenyl-2- oxazolidinone 
O NH
Ph
O
 
0.49 1.16 0.8 ACN/TFA =100/0.1 
19 Furoin O
OH
O
O  
0.16 1.44 1.0 ACN/TFA =100/0.1 
20 Ftorafur N
NH
O
F
O
O
 
0.89 1.15 0.9 ACN/TFA =100/0.1 
23 Mandelamide NH2
O
OH  
1.31 1.05 0.5 ACN/TFA =100/0.1 
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Table 2. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
24 Mephenesin 
O
OH
OH
 
0.57 1.05 0.3 ACN/TFA =100/0.1 
25 Hydrobenzoin 
OH
HO  
0.45 1.28 1.5 ACN 
26 Sulindac 
S
O
CH3
F OH
O
 
3.38 1.12 1.1 ACN/TFA =100/0.1 
27 cis-3,3a,8,8a-Tetrahydro-2H-indeno[1,2-d]oxazol-2-one 
NH
O O
 
0.76 1.47 2.3 ACN/TFA =100/0.1 
31 5-(α-phenethyl)- semioxamazide 
N
O
NHNH2
O
H
 
1.00 1.17 1.0 ACN/MeOH =99/1 
43 Althiazide 
H
O O
S
NH
NCl
S
O
O
H2N
S
 
0.76 1.50 1.5 ACN/MeOH/TFA =99/1/0.1 
44 N, N’-Bis(α-methylbenzyl)- sulfamide 
N S
N
O
O
H
H
 
0.21 1.71 1.5 ACN/TFA =100/0.1 
45 Bendroflumethiazide 
S
NH
NF3C
S
O
O
H2N
H
O O
 
0.53 1.40 1.4 ACN/TFA =100/0.1 
46 4-Benzyl-2-oxazolidinone 
OHN
O
 
0.48 1.12 0.6 ACN/TFA =100/0.1 
47 4-Benzyl-5,5-dimethyl-2- oxazolidinone 
OHN
O
 
0.46 1.28 1.4 ACN/TFA =100/0.1 
48 Chlorthalidone NH
HO
Cl
S NH2
O
O
O
 
3.57 1.36 1.5 ACN/MeOH/TFA =99/1/0.1 
49 4-(Diphenylmethyl)- 2-oxazolidinone 
O
NH
O 
0.41 1.36 1.5 ACN/MeOH/TFA =99/1/0.1 
50 3,4-dihydroxyphenyl-α- propylacetamide 
OH
OH
O
NH2
 
3.78 1.10 0.6 ACN/MeOH/TFA =99/1/0.1 
51 
7,8-benzo-1,3-
diazaspiro[4,5]decane-2,4-
dione 
NH
NHO
O
 
3.09 1.23 1.5 ACN/TFA =100/0.1 
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Table 2. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
52 Phenylsuccinic anhydride 
O O
O
 
4.05 1.67 3.0 ACN/TFA =100/0.1 
53 
Trans-N,N'-1,2- 
cyclohexanediylbis- 
2-Propenamide 
N
N
O
O
H
H  
0.72 1.56 1.7 ACN/MeOH = 95/5 
54 Oxazepam 
N
N
Cl
O
OH
Ph
H
 
3.21 2.31 4.5 ACN/MeOH = 95/5 
55 Dioxibrassinin 
N
O
HO
N
SMe
S
H
H
 
1.54 1.30 1.4 ACN/MeOH/TFA = 95/5/0.1 
56 FMOC-Phenylalanine 
HN
OH
O
O
O
 
0.92 1.26 1.0 ACN/MeOH/NH4OAc=85/15/10mM 
a ACN: acetonitrile, MeOH: methanol, TFA: trifluoroacetic acid. 
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Poly-DPEDA CSP
 Si OH
Si OH
 
H3CO Si
H3CO
H3CO
O
O
 
Si O
Si O
Si
Si
O
O
O
O
NH
NH
O
O
AIBN
 
Fig. 1. Synthesis of the poly-DPEDA chiral stationary phase. 
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Fig. 2. Summary of the number of partial and baseline separations achieved on the poly-
DPEDA CSP. 
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Fig. 3. Comparison of the enantiomeric separation of compound 17 in the a) polar organic 
mode and b) normal phase mode. Mobile phase: a) ACN/TFA = 100/0.1, b) HEP/IPA/TFA = 
70/30/0.1. Enantioselectivity α: a) α = 1.50, b) α = 1.41. Resolution Rs: a) Rs = 2.8, b) Rs = 
1.3. Number of theoretical plates of the first peak N1: a) N1 = 2500, b) N1 = 310. 
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Fig. 4. Comparison of the enantiomeric separations of compound 20 (a), b)) and 4 (c), d)) on 
the poly DPEDA (a), c)) and P-CAP (b), d)) CSPs. Mobile phase: a) HEP/IPA/TFA = 
80/20/0.1, b) HEP/IPA/TFA = 50/50/0.1, c) ACN, d) ACN/MeOH = 95/5. Enantioselectivity 
α: a) α = 1.69, b) α = 1.04, c) α = 1.11, d) α = 1.42. 
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Fig. 5. The effect of sample loading on the separation of fipronil (compound 35) with a) 7.5 
μg and b) 500 μg of compound injected; and fuoroin (compound 19) with c) 12.5 μg and d) 
1000 μg of compound injected on the poly DPEDA CSP. Mobile phases: a) and b), HEP/IPA 
= 90/10. c) and d), HEP/IPA = 80/20. 
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Chpater 7. Preparation and evaluation of a new synthetic polymeric chiral 
stationary phase for HPLC based on the trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid bis-4-
vinylphenylamide monomer 
A paper published in Analytical and Bioanalytical Chemsitry1  
Xinxin Han, Chunlei Wang, Lingfeng He, Thomas E. Beesley,  
Daniel W. Armstrong 
Abstract 
A new synthetic polymeric chiral stationary phase for liquid chromatography was 
prepared via free radical initiated polymerization of trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid bis-4-vinylphenylamide. The new 
polymeric chiral stationary phase (CSP) showed enantioselectivities for many chiral 
compounds in multiple mobile phases. High stability and sample capacities were observed on 
this polymeric chiral stationary phase. Mobile phase components and additives affected 
chiral separation greatly. This new synthetic chiral stationary phase is complementary to two 
other related commercially available CSPs; the P-CAP and P-CAP-DP columns. Interactions 
between the chiral stationary phase and analytes that lead to retention and chiral recognition 
include hydrogen bonding, dipolar, and π-π interactions. Repulsive (steric) interactions also 
contribute to chiral recognition. 
Keywords: Chiral stationary phase (CSP) · Enantioselectivity · Polymeric CSP · Preparative 
chromatographic separation · Normal phase LC 
7.1. Introduction 
HPLC on chiral stationary phases (CSPs) continues to be the most powerful and 
versatile method for the separation of racemates in both analytical and preparative scales [1-
4]. More than 100 chiral stationary phases have been commercialized [2]. Based on the 
structure of the chiral selector, they can be divided into five classes: 1) polymeric, 2) 
macrocyclic, 3) π-π association, 4) ligand exchange, and 5) hybrid chiral stationary phases 
                                                          
1 Reprinted with permission of Analytical and Bioanalytical Chemistry, 2007, 387, 2681-2697. Copyright © 
2007 Springer-Verlag. All rights reserved. 
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[2]. In general, polymeric CSPs, with the exception of ones based on proteins, are highly 
suitable for preparative separation due to their high loading of chiral selector on the support 
and the fact a single bonded or adsorbed polymer molecule can interact with and separate 
several analyte molecules simultaneously along its length. The polymeric chiral selectors can 
be classified as two types by their origins [4]. One class uses natural polymers such as 
polysaccharides and proteins or their derivatives as chiral selectors; another class uses purely 
synthetic polymers as chiral selectors. Chiral stationary phases based on polysaccharide 
derivatives have been extensively used for the analytical and preparative separations of chiral 
molecules because of their broad enantioselectivities and high sample loading capacity [4-5]. 
Until recently, no synthetic polymeric CSP has achieved comparable success [4]. However, 
research on synthetic polymeric CSPs also is evolving due to a combination of attractive 
features such as: the richness of the possible chemical structures available, ease of their 
chemical modification, the possibility to obtain chiral selectors with opposite absolute 
configuration, and their high sample capacity [6-9]. 
At least four approaches have been used to make the synthetic polymeric CSPs. The 
first involved the co-polymerization of chiral monomers with an achiral cross-linking agent. 
Blaschke and his coworkers reported the first polymeric CSPs of this type [10-12]. The CSPs 
are polymeric beads prepared through copolymerization of chiral acrylamides or 
methacrylamides with ethylene diacrylate as the cross-linking agent. These CSPs could not 
be used under high pressure and were mainly useful for preparative purposes. A second 
approach used to prepare chiral polymers uses prochiral monomers via asymmetric catalyzed 
polymerization [4, 13]. “One-handed” helical polymers were prepared by Okamoto and co-
workers from prochiral monomers such as triphenylmethyl methacrylate (TrMA) and 
diphenyl-2-pyridylmethyl methacrylate (D2PymA) via asymmetric catalyzed anionic 
polymerization [4, 13-15]. These chiral active polymers were either coated or bonded to 
silica gel to form CSPs. The third approach used by Allenmark and co-workers involved the 
catalyzed copolymerization of chiral monomers with diallyl groups with multifunctional 
hydrosilane molecules to form network polymeric chiral selectors [16-18]. Derivatives of N, 
N’-diallyl-L-tartradiamide (DATD) [16] and derivatives of trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid [17-18] have been used as monomers. 
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These chiral selectors were then bonded to vinyl-functionalized silica gel to form CSPs. The 
separations of many compounds have been reported on these CSPs. The last approach 
involves the creation of a chiral linear homopolymer attached to the surface of a silica gel 
support. Polyacrylamide and polymethacrylamide CSPs with phenylalanine, 1-phenylethyl, 
1-cyclohexylethyl [19], penicillin [20], and menthone or menthol [21] moieties were reported. 
These CSPs just showed enantioselectivity for a few chiral molecules. Recently, two new 
synthetic polymeric CSPs of this type, based on trans-1,2-diaminocyclohexane (commercial 
name = P-CAP) [6-8] and trans-1,2-diphenylethylenediamine (commercial name = P-CAP-
DP) [9], were first developed by Gasparrini’s group [6-8] and then our group [9], respectively. 
The “P-CAP” chiral stationary phase is prepared from radical initiated polymerization of the 
N,N’-diacryloyl derivative of trans-1,2-diaminocyclohexane (DACH), while the “P-CAP-
DP” CSP was made from the N,N’-diacryloyl derivative of trans-1,2-
diphenylethylenediamine (DPEDA). In the first case, the free radical initiator was bonded to 
the silica gel; while in the second case, the initiator was dissolved in the bulk reaction 
solution. Both CSPs were stable and can be used in multiple mobile phase modes such as the 
normal phase mode and the polar organic mode. Many racemates with different structures 
have been separated on these two synthetic polymeric CSPs. These two CSPs are known to 
have high sample capacities and thus have considerable potential as preparative columns; 
also both enantiomeric forms of these CSPs are available. Finally, these two columns are 
complementary to one another. Some analytes are only separated on one or the other of these 
two columns, and the enantioselectivities are usually different for the racemates, which can 
be separated on both columns.  
The P-CAP CSP contains relatively rigid rings that have no aromatic moieties, while the 
P-CAP-DP CSP has aromatic units, and the conformation of the monomer is flexible. 
Another chiral monomer presented here has structural features of both of the two commercial 
CSPs. trans-9,10-Dihydro-9,10-ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid 
provides the possibility of making a new synthetic polymeric CSP with different 
enantioselectivities in comparison with the P-CAP and P-CAP-DP columns. In this paper, we 
reported a new synthetic polymeric CSP prepared via radical initiated polymerization of the 
bis-4-vinylphenylamide derivative of this molecule. The synthesis of the chiral selector, its 
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enantiomeric resolution, bonding chemistry, and chromatographic evaluation of its 
enantiomeric separation abilities in the normal phase mode, and polar organic mode are 
presented. The effect of the polar modifier in the mobile phase, mobile phase additives, its 
complementary nature to related polymeric columns, and the relevant interactions that lead to 
chiral recognition also are discussed.   
7.2. Experimental 
7.2.1. Materials 
Spherical silica gel (particle diameter: 5 μm, pore size: 200 Å, surface area: 213 m2/g) 
functionalized with dichloride of 4,4’-azo-bis-cyanovaleric acid was obtained from 
Advanced Separation Technologies (Whippany, NJ, USA). Cyclobond I 2000 RSP column 
was also obtained from Advanced Separation Technologies. Anthracene, fumaric acid, 
brucine, 4-vinylaniline, triethylamine, anhydrous chloroform, anhydrous toluene, acetone, 
thionyl chloride, and trifluoroacetic acid (TFA) were purchased from Aldrich (Milwaukee, 
WI, USA). HPLC grade methylene chloride, methanol, ethanol, acetonitrile, 2-propanol, and 
n-heptane were purchased from Fisher (Fairlawn, NJ, USA). 
7.2.2. Synthesis 
Preparation of trans-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid  
The racemic dicarboxylic acid was synthesized as reported previously [18]. 
Anthracene (71.2 g, 0.4 mol) and fumaric acid (15.6 g, 0.134 mol) were added to 1,4-
dioxane (600 mL). The solution was refluxed for 72 h. After removal of solvent under 
reduced pressure, 2.5% sodium carbonate solution (1 L) was added to the residue. The 
mixture was stirred for 24 h and filtered to remove the excessive anthracene. Hydrochloric 
acid (6 M) was then added to the residue until pH 1 and white precipitate appeared. The 
mixture was heated to reflux. After filtration of the hot mixture, 35.45 g light green solid 
(yield: 90%) was obtained. This product can be used directly in the next step without further 
purification.  
Resolution of trans-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid 
As reported previously [18], racemic trans-9,10-dihydro-9,10-ethanoanthracene-11,12-
dicarboxylic acid (29.4 g, 0.1 mol) and brucine (82.84g, 0.21 mol) were dissolved in 37% 
ethanol under reflux. After cooling the solution, the brucine salt was precipitated and 
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collected by filtration. After two more recrystallizations, the precipitate salts from the third 
recrystallization were treated with 6M HCl until pH 1 to release the (S,S)-enantiomer. Ether 
was added to the mixture to dissolve the diacid. The aqueous phase was extracted with ether 
twice. The combined ether solution was then washed with water twice. After dried over 
anhydrous MgSO4, ether was removed under vacuum to obtain 13.17 g (S,S)-enantiomer 
(yield: 44.8%) in ee higher than 99%. (R,R)-Enantiomer 10.6 g (yield: 36.0%) in ee 92% 
were obtained via treatment of the filtrate of the first recrystallization as similar way as the 
precipitate. The ee of (R,R)-enantiomer can further increase to ≥ 95% via recrystallization of 
the enantiomeric enriched (R,R)-enantiomer with ether/chloroform. The enantiomeric 
purities were determined by HPLC on a Cyclobond I 2000 RSP column (detection 
wavelength: 254 nm, flow rate: 1 mL/min, mobile phase: acetoniltrile/TEAA (pH = 4.1) = 
15/85). TEAA solution was prepared through addition of acetic acid to 0.1% triethylamine 
aqueous solution until pH 4.1. These are shown in Fig. 1. 
Preparation of trans-9,10-dihydro-9,10-ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid 
bis-4-vinylphenylamide (DEABV) 
trans-9,10-Dihydro-9,10-ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid (1.0 g, 
3.40 mmol) and thionyl chloride (0.8 mL, 11.0 mmol) were added into 30 mL anhydrous 
toluene. The mixture was refluxed for 12 h. After removal of volatile components under 
vacuum, the residue was dissolved in 10 mL anhydrous chloroform. This solution was then 
added dropwise into the 40 mL well-stirred chloroform solution of triethylamine (1.5 mL, 
11.0 mmol) and 4-vinylaniline (1.0 g, 8.40 mmol) at 0 ºC. The mixture was then raised to 
room temperature in 30 minutes and stirred for 12 h. The chloroform solution was washed 
with 1 M hydrochloric acid, 1 M sodium bicarbonate, and water twice, respectively. The 
organic layer was dried over sodium sulfate, filtered, and the solvent was evaporated under 
vacuum. The product was purified by flash chromatography on silica gel using methylene 
chloride as eluent to obtain 1.20 g light yellow solid (yield: 71%). 1H NMR (300 MHz, 
CDCl3): δ 8.75 (s, 2H), 7.56-7.53 (m, 2H), 7.43-7.32 (m, 10H), 7.24-7.16 (m, 4H), 6.65 (dd, 
J1 = 17.4 Hz, J2 = 11.1 Hz, 2H), 5.66 (dd, J1 = 17.4 Hz, J2 = 0.6 Hz, 2H), 5.18 (dd, J1 = 11.1 
Hz, J2 = 0.6 Hz, 2H), 4.80 (s, 2H), 3.10 (s, 2H). 13C NMR (75 MHz, CDCl3): δ 171.6, 143.2, 
140.0, 137.3, 136.2, 134.0, 127.0, 126.9, 125.7, 123.9, 120.0, 113.3, 51.0, 45.7.  
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Preparation of the poly-DEABV CSP 
    The procedure of preparation of poly-DEABV CSP is shown in Fig. 2. The silica gel 
functionalized with dichloride of 4,4’-azo-bis-cyanovaleric acid was synthesized as reported 
previously [6-7]. To 50 mL of a heated anhydrous, degassed chloroform solution of DEABV 
(0.7 g), silica gel functionalized with dichloride of 4,4’-azo-bis-cyanovaleric acid (3.20 g) 
was added under an argon atmosphere. The suspension was stirred at 60 ºC for 5 h and was 
heated to reflux for 1 h. The CSP was collected by filtration, washed with 100 mL of 
methanol, acetone, and chloroform respectively to remove the unreacted monomer. The CSP 
was dried under vacuum at 50 ºC over night to obtain 3.69 g. Loading: 15.30%. Elemental 
Analysis: C, 18.96%; H, 1.68%; N, 3.07%. The CSP was packed into a 250 mm x 4.6 mm (i. 
d.) stainless steel column. 
7.2.3. Equipment 
Chromatographic separations were carried out using a HP 1050 HPLC system with an 
auto sampler, a UV VWD detector, and computer controlled Chem-station data processing 
software (Agilent Technologies, Palo Alto, CA, USA). The mobile phases were degassed 
under helium for 7 min. UV detection was carried out at 254 nm for all analytes. All 
separations were carried out at room temperature (~ 23˚C) and the flow rate of the mobile 
phase for all separations was 1.0 mL min-1. 
7.2.4. Column evaluation 
The performance of the poly-DEABV chiral stationary phase was evaluated in the polar 
organic mode using an acetonitrile/methanol mobile phase, and in the normal phase mode 
using 2-propanol/heptane, ethanol/heptane, and methylene chloride/methanol mobile phases. 
Before using a new mobile phase for enantiomeric separations, ten column volumes of it 
were pumped through the column prior to the injection of the analyte. 
7.2.5. Calculations 
The dead time (t0) was estimated using the peak resulting from the change in refractive 
index from the injection solvent. The retention factor (k) was calculated using the equation k 
= (tr-t0) / t0. The enantioselectivity (α) was calculated using α = k2 / k1. The resolution factor 
(RS) was calculated using the equation RS = 2 x (tr2-tr1) / (w1+w2), where tr2 and tr1 are the 
retention times of the second and first enantiomers, respectively, and w1 and w2 are the 
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corresponding base peak widths (as measured manually). The efficiency (number of 
theoretical plates, N) was calculated using N = 16(tr/w)2. 
7.3. Results and Discussion 
7.3.1. Column performance of poly-DEABV CSP 
Two mobile phase modes were investigated with the new poly-DEABV CSP. They are 
the normal phase mode and the polar organic mode. The major solvent components for 
normal phase separations were heptane/isopropanol or heptane/ethanol. For the polar organic 
mode, the mobile phase consisted of acetonitrile with a small amount of methanol. Another 
combination of normal phase solvents (consisting of methylene chloride and methanol) was 
also evaluated. The separation factors of the separated compounds are listed in Tables 1, 2, 
and 3 for the three mobile phases, respectively. With the heptane/ethanol and 
heptane/isopropanol mobile phases, 59 enantiomeric separations and 25 baseline separations 
of chiral molecules were observed. The other two mobile phases were not as broadly 
effective as were the heptane/ethanol or heptane/isopropanol mobile phases. Only 20 
enantiomeric separations and 5 baseline separations were obtained in the polar organic mode 
(Table 2). Nineteen separations and 7 baseline separations were acquired with the methylene 
chloride/methanol mobile phase (Table 3). Totally, this new polymeric CSP showed 
enantioselectivity for 70 chiral molecules and 28 of them were baseline separated. The 
number of enantiomeric separations in each mobile phase is summarized in Fig. 3. The new 
polymeric CSP showed enantioselectivities for 35% of all chiral molecules tested (e. g. 200 
randomly chosen chiral molecules were evaluated). 
The polymeric chiral selectors, which were covalently bonded to the surface of silica gel, 
showed exceptional stability throughout the column evaluation process. After more than 
2000 injections and several mobile phase mode changes, no decrease in retention, efficiency, 
or enantioselectivity were observed, which indicated that no degradation of the CSP occurred.  
7.3.2. Comparison of separations with the three mobile phases 
Although the polar organic mode and the methylene chloride/methanol mobile phases 
did not produce as great a number of enantiomeric separations as the typical heptane/alcohol 
normal phase mobile phase, these two mobile phases have some advantages. First, 11 new 
separations of racemates (compounds not separated with the heptane/alcohol mobile phase) 
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were obtained using these two eluents (Tables 1, 2, and 3). Second, the separations with these 
two mobile phases are normally complete in 10 minutes or less. Finally, for some analytes 
such as compounds 1, 21, 26, 45, 56, and 57, better separations were achieved in either the 
polar organic mode or with the methylene chloride/methanol mobile phase compared with 
the same separations achieved with the heptane/alcohol mobile phase. In all cases, this 
improvement was due to an increase in selectivity (α) rather than in the efficiency (Tables 1, 
2, and 3). 
7.3.3. Effect of polar modifiers in the normal phase mode 
 Two polar modifiers, ethanol and isopropanol were assessed in the normal phase mode. 
Generally, ethanol was the better polar modifier. For most analytes, better efficiencies and 
resolutions were observed with the ethanol/heptane mobile phase. Typical examples are the 
separations of compounds 6 and 24 (Fig. 4). Although enantioselectivities of compounds 6 
and 24 decreased a little bit when changing from the ethanol/heptane mobile phase to the 
isopropanol/heptane mobile phase, the resolutions increased greatly due to the significant 
improvement of peak efficiency. For compound 6, N1 (theoretical plate numbers of the first 
peak) was 2600 when ethanol was used as polar modifier, while N1 was just 700 when 
isopropanol was used. For compound 24, N1 also increased from 200 to 800 when the mobile 
phase was changed from isopropanol/heptane to ethanol/heptane. The likely reason for this is 
that the viscosity of ethanol is lower than that of isopropanol. The low viscosity of mobile 
phase improves mass transfer, thus increases efficiency and resolution. However, for a few 
analytes such as compounds 41 and 46, better resolutions were achieved using the 
isopropanol/heptane mobile phase (data not shown). This was due to the better 
enantioselectivities obtained when isopropanol was used as the modifier. 
7.3.4. Effect of mobile phase additive: trifluoacetic acid (TFA) 
A small amount of trifluoroacetic acid (TFA) in the mobile phase plays an important 
role in the enantiomeric separations on this new polymeric CSP. The effect of TFA depends 
on the structural characteristics of the analytes. For neutral analytes without ionizable groups, 
addition of TFA into mobile phase has little or no effect on the enantiomeric separations. For 
example, no difference was observed on the retention, enantioselectivitiy, and resolution of 
compound 33 (Figs. 5a, 5b). However, for the separation of acidic analytes, addition of TFA 
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into the mobile phase can decrease the retention and increase the efficiency, selectivity and 
resolution in many cases. A typical example is the separation of compound 31 (Figs. 5c, 5d)). 
Clearly, better efficiency, enantioselectivity, and resolution were obtained when 0.1% TFA 
was added to the mobile phase. Another advantage of TFA is the decrease in separation time. 
A similar phenomenon has also been observed on the P-CAP column [8]. A small amount of 
TFA in the mobile phase can cover the residual amino groups on the stationary phase (Fig. 2), 
thus preventing strong acid-base interactions between the acidic analytes and basic sites on 
the stationary phase.  
7.3.5. Sample loading study 
   This polymeric CSP showed high sample capacities and often contained high 
enantioselectivities, even when excess analyte was injected. For example, an excellent 
separation with a resolution 5.1 was achieved when 1 μg of compound 30 was injected into 
the column (Fig 6a). However, when 1000 μg or 5000 μg of analyte was injected into the 
analytical column, baseline separations still were obtained (Figs. 6b, 6c). Considering that 
the baseline separation of such a large amount of analyte was achieved on an analytical size 
column (250 x 4.6 mm), this new polymeric CSP has the potential to be an exceptional 
medium for preparative separations. 
7.3.6. Complementary nature of the synthetic polymeric CSPs 
Poly-DEABV CSP is complementary to the other two synthetic polymeric P-CAP and 
P-CAP-DP CSPs. For compounds that can be separated on all these three columns, different 
enantioselectivities were always observed [8-9]. Two examples are shown in Fig. 7. For the 
separation of compound 30, the best enantioselectivity was achieved on the poly-DEABV 
column. However, the P-CAP column was best for the separation of compound 13. It appears 
that the new polymeric CSP is particularly suitable for the separation of amino acid and 
oxazolidinone derivatives compared with the P-CAP and P-CAP-DP CSPs. All the amino 
acid derivatives (compounds 6, 17, 23, 24, 30, 31, 52) and oxazolidinone derivatives 
(compounds 7, 9, 29, 32, 33, 45, 56) tested were baseline separated, while the P-CAP and P-
CAP-DP CSPs were not as effective in the separation of these compounds [8-9]. Finally, 30 
enantiomeric separations of racemates were obtained that have not been reported before on 
either the P-CAP or the P-CAP-DP CSP. 
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7.3.7. Enantioselective interactions 
The new DEABV CSP contains quite a number of amide linkages and aromatic groups 
(Fig. 2). Therefore, hydrogen bonding, dipolar, and π-π interactions likely play an important 
role in the chiral recognition process. Most chiral samples separated on this CSP had more 
than one hydrogen bonding groups such as amide, ester, carboxylic acid, and hydroxyl 
groups. This is similar to what was found for the P-CAP CSP [8]. However, for compounds 
with strong π-acid groups such as 3, 30, and 31, much better enantioselectivities were 
observed on the new CSP than on the P-CAP CSP [8]. This indicated that π-π interactions 
also may affect chiral recognition. In addition, the separation of enantiomers just with one 
hydrogen bonding group (compounds 8 and 15,) were found on this new CSP. This did not 
occur on the P-CAP CSP [8]. The only way for these separations to occur on the poly-
DEABV CSP is if it can utilize one or more interactions that are not available to the related 
P-CAP CSP. 
7.4. Conclusions 
A synthetic polymeric CSP based on a new chiral monomer, trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid bis-4-vinylphenylamide, was prepared 
via the surface initiated free radical polymerization method. The new CSP was stable and 
showed enantioselectivities for many chiral compounds in multiple mobile phases. Most 
enantiomeric separations were achieved with an alcohol/heptane mobile phase, while better 
separations for a few analytes were obtained in the polar organic mode and with a methylene 
chloride mobile phase. Hydrogen bonding, dipolar, and π-π interactions are important for the 
enantiomeric separation. In the normal phase mode, ethanol is the better polar modifier 
compared with isopropanol. An acidic mobile phase additive such as trifluoroacetic acid is 
important for the separations of many compounds with ionizable groups. This new polymeric 
CSP shows great potential for preparative scale applications. Furthermore, the poly-DEABV 
CSP is complementary to other synthetic polymeric CSPs such as the P-CAP and P-CAP-DP 
CSPs. 
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Table 1. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (Rs) of the separated racemic compounds on the poly-DEABV column in the 
normal phase mode 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
1 N-Acetylhomo- cysteine thiolactone 
S
O
N
O
H
 
3.27 1.10 0.9 HEP/EtOH/TFA = 70/30/0.1 
2 O-Acetyl-mandelic acid 
COOH
O O
 
3.70 1.07 0.7 HEP/EtOH/TFA = 90/10/0.1 
3 
1-(2-Aminocyclohexyl)-3-(3, 
5-bis-trifluoromethyl 
-phenyl)urea N N
O
CF3
CF3
NH2
H H
 
3.58 1.33 1.6 HEP/EtOH/TFA = 90/10/0.1 
4 cis-1-Amino-2-indanol 
NH2
OH
 
3.19 1.12 0.8 HEP/EtOH/TFA = 70/30/0.1 
5 Benzoin 
O
HO  
5.48 1.07 0.9 HEP/EtOH/TFA = 95/5/0.1 
6 N-Benzoyl-valine 
O
N
COOH
H
 
5.20 1.30 2.7 HEP/EtOH/TFA = 90/10/0.1 
7 4-Benzyl-5,5-dimethyl-2- oxazolidinone 
O
N
O
Ph
H
 
1.63 1.20 1.5 HEP/EtOH/TFA = 60/40/0.1 
8 N-Benzyl-1-(1-naphthyl)- ethylamine 
N Ph
H  
4.21 1.12 0.5 HEP/EtOH/TFA = 70/30/0.1 
9 4-Benzyl-2-oxazolidinone HN
O
O  
2.58 1.24 1.6 HEP/EtOH/TFA = 60/40/0.1 
10 3-(Benzyloxycarbonyl)-4- oxazolidine carboxylic acid 
O
O
N O
HOOC  
3.79 1.06 0.5 HEP/EtOH/TFA = 80/20/0.1 
11 Benzylphthalide 
O
O
 
3.58 1.07 0.7 HEP/EtOH/TFA = 80/20/0.1 
12 4-Benzyl-3-propoinyl-2- oxazolidinone 
O
N
O
O
 
6.43 1.23 1.9 HEP/EtOH/TFA = 80/20/0.1 
13 1, 1’-Bi-2-naphthol OHHO
 
8.65 1.07 0.7 HEP/EtOH/TFA = 90/10/0.1 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
14 N,N’-Bis(α-methyl- benzyl)sulfamide N
S
N
O
O
H H
 
4.67 1.05 0.5 HEP/EtOH/TFA = 80/20/0.1 
15 Bis[1-phenylethyl]- amine hydrochloride Me
Ph
N Me
Ph
H HCl  
4.11 1.30 1.7 HEP/EtOH/TFA = 80/20/0.1 
16 α-Carbethoxy-γ-phenyl-γ- butyrolactone 
O
O
O
O
 
6.67 1.12 1.5 HEP/EtOH/TFA = 90/10/0.1 
17 Carbobenzyloxy-alanine 
H
N O
O
OHO  
2.33 1.33 2.5 HEP/EtOH/TFA = 80/20/0.1 
18 Carprofen 
N
Cl
COOH
 
3.72 1.09 0.7 HEP/EtOH/TFA = 80/20/0.1 
19 4-Chloromandelic acid Cl
OH
COOH 
11.3 1.03 0.4 HEP/EtOH/TFA = 95/5/0.1 
20 4-Chlorophenyl-2, 3- epoxypropyl ether Cl O
O
 
3.51 1.04 0.7 HEP/EtOH/TFA = 100/1/0.1 
21 Chlorthalidone NH
O
HO
Cl
S
O
O
NH2
 
5.48 1.12 0.7 HEP/EtOH/TFA = 60/40/0.1 
22 trans-4-Cotinine-carboxylic acid 
N
N
O
O
HO
 
4.63 1.13 0.7 HEP/EtOH/TFA = 60/40/0.1 
23 Dansyl-norleucine cyclohexylammonium salt 
N
S
HN O
O
OOC
NH3
 
4.37 1.24 1.5 HEP/EtOH/TFA = 80/20/0.1 
24 Dansyl-phenylalanine cyclohexylammonium salt 
N
S
HN O
O
OOC
Ph
NH3
 
2.60 1.49 1.8 HEP/EtOH/TFA = 60/40/0.1 
25 2,3-Dibenzoyl-tartaric acid 
O
O
OH
O
O
OH
O
O  
7.41 1.23 1.5 HEP/EtOH/TFA = 80/20/0.1 
26 N,N’-Dibenzyl-tartramide Ph N N Ph
O
OH
OH
O
H
H
 
4.42 1.33 1.6 HEP/EtOH/TFA = 70/30/0.1 
27 3,4-Dihydroxyphenyl-α- propylacetamide 
OH
OH
O
NH2
 
5.99 1.05 0.5 HEP/EtOH/TFA = 80/20/0.1 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
28 1,5-Dimethyl-4-phenyl-2- imidazolidinone 
HN N
O
Ph  
2.67 1.08 0.8 HEP/EtOH/TFA = 80/20/0.1 
29 5,5-Dimethyl-4-phenyl-2- oxazolidinone 
NH
O
Ph
O
 
3.63 1.18 1.5 HEP/EtOH/TFA = 80/20/0.1 
30 N-(3,5-Dinitrobenzoyl)- leucine 
O2N
NO2
O
N
CO2H
H
 
1.79 3.93 5.1 HEP/EtOH/TFA = 60/40/0.1 
31 N-(3,5-Dinitrobenzoyl)- -phenylglycine 
O2N
O2N
O
NH
OH
O
Ph  
4.52 1.87 2.8 HEP/EtOH/TFA = 60/40/0.1 
32 4-(Diphenylmethyl)- 2-oxazolidinone 
O
N
O Ph
Ph
H
 
5.23 1.23 1.6 HEP/EtOH/TFA = 70/30/0.1 
33 cis-4,5-Diphenyl-2- oxazolidinone 
O
NH
Ph
Ph O 
2.57 1.30 1.8 HEP/EtOH/TFA = 60/40/0.1 
34 Flavanone 
O
O
Ph 
2.96 1.06 0.7 HEP/EtOH/TFA = 95/5/0.1 
35 Furoin 
O
OH
O
O
 
9.29 1.03 0.5 HEP/EtOH/TFA = 90/10/0.1 
36 Guaiacol glyceryl ether carbamate 
O
O
OH
O NH2
O
 
3.62 1.05 0.5 HEP/EtOH/TFA = 70/30/0.1 
37 Hydrobenzoin 
OH
HO  
7.03 1.04 0.5 HEP/EtOH/TFA = 95/5/0.1 
38 2-(4-Hydroxyphenoxy)- propionic acid 
HO O
COOH
 
2.89 1.09 0.8 HEP/EtOH/TFA = 80/20/0.1 
39 
4-((1-(Isopropoxycarbonyl-
4-methyl)-butyl)amino)- 
benzoic acid 
HN
O
O
COOH 
1.10 2.68 3.3 HEP/EtOH/TFA = 60/40/0.1 
40 
2,3-O-Isopropylidene-2,3- 
dihydroxy-1,4-bis- 
(diphenylphosphino)butane 
OO
PP
Ph
Ph
Ph
Ph
 
3.64 1.35 1.3 HEP/EtOH/TFA = 60/40/0.1 
41 Ketamine hydrochloride 
O
NH
Cl
HCl
 
8.77 1.17 0.5 HEP/IPA/TFA = 50/50/0.1 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
42 Lormetazepam 
N
N
Cl
Cl
O
HO
 
3.51 1.37 1.6 HEP/EtOH/TFA = 60/40/0.1 
43 Mandelamide 
OH
NH2
O
 
6.67 1.17 1.7 HEP/EtOH/TFA = 85/15/0.1 
44 N-(α-Methylbenzyl)phthalic acid monoamide 
COOH
O
N
H
 
2.38 1.16 0.9 HEP/EtOH/TFA = 70/30/0.1 
45 cis-4-Methyl-5-phenyl-2- oxazolidinone 
HN
OO  
11.3 1.15 1.7 HEP/EtOH/TFA = 90/10/0.1 
46 α-Methyl-α-phenyl- succinimide NH
O
O  
3.73 1.05 0.4 HEP/IPA/TFA = 70/30/0.1 
47 Omeprazole 
N
N
S
O
N
MeO
OMe
H  
6.04 1.42 1.4 HEP/EtOH/TFA = 60/40/0.1 
48 Oxazepam 
N
N
Cl
O
HO
H
 
18.0 1.18 0.8 HEP/EtOH/TFA = 85/15/0.1 
49 N-(α-Methylbenzyl)- phthalimide N
O
O  
2.75 1.04 0.4 HEP/EtOH/TFA = 95/5/0.1 
50 5-(α-Phenylethyl)- semioxamazide 
N
O
NHNH2
O
H
 
2.77 1.13 0.6 HEP/EtOH = 60/40 
51 2-Phenoxypropionic acid 
O COOH
CH3  
3.66 1.07 0.7 HEP/EtOH/TFA = 95/5/0.1 
52 N-Carbobenzoxy- phenylalanine 
N O
O
OHO
H
 
1.09 1.58 2.2 HEP/EtOH/TFA = 60/40/0.1 
53 3-Phenylphthalide O
O
Ph
 
10.0 1.10 1.5 HEP/EtOH/TFA = 95/5/0.1 
54 
5-Phenyl-2- 
(2-propynylamino)-2- 
oxazolin-4-one 
O
N
O
N
H
 
5.04 1.21 1.5 HEP/EtOH/TFA = 70/30/0.1 
55 Propranolol hydrochloride 
O
OH
N
H
HCl
 
4.02 1.11 0.5 HEP/EtOH/TFA = 70/30/0.1 
56 
cis-3,3a,8,8a- 
Tetrahydro-2H-indeno[1,2-
d]oxazol-2-one 
NH
O O
 
12.4 1.13 1.5 HEP/EtOH/TFA = 85/15/0.1 
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Table 1. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
57 
3a,4,5,6-Tetrahydro- 
succininido[3,4-b]- 
acenaphthen-10-one 
NH
O
O
O
 
6.96 1.16 0.9 HEP/EtOH/TFA = 60/40/0.1 
58 Trihexyphenidyl 
Ph
OH
N
 
7.72 1.08 0.5 HEP/EtOH/TFA = 80/20/0.1 
59 Warfarin 
O
OH
O
O
 
14.1 1.05 0.4 HEP/EtOH/TFA = 90/10/0.1 
a HEP: n-heptane. EtOH: ethanol. IPA: isopropanol. TFA: trifluoroacetic acid.  
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Table 2. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (Rs) of the separated racemic compounds on the poly-DEABV column in the polar 
organic mode 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
1 N-Acetylhomo- cysteine thiolactone 
S
O
N
O
H
 
0.27 1.07 0.3 ACN/TFA=100/0.1 
7 4-Benzyl-5,5-dimethyl-2- oxazolidinone 
O
N
O
Ph
H
 
0.18 1.28 0.7 ACN/TFA =100/0.1 
9 4-Benzyl-2-oxazolidinone HN
O
O  
0.24 1.32 1.3 ACN/TFA =100/0.1 
12 4-Benzyl-3-propoinyl-2- oxazolidinone 
O
N
O
O
 
0.25 1.32 1.4 ACN/TFA =100/0.1 
18 Carprofen 
N
CL
COOH
 
0.85 1.06 0.4 ACN/TFA =100/0.1 
26 N,N’-Dibenzyl- tartramide Ph N
N Ph
O
OH
OH
O
H
H
 
0.68 1.48 2.0 ACN/MeOH/TFA =100/1/0.1 
29 5,5-Dimethyl-4-phenyl-2- oxazolidinone 
NH
O
Ph
O
 
0.23 1.43 1.4 ACN/ TFA=100/0.1 
30 N-(3,5-Dinitro-benzoyl)- leucine 
O2N
NO2
O
N
CO2H
H
 
0.30 2.31 2.6 ACN/MeOH/TFA =100/1/0.1 
31 N-(3,5-Dinitrobenzoyl)- -phenylglycine 
O2N
O2N
O
NH
OH
O
Ph  
0.50 1.40 1.4 ACN/MeOH/TFA =100/1/0.1 
32 4-(Diphenylmethyl)- 2-oxazolidinone 
O
N
O Ph
Ph
H
 
0.29 1.38 1.6 ACN/TFA =100/0.1 
33 cis-4,5-Diphenyl-2- oxazolidinone 
O
NH
Ph
Ph O 
0.26 1.54 1.9 ACN/TFA =100/0.1 
39 
4-((1-(Isopropoxycarbonyl-4-
methyl)-butyl)amino)- 
Benzoic acid 
HN
O
O
COOH 
0.04 6.06 3.0 ACN/TFA =100/0.1 
44 N-(α-Methylbenzyl)phthalic acid monoamide 
COOH
O
N
H
 
0.46 1.15 0.6 ACN/MeOH/TFA =100/1/0.1 
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Table 2. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
45 cis-4-Methyl-5-phenyl-2- oxazolidinone 
HN
OO  
0.24 1.25 0.8 ACN/TFA =100/0.1 
52 Z-Phenylalanine N O
O
OHO
H
 
0.33 1.33 1.0 ACN/TFA =100/0.1 
54 
5-Phenyl-2- 
(2-propynylamino)-2- 
oxazolin-4-one 
O
N
O
N
H
 
0.31 1.16 0.5 ACN/MeOH/TFA =100/1/0.1 
56 
cis-3,3a,8,8a- 
Tetrahydro-2H-indeno[1,2-
d]oxazol-2-one 
NH
O O
 
0.38 1.24 1.3 ACN/TFA =100/0.1 
60 Bendroflumethiazide 
H
S
NH
NF3C
S
O
H2N
O O O
 
0.10 1.40 0.4 ACN/TFA =100/0.1 
61 Sulindac 
F
HO2C
S
O  
1.38 1.05 0.4 ACN/MeOH/TFA =100/1/0.1 
62 1,2,3,4-Tetrahydro-1- naphthylamine 
NH2
 
0.38 1.24 1.4 ACN/TFA =100/0.1 
a ACN: acetonitrile. MeOH: methanol. TFA: trifluoroacetic acid. 
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Table 3. Retention factor of the first peak (k1), enantioselectivity (α), and enantiomeric 
resolution (Rs) of the separated racemic compounds on the poly-DEABV column in the 
normal-phase mode with halogenated solvent 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
1 N-Acetylhomo- cysteine thiolactone 
S
O
N
O
H
 
0.93 1.22 1.3 CH2Cl2/MeOH /TFA = 99/1/0.1 
4 Cis-1-Amino-2-indanol 
NH2
OH
 
3.62 1.13 0.8 CH2Cl2/MeOH /TFA = 95/5/0.1 
9 4-Benzyl-2-oxazolidinone HN
O
O  
0.11 2.04 1.8 CH2Cl2/MeOH /TFA = 95/5/0.1 
18 Carprofen 
N
CL
COOH
 
1.65 1.10 0.6 CH2Cl2/MeOH /TFA = 97/3/0.1 
21 Chlorthalidone NH
O
HO
Cl
S
O
O
NH2
 
2.77 1.21 1.4 CH2Cl2/MeOH /TFA = 95/5/0.1 
26 N,N’-Dibenzyl-tartramide Ph N N Ph
O
OH
OH
O
H
H
 
0.26 1.43 1.5 CH2Cl2/MeOH /TFA = 95/5/0.1 
45 cis-4-Methyl-5-phenyl-2- oxazolidinone 
HN
OO  
1.18 1.32 2.2 CH2Cl2/MeOH /TFA = 99/1/0.1 
54 
5-Phenyl-2- 
(2-propynylamino)-2- 
oxazolin-4-one 
O
N
O
N
H
 
0.96 1.18 1.4 CH2Cl2/MeOH /TFA = 97/3/0.1 
56 
cis-3,3a,8,8a- 
Tetrahydro-2H-indeno[1,2-
d]oxazol-2-one 
NH
O O
 
0.36 1.70 2.6 CH2Cl2/MeOH /TFA = 95/5/0.1 
57 
3a,4,5,6-Tetrahydro- 
succininido[3,4-b]- 
acenaphthen-10-one 
NH
O
O
O
 
0.95 1.30 2.0 CH2Cl2/MeOH /TFA = 97/3/0.1 
62 1,2,3,4-Tetrahydro-1- naphthylamine 
NH2
 
0.40 1.70 2.7 CH2Cl2/MeOH /TFA = 95/5/0.1 
63 N-Desmethylnefopam 
N
O
H  
0.94 1.26 1.1 CH2Cl2/MeOH /TFA = 95/5/0.1 
64 1,2-Diphenylethylene- diamine 
NH2
H2N
 
0.69 1.39 1.1 CH2Cl2/MeOH /TFA = 95/5/0.1 
  
157
 
Table 3. (continued) 
# Compound Structure k1 α Rs Mobile Phase (v/v)a 
65 α, α-Diphenylprolinol 
N
OH
Ph
PhH
 
0.95 1.26 1.4 CH2Cl2/MeOH /TFA = 95/5/0.1 
66 5-Hydroxymethyl-2(5H)- furanone 
OO
OH
 
1.75 1.28 2.0 CH2Cl2/MeOH /TFA = 99/1/0.1 
67 5-(4-Hydroxyphenyl)-5- phenylhydantoin N
N
OH
Ph
O
O
H
H
 
4.85 1.13 0.8 CH2Cl2/MeOH /TFA = 95/5/0.1 
68 1-(1-Naphthyl)ethylamine 
H2N
 
3.20 1.08 0.6 CH2Cl2/MeOH /TFA = 95/5/0.1 
69 Ofloxacine 
N
O
N
N
COOH
O
F
 
0.83 1.34 0.9 CH2Cl2/MeOH /TFA = 95/5/0.1 
70 2-Phenylglycinol 
NH2
OH
 
3.75 1.12 0.7 CH2Cl2/MeOH /TFA = 95/5/0.1 
a MeOH: methanol. TFA: trifluoroacetic acid. CH2Cl2: methylene chloride. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
158
 
 
Fig. 1. Enantiomeric separation of the synthesized chiral dicarboxylic acid (trans-9,10-
dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid) from which the new chiral selector 
was made. a) Racemate, b) Purified (S,S)-enantiomer, c) Purified (R,R)-enantiomer. The 
separations were done on a Cyclobond I 2000 RSP column. Mobile phase: 
Acetonitrile/TEAA buffer (pH=4.1) = 15/85. Flow rate: 1 mL/min. Detection wavelength: 
254 nm. 
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Fig. 2. Preparation of the poly-DEABV chiral stationary phase. 
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Fig. 3. Summary of the number of observable (Rs ≥ 0.4) and baseline separations (Rs ≥ 1.5) 
achieved on the poly-DEABV CSP. 
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Fig. 4. The effect of polar modifier on the enantiomeric separations of compounds 6 (a), b)) 
and 24 (c), d)) in the normal phase mode. Mobile phase: a) Heptane/Ethanol/TFA = 90/10/0.1, 
b) Heptane/Isopropanol/TFA = 90/10/0.1, c) Heptane/Ethanol/TFA = 60/40/0.1, d) 
Heptane/Isopropanol/TFA = 50/50/0.1. Enantioselectivity, α: a) α = 1.30, b) α = 1.39, c) α = 
1.49, d) α = 1.67. Resolution, Rs: a) Rs = 2.7, b) Rs = 1.8, c) Rs = 1.8, d) Rs = 1.4. Number 
of theoretical plates of the first peak, N1: a) N1 = 2600, b) N1 = 700, c) N1 = 800, d) N1 = 200. 
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Fig. 5. The effect of the acidic additive on the enantiomeric separations of compound 33 (a), 
b)) and 31 (c), d)) in the normal phase mode. Mobile phase: a), c) Heptane/Ethanol/TFA = 
60/40/0.1, b), d) Heptane/Isopropanol/TFA = 60/40. Enantioselectivity, α: a), b) α = 1.30, c) α 
= 1.87, d) α = 1.54. Resolution, Rs: a), b) Rs = 1.8, c) Rs = 2.8, d) Rs = 1.4. 
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Fig. 6. The effect of sample loading on the enantiomeric separation of compound 30 with a) 
1.0 μg, b) 1000 μg, and c) 5000 μg of analyte injected on the poly DEABV CSP. Mobile 
phases: a), b), and c) Heptane/Ethanol/TFA = 60/40/0.1. 
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Fig. 7. Comparison of the enantiomeric separations of compound 13 (a), b), c)) and 30 (d), e), 
f)) on the P-CAP (a), d)), P-CAP-DP (b), e)), and poly-DEABV (c), f)) CSPs. Mobile phase: 
a) Heptane/Ethanol/TFA = 90/10/0.1, b) Heptane/Isopropanol = 80/20, c) 
Heptane/Isopropanol = 50/50, d) Heptane/Ethanol/TFA = 80/20/0.1, e) 
Heptane/Isopropanol/TFA = 70/30/0.1, f) Heptane/Ethanol/TFA = 60/40/0.1. 
Enantioselectivity, α: a) α = 1.36, b) α = 1.23, c) α = 1.07, d) α = 1.07, e) α = 1.41, f) α = 3.93. 
 
 
 
 
 
 
  
165
 
Chapter 8. Super/subcritical fluid chromatography separations with four 
synthetic polymeric chiral stationary phases 
A paper published in Chromatographia1  
X. Han, A. Berthod, C. Wang, K. Huang, D. W. Armstrong 
Abstract 
New synthetic polymeric chiral selectors were developed recently as chiral stationary 
phases. They were tested with supercritical fluid mobile phases made of CO2 plus an alcohol 
modifier and 0.2% v/v trifluoroacetic acid. The polymeric N,N’-(1S,2S)-1,2-
cyclohexanediyl-bis-2-propenamide (P-CAP), the polymeric N,N’-[(1R,2R)]-1,2-diphenyl-
1,2-ethanediyl] bis-2-propenamide (P-CAP-DP), the polymeric trans-9,10-dihydro-9,10-
ethanoanthracene-(11S,12S)-11,12-dicarboxylic acid bis-4-vinylphenylamide (DEABV) and 
the polymeric N,N’-[(1R,2R)-1,2-diphenyl-1,2-ethanediyl] bis-4-vinylbenzamide (DPEVB) 
were bonded to 5 µm silica particles and used to prepare four columns that were tested with a 
set of 88 chiral compounds with a wide variety of chemical functionalities. All 88 test 
compounds were separated on one or more of these ‘‘related’’ polymeric CSPs. Forty-three 
enantiomeric pairs were separated in SFC conditions by only one of the CSPs. Twenty pairs 
were separated by two CSPs and 18 and 7 enantiomeric pairs were separated by 3 and all 4 
CSPs, respectively. The three P-CAP, P-CAP-DP and DEABV CSPs have equivalent success 
being able to separate 49 enantiomeric pairs of the studied set with respectively 12, 14 and 
20 at baseline (Rs > 1.5). The DPEVB CSP was significantly less efficient separating only 18 
chiral compounds with only one at baseline. The great advantage of the SFC mobile phases is 
the rapid separation, which most achieved in less than 5 min. 
Keywords: Supercritical fluid chromatography, Enantiomeric separations, Enantioselectivity, 
Synthetic polymeric chiral stationary phases 
8.1. Introduction 
Liquid chromatography chiral stationary phases (CSPs) can be used for analytical and 
preparative enantiomeric separations. However, the effectiveness of different classes of CSPs  
                                                          
1 Reprinted with permission of Chromatographia, 2007, 65, 381-400. Copyright © 2007 Frider. Vieweg & 
Sohn/GWV Fachverlage GmbH. All rights reserved. 
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at each task can vary widely. Modern chiral selectors include π-complex, ligand exchange, 
chiral crown ethers, cyclodextrins, polysaccharides, proteins and macrocyclic glycopeptide 
chiral selectors [1, 2]. All these chiral selectors were found to be very useful in separating 
enantiomers on an analytical scale (microgram to milligram amounts). One of the important 
challenges in enantiomeric separations is enhancing production, i.e. going to gram, kilogram 
and even to greater amounts in a facile manner. Many polymeric chiral selectors have a 
significant higher loading capability than smaller chiral selectors [1]. An exception to this 
statement is the protein CSPs which have very low capacities. Successful polymeric CSPs 
include natural polymers such as polysaccharide derivatives, cellulose and amylose 
carbamates, or synthetic polymers such as polyamides, vinyl polymers, polyurethanes and 
polyacetylene derivatives [3–5], polymetacrilates and polytartardiamide based CSPs [6–10]. 
Recent polymeric chiral selectors based on trans-1,2-diaminocyclohexane were found very 
useful when used to prepare CSPs for normal phase liquid chromatography (NPLC) [5, 11–
13].  
The need for preparative enantiomeric separations is driving the renewed interest in 
supercritical fluid chromatography (SFC). In the 1980s, some studies overestimated the 
solvent strength of supercritical CO2 and this lead to some disappointments especially in the 
applicability of capillary SFC [14]. It became clear that some percentage of a more polar 
cosolvent, like methanol, was needed to elute most analytes. With the increased interest in 
high throughput separations, preparative separations and solvent disposal concerns, SFC with 
packed columns underwent a rebirth as a potential replacement for NPLC [15]. 
Enantiomeric separations using SFC with packed columns were first performed by 
Mourier et al. [16] separating phosphine oxide enantiomers on a π-complex based CSP. 
Supercritical CO2, almost exclusively used in its subcritical state associated with significant 
amounts of organic modifier, was found to increase dramatically the preparative productivity 
of enantiomeric separations [17, 18]. Many different CSPs have been used in packed column 
SFC [19, 20].  
The focus of this work is to evaluate the enantioselective capabilities of the recently 
introduced synthetic polymeric CSPs in SFC [5, 11]. Two new related polymeric CSPs will 
also be evaluated with the same set of solutes and SFC mobile phases. The results obtained 
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with the four CSPs will be discussed and compared. A set of 88 chiral compounds with a 
wide variety of functionalities was used to test the four CSPs. Experimental conditions were 
deliberately selected to favor fast rather than efficient separations. The results obtained on 
the four CSPs are compared and discussed in terms of enantiorecognition capabilities. The 
other properties that must be studied when dealing with a new CSP, such as pH and thermal 
stabilities and loading capability, will not be treated in this work exclusively dedicated to 
SFC enantioselectivity. 
8.2. Experimental 
8.2.1. Chemicals 
Eighty-eight enantiomeric pairs with a wide variety of functionalities were evaluated 
on four different polymeric CSPs. All the test compounds could be placed into one of four 
classes: (1) compounds with a sp2 hybridized carbon directly attached to the asymmetric 
center; (2) compounds whose asymmetric center is part of a ring; (3) chiral acids and 
derivatized amino-acids; (4) other compounds including atropoisomers, alcohols, and 
stereogenic phosphorous and sulfoxide compounds. All analytes were obtained from Sigma 
(St. Louis, MO, USA) or Aldrich (Milwaukee, WI, USA). The set of compounds contains 
only nine highly basic analytes that were all separated in their cationic (acidified) form. 
Stock solutions of 1 mg mL-1 of each compound were prepared and injected individually on 
the four polymeric CSPs. 
8.2.2. Chiral Stationary Phases 
Figure 1 shows the chiral monomers used to prepare the four synthetic polymeric CSPs 
evaluated in this work. All chiral selectors were bonded on spherical 5 µm porous silica gel 
(Akzo Nobel, EKA Chemicals AB, Sweden, pore size 20 nm, pore volume 0.9 mg L-1, 
specific surface area 210 m2 g-1). The bonded particles were used to fill 250 x 4.6 mm 
columns. The P-CAP, from ‘‘poly Cyclic Amine Polymer’’, is actually a polymer of trans-
1,2-cyclohexanediyl-bis-acrylamide (Fig. 1a). The P-CAP denomination comes from the 
Astec trade name (Astec, Whippany, NJ, USA). This stationary phase was fully described 
recently [5]. The P-CAP-DP, also an Astec trade name, is a polymer of N,N’-[(1R,2R)]-1,2-
diphenyl-1,2-ethanediyl]-bis-2-propenamide (Fig. 1b). It was prepared as fully described in 
[11]. Figure 1c shows the monomer trans-9,10-dihydro-9,10-ethanoanthracene-(11S,12S)-
  
168
 
11,12-dicarboxylic acid bis-4-vinylphenylamide that was used to prepare the DEABV 
stationary phase. This molecule was synthesized in our group using a chiral dicarboxylic acid 
originally reported by Thunberg and Allenmark [21] and then coupled to p-
vinylphenylamine. The chiral selector and the phase preparation were fully described in a 
recent article [22]. Figure 1d shows the N,N’-[(1R,2R)-1,2-diphenyl-1,2-ethanediyl] bis-4-
vinylbenzamide monomer, a variation of b, used to prepare the DPEVB stationary phase 
according to the procedure described in [5] and [11]. The bonding density of the P-CAP CSP 
was estimated using the carbon elemental analysis to 400 µmol g-1 or about 2.4 µmol m-2 [5]. 
The corresponding values for the P-CAP-DP CSP were 350 µmol g-1 and 2.1 µmol m-2 [11] 
and 290 µmol g-1 and 1.7 µmol m-2 for the DEABV CSP and 340 µmol g-1 and 2.0 µmol m-2 
for the DPEVB CSP. 
8.2.3. Supercritical Fluid Chromatography 
The SFC apparatus was from Thar Technologies, Inc. (Pittsburgh, PA, USA). The SFC 
system includes a fluid delivery module (liquid CO2 pump and cosolvent pump), an auto 
sampler with a 48 sample tray, a column oven with column selection, an auto back pressure 
regulator, a UV VWD detector, and the SuperChromTM software for data treatment. SFC-
grade CO2 was from Air Liquide America (Houston, TX, USA).  
8.2.4. Operating Conditions 
All studies of the effect of temperature in enantiomeric separations have shown that the 
enantioselectivity factors decrease as the temperature increases [23]. So a constant and low 
temperature of 32 ºC (CO2 critical temperature is 31.3 °C) was selected for all analyses. 
Similarly, raising the pressure does produce faster analyses, but it is associated with a poorer 
enantioselectivity [24]. Consequently, a constant outlet pressure of 100 bar (1,430 p.s.i.) was 
used in all cases. The polarity of pure CO2 mobile phase can be compared to that of pentane 
[20]. It is not high enough to perform useful separations. Therefore, significant amounts of 
polar organic modifier were added in all mobile phases used [20]. Trifluoroacetic acid (TFA) 
was also added at a concentration of 0.2% v/v in the organic modifier (unless otherwise 
indicated) used in all mobile phases to protonate the solutes and any stationary phase basic 
sites. The total flow rate (CO2 + MeOH) was always 4 mL min-1 at the column inlet. The 
amount of methanol (MeOH) added to CO2 was selected so that the solute peaks elute in less 
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than 8 min. When a particular solute was not separated on all four CSPs, another mobile 
phase was tested either with first another MeOH concentration and next another organic 
modifier (ethanol, EtOH, or isopropyl alcohol, IPA) keeping the CO2 pressure at 100 bar and 
the TFA concentration at 0.2% v/v in the organic modifier until the solute’s enantiomers are 
separated by at least one CSPs. This procedure shows that the listed results are certainly not 
the best results that could be obtained working with the studied polymeric CSPs. Further 
optimization of the mobile phase composition for each individual compounds could be done 
if desired. There is no objection other than silica stability to use higher pH mobile phases 
and/or silanol screening agents. 
8.3. Results and Discussion 
Table 1 gives the number code used to identify the 88 compounds; along with their 
names, chemical structures and chromatographic parameters obtained on the four polymeric 
CSPs. All blank entries correspond to non-observable enantiomeric separation (a single peak, 
enantioselectivity and resolution factors are respectively 1 and 0). In these cases, the 
retention times were deliberately omitted. With no exception, the retention times decreased 
dramatically when the methanol contents increased. Then, the retention values could be 
misleading when obtained with different mobile phase compositions. Since the retention 
values do not give reliable information on the retentive properties of the CSPs, they were not 
reported. 
8.3.1. Overall CSP Effectiveness 
Figure 2 (top) shows the number of enantiomeric separations obtained on each 
polymeric CSP. It clearly shows that the DPEVB CSP is less effective than the three other 
CSPs and is able to baseline separate only one compound (compound 58, Rs = 1.6, Table 1). 
By chance, the other three CSPs, P-CAP, P-CAP-DP and DEABV, were able to separate 
exactly the same number of compounds (49). The DEABV CSP baseline separated 20 
compounds (41% of the 49 separations, Table 1). Fifteen of the 49 fully or partially 
enantioseparated compounds were separated only on the DEABV-CSP. The number of 
baseline separations for the P-CAP and P-CAP-DP CSPs was, respectively, 12 and 14 
compounds. The number of unique separations for the P-CAP and P-CAP-DP CSPs was 11 
compounds. With the 6 compounds uniquely separated by the DPEVB CSP, a total of 43 
  
170
 
compounds or 49% of the selected set were separated by only one CSP. Figure 2 (bottom) 
shows that 20 compounds were separated by 2 CSPs, 18 by 3 CSPs and 7 compounds were 
enantioseparated by all 4 CSPs. These later compounds are 6, 22, 23, 26, 45, 52 and 63 
(Table 1). The DEABV-CSP seems to be somewhat better than the other two P-CAP CSPs in 
terms of the number of baseline separations and separations of compounds which contain the 
stereogenic center in a ring. 
8.3.2. Compound Structure and Polymer CSP Enantiorecognition 
In our recent work studying the behavior of the macrocyclic glycopeptide CSPs in 
subcritical chromatography, strong difference in enantiorecognition was found between the 
different related CSPs [20]. Chiral acid and amino-acid enantiomers were significantly better 
separated by the teicoplanin aglycone (TAG) CSP while the chiral amino alcohols (β-
blockers) were better separated on the native teicoplanin CSP [20]. The data in Fig. 3 does 
not indicate that there is such a profound structural selectivity difference between the 
polymer CSPs. The 43 compounds that are enantioseparated by a single CSP are more 
randomly spread among the four structural classes of compounds.  
However, a closer look at solute structure and CSP enantiorecognition allows one to 
find some structural selectivity. More specifically, the 9 oxazolidinone derivatives 
(compounds 26, 35, 36, 37, 38, 41, 42, 47 and 48) with an asymmetric carbon in position 4 
are all baseline separated on the DEABV CSP. Four of these compounds (36, 37, 38 and 41) 
are separated only on the DEABV CSP (Table 1). For the five oxazolidinone that are 
separated on several CSPs, the resolution factor obtained with the DEABV CSP is the 
highest. Clearly, there is an interaction between the oxazolidinone ring and the DEABV CSP 
that is very sensitive to substitution on the ring’s 4-carbon. 
Some general trends that have been observed with other CSPs also were observed with 
the polymeric CSPs studied here. First, it was observed that compounds having four very 
different substituents on the stereogenic center are well differentiated by many CSPs [25]. 
For example, the enantiomers of warfarin (23), with a hydrogen atom, a phenyl group, an 
acetonyl group and a huge hydroxylcoumarinyl group on its asymmetric center are 
differentiated by all four CSPs in this study. Also, it was observed that a minor change in the 
molecular structure of a chiral analyte can produce a dramatic change in enantioseparation 
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[25]. For example, compounds 39 and 40 differ only in the position of their hydroxyl group 
(changing from the meta to para position). Compound 39 is separated by the P-CAP CSP 
only and 40 is separated by the P-CAP-DP CSP only (Table 1). Such a change in 
enantiomeric recognition is observed only if the minor structural change occurs on an 
‘‘enantiosensitive’’ part of the molecule. Considering Coumachlor (22) and Warfarin (23), 
they differ only by a chlorine atom, but both are equally well separated by all four CSPs 
indicating that the chlorine atom is not located in a part of the molecule involved in any 
enantioselective interactions. A similar observation can be made with Benzoin (9) and 
Hydrobenzoin (14) whose enantiomers are equally well separated by three polymeric CSPs 
(Table 1). 
8.3.3. Chiral Stationary Phases and Chemical Interactions 
Figure 1a shows that the P-CAP monomer does not contain any aromatic moieties. 
Consequently, π–π interactions cannot be important in the chiral recognition mechanism of 
this CSP. The P-CAP polymeric CSP has a large number of amide linkages providing a 
wealth of sites for hydrogen bonding and dipolar interactions [5]. The three other CSPs do 
have several aromatic rings in their structures (Fig. 1b–d) along with amide linkages. They 
should be able to combine π–π interactions with other types of interactions for chiral 
recognition [25].  
Figure 3 shows the separation of compounds 63 (left) and 64 (right), respectively DNB-
leucine and DNB-phenylglycine, on the three CSPs, PCAP, P-CAP-DP and DEABV. Pi–pi 
interactions are likely in the case of the DNB-leucine (63, Fig. 4left). The DNB derivative is 
a strongly π-acid substituent on the amine group of leucine. The two enantiomeric forms of 
DNB leucine are well (Rs = 1.6) and extremely well (Rs = 4.7) separated by the π–π capable 
P-CAP-DP and DEABV CSPs, respectively. They are poorly separated by the P-CAP CSP 
which is unable to interact through π–π interactions (Fig. 4-left). However, the P-CAP CSP 
separates well (Rs = 1.4) the structurally related DNB-phenylglycine (Fig. 4-right). This 
compound (64) is equally or better separated by the two other CSPs as shown. In this case, 
the dipolar interactions with the DNB amide group and/or the H-bond interactions with the 
carboxylic acid moiety are more important than the π–π interactions for enantiorecognition of 
DNB-phenylglycine. 
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The results obtained with atropoisomers suggest that π–π interactions play little or no 
role in their enantioseparation. Indeed, the highest enantioresolution factor of all 
atropoisomers is obtained with 1,1’-binaphthol (76) on the P-CAP CSP (no π–π interactions). 
All other three CSPs are able to separate partially (Rs < 0.9) the binaphthalene atropoisomers 
76, 77 and 78 (Table 1). However, the exact nature of the enantioselective interactions has 
not been identified. 
8.3.4. Normal Phase LC versus SFC 
The synthetic polymeric CSPs were shown to be highly efficient in normal phase liquid 
chromatography using heptane-alcohol, halogenated solvent or waterless acetonitrile-
methanol mobile phases. The later mobile phase is used in the special mode called polar 
organic mode [5, 11, 22]. Most of the compounds whose enantiomers were successfully 
separated with a given polymeric phase in the normal or polar organic mode also produced 
successful enantioseparations with subcritical CO2 + MeOH mobile phases. The main 
obvious advantage of the SFC mobile phases is their low viscosity compared to classical 
liquid mobile phases. The low SFC mobile phase viscosity allows for much higher flow rates 
allowing for faster separations at the same pressure drop.  
The separations of N-(α-methylbenzyl) phthalic acid monoamide (16) and Furoin (13) 
respectively on the DEABV and P-CAP-DP CSPs will be used to illustrate the difference that 
can be observed between the normal phase mode and the subcritical fluid mode. The two 
enantiomers of 16 are partially separated (a = 1.13, Rs = 1.2, Fig. 4a) in the normal phase 
mode with an heptane/MeOH mobile phase in more than 12 min at 1 mL min-1. They are 
separated with a similar enantioselectivity factors in less than 8 min in SFC with a 
CO2/MeOH 75/25% v/v mobile phase at 4 mL min-1 (Fig. 4b). Raising the amount of 
methanol to 30% halves the separation duration without losing any enantioresolution (Fig. 
4c). The two enantiomers of Furoin are very well separated (a = 1.69, Rs = 3.7, Fig. 4d) in 
the normal phase mode with a heptane-IPA mobile phase in about 32 min at 1 mL min-1. 
Table 1 and Fig. 4e shows the separation obtained with a SFC mobile phase, also baseline 
and obtained in less than 3 min at 4 mL min-1. Better resolution factors were obtained in the 
normal phase mode compared to the Table 1 results in SFC for many compounds. It is 
recalled that the SFC separations were not optimized and all Rs-factors listed in Table 1 
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could likely be increased. However, the solute retention times were always significantly 
lower in the SFC mode than in both the normal phase and polar organic modes of classical 
liquid chromatography. 
8.3.5. Efficiency 
Table 1 lists the average plate number measured for the observed enantioseparated 
peaks. A huge plate count variation, with efficiencies that could be as low as 500 plates for a 
25 cm column (hetp = 5,000 µm or 1,000 particle diameters) or reach 9,000 plates (hetp = 
270 µm or 50 particle diameters), could be observed on the four CSPs studied. Of course, a 
low efficiency is not favorable for an acceptable resolution factor as illustrated by Fig. 5. The 
enantiomers of 27 are separated with a measured plate number of about 7,000 plates and an 
enantioselectivity factor of 1.08 producing an almost baseline resolution factor (Rs = 1.3). 
With the same retention times and selectivity factor, the enantiomers of Chlorthalidone 
(compound 45) are separated with a low resolution factor of 0.4 because the observed 
efficiency is very low (600 plates) for this compound (Fig. 5, bottom).  
The observed efficiency is a measure of the kinetics of the solute exchange between the 
mobile phase and the stationary phase. This parameter is difficult to predict. It is known that 
strong interactions between a solute and the stationary phase may be linked to a slow 
adsorption–desorption process being associated with a low efficiency. In the case illustrated 
by Fig. 5, Chlorthalidone has a plethora of functionality including a sulfamide group, an 
amide, an alcohol, a chlorinated phenyl and another aromatic ring. These numerous 
functionalities are subject to a variety of different interactions with the polymeric P-CAP-DP 
stationary phase. At least one of these possible interactions is slow, producing the observed 
poor peak shape. Compound 28 has less functionalities (only phenol and alcohol) that 
interact rapidly with the CSP producing sharper peaks. The kinetics of a particular solute-
stationary phase interaction can be completely independent of the solute’s chiral recognition 
interactions. In some cases, a strong interaction with slow adsorption/desorption kinetic may 
be critical for enantiorecognition. In other cases, the strong interaction may play no role [25]. 
The observed peak efficiency of a particular solute separated on a given CSP is very 
dependent on the experimental conditions. The nature of the alcohol modifier used is 
especially important. However quantitative comparison is difficult because most often the 
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retention times and enantioselectivity factors are also changed when the organic modifier is 
changed. As a general trend, ethanol produced better efficiencies than methanol and 
isopropyl alcohol. The TFA additive has also a critical influence on efficiencies since it 
reduces the strong (and slow) charge–charge interactions that occur with acidic analytes. 
8.4. Conclusions 
The synthetic polymeric P-CAP, P-CAP-DP, DEABV and DPEVB CSPs are all 
capable of producing effective enantioseparations with supercritical fluid mobile phases. The 
DPEVB CSP is significantly less successful than the three other CSPs in separating a large 
number of compounds with a variety of functionalities. The DEABV CSP seems to be the 
most broadly applicable and useful of these CSPs. The biggest advantage of the SFC mobile 
phase is the short separation times observed compared to those in the normal phase mode due 
to the high flow rates possible thanks to the low SFC mobile phase viscosity. Retention times 
lower than 5 min, with 25 cm columns, were obtained for 90% of the separations presented in 
this work. The second advantage of SFC mobile phases is the easy recovery of the separated 
solutes. There is no hindrance to injecting large amounts of sample on these columns and 
maintaining the enantiomeric separations as was demonstrated in the normal phase mode [5, 
11, 22], however the SFC loading capability was not evaluated in this study. 
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 CF3HO
Table 1.  Enantiomeric separations on four polymeric CSPs by SFC. 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
Compounds with sp2 hybridized carbon on the asymmetric center    
1 1-(9-Anthryl)-2,2,2-
trifluoroethanol 
 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
2.64 
3.54 
 
1.07 
1.07 
0.7 
0.7 
30%/0.2% 
15%/0.2% 
4900 
3700 
 
2 2-(4-Nitrophenyl)-
propionic acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
7.62 
 
 
 
1.05 
 
 
 
0.8 
 
 
 
5%EtOH/0.2% 
 
 
 
7200 
3 3,4-Dihydroxy-
phenyl-2-
propylacetamide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.27 
7.31 
6.18 
1.16 
1.03 
1.04 
1.6 
0.3 
0.3 
25%/0.2% 
20%/0.2% 
20%/0.2% 
 
2900 
2200 
2100 
4 4-Chloromandelic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
2.96 
 
1.08 
 
0.3 
 
20%/0.2% 
 
 
600 
5 4-Isobutyl-α-
methyl-phenylacetic 
acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.75 1.05 0.5 5%/0.2% 
 
3400 
6 5-(α-Phenethyl)-
semioxamazide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
2.19 
3.58 
1.73 
3.69 
1.13 
1.05 
1.21 
1.22 
0.8 
0.4 
1.1 
1.1 
30%/0.2% 
15%/0.2% 
40%/0.2% 
10%/0.2% 
2200 
2400 
3000 
1000 
7 1-Phenyl-1,2-ethanediol P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.63 
11.2 
1.16 
1.06 
1.8 
1.4 
15% IPA/0.2% 
5%/0.2% 
 
3500 
9000 
8 Atrolactic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.02 
 
1.05 
 
0.6 
 
10%/0.2% 
 
3900 
9 Benzoin P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.31 
3.81 
4.93 
1.07 
1.18 
1.07 
0.9 
2.0 
1.1 
10%/0.2% 
5%/0.2% 
10%/0.2% 
6900 
4700 
7700 
10 Bis[1-phenylethyl]-
Amine hydrochloride 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.34 
3.02 
4.30 
1.09 
1.16 
1.28 
1.1 
0.9 
2.0 
5%/0.2% 
15%/0.2% 
20%/0.2% 
 
4000 
1400 
2000 
11 Carprofen P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.54 
4.19 
4.81 
 
1.07 
1.08 
1.08 
 
0.8 
0.5 
0.7 
 
25%/0.2% 
40%/0.2% 
30%/0.2% 
 
4400 
1300 
2400 
12 Doxylamine P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.06 1.07 0.3 15%/0.2% 
 
700 
 
 
O2N
COOH
 
O
H2N
OH
OH
 
Cl
OH
COOH
 CO2H
 
OH
HO
 
N
O
NHNH2
O
H
 O
HO
Me
Ph
N Me
Ph
H HCl
 N
Ph
O
NMe2
 OH
COOH
Me
 N
CL
COOH
l 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
13 Furoin P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
2.48 
4.15 
3.91 
 
1.25 
1.04 
1.03 
 
2.0 
0.4 
0.5 
 
10%/0.2% 
10%/0.2% 
5%/0.2% 
 
3800 
2800 
8000 
14 Hydrobenzoin P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.12 
5.23 
7.18 
1.12 
1.06 
1.03 
1.8 
0.9 
0.5 
15%EtOH/0.5% 
10%/0.5% 
10%/0.5% 
6500 
5400 
5000 
15 Mandelamide P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.25 
 
 
1.13 
 
 
1.5 
 
 
20%/0.5% 
 
 
5300 
16 N-(α-Methylbenzyl) phthalic 
acid monoamide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.29 
 
7.06 
1.08 
 
1.14 
0.8 
 
1.4 
15%/0.2% 
 
25%/0.2% 
 
2800 
 
2800 
17 N,N’-Bis(2-
methyl-
benzyl) 
sulfamide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.92 
3.01 
3.31 
1.06 
1.70 
1.09 
0.7 
3.4 
0.7 
15%/0.2% 
20%/0.2% 
30%/0.2% 
 
3800 
1800 
2200 
18 N-Benzyl-1-(1-
naphthyl)-ethylamine 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
5.31 
 
 
1.12 
 
 
0.6 
 
 
35%EtOH/0.2% 
 
 
700 
19 O-Acetyl mandelic 
acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
5.33 
3.75 
 
1.06 
1.04 
 
0.7 
0.3 
 
5%/0.2% 
10%/0.2% 
 
3300 
1500 
20 Tropic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.44 
 
1.15 
 
1.6 
 
15%EtOH/0.2% 
 
3700 
21 Verapamil P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.10 1.06 0.4 10%/0.2% 1300 
22 Coumachlor P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.48 
4.66 
5.96 
5.10 
1.12 
1.06 
1.06 
1.07 
1.4 
0.6 
0.4 
0.7 
15%/0.2% 
15%/0.2% 
30%/0.2% 
20%/0.2% 
3600 
2600 
1000 
2100 
 
23 Warfarin P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.50 
4.08 
4.89 
4.30 
1.11 
1.07 
1.07 
1.11 
1.3 
0.8 
0.5 
1.1 
15%/0.2% 
15%/0.2% 
30%/0.2% 
20%/0.2% 
4500 
4200 
1400 
3100 
 
Compounds whose asymmetric center is part of a ring    
24 Althiazide P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.00 
 
1.31 
 
1.4 
 
40%/0.2% 
 
900 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
25 2-Azabicyclo[2.2.1]-hept-5-en-3-one P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.17 1.10 1.4 3%/0.2% 5300 
26 (3a-cis)-3,3a,8,8a-
Tetrahydro-2H-
indenol[1,2-d] oxazol-2-
one 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.31 
4.35 
5.8 
2.95 
1.16 
1.12 
1.13 
1.06 
1.5 
1.1 
1.5 
0.8 
20%/0.2% 
15%/0.2% 
20%/0.5% 
20%/0.2% 
2900 
2700 
4100 
5700 
27 1,2,3,4-Tetrahydro- 
1-naphthol                                                       
 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.25 
 
1.05 
 
0.9 
 
5%EtOH/0.2% 
 
8000 
28 1,5-Dihydroxy-1,2,3,4-
tetrahydronaphthalene  
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.6 
 
1.08 
 
1.3 
 
15%/0.2% 
 
 
7000 
29 1,5-Dimethyl-4-phenyl-2-
imidazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
3.40 
2.94 
6.15 
 
1.08 
1.07 
1.09 
 
1.0 
0.8 
1.2 
 
10%/0.2% 
20%/0.2% 
5% EtOH/0.2% 
 
5100 
5000 
5000 
30 2-Carbethoxy-γ-
phenyl-γ-
butyrolactone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.59 
 
 
1.07 
 
 
0.9 
 
 
10%/0.2% 
 
 
5100 
31 3-(Benzyloxy 
carbonyl)-4-
oxazolidine 
carboxylic acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
7.07 
 
 
1.05 
 
 
0.5 
 
 
10%/0.5% 
 
 
2400 
32 3a,4,5,6-Tetrahydro-
succininido[3,4-b]-
acenaphthen-10-one 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.08 
 
5.60 
1.04 
 
1.13 
0.5 
 
1.0 
15%/0.2% 
 
35%EtOH/0.2% 
3300 
 
1800 
33 3-Oxo-1-indancarboxylic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.79 
 
 
1.05 
 
0.6 
 
10%EtOH/0.2% 
 
4000 
34 3-Phenylphthalide P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
6.87 
 
 
1.08 
 
 
1.5 
 
 
10%/0.5% 
 
 
8000 
35 4-(Diphenylmethyl)-2-
oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.00 
6.86 
2.97 
1.08 
1.04 
1.18 
1.3 
0.4 
1.5 
10%/0.2% 
10%/0.2% 
40%/0.2% 
6300 
2400 
3000 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
36 4-Benzyl-2-
oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
2.85 
 
 
1.18 
 
 
1.5 
 
 
30%/0.2% 
 
 
3300 
37 4-Benzyl-3-propionyl-
2-oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
4.44 
 
 
1.18 
 
 
2.0 
 
 
20%/0.2% 
 
 
4300 
38 4-Benzyl-5,5-dimethyl-
2-oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.17 
 
 
1.17 
 
 
1.5 
 
 
25%EtOH/0.2% 
 
 
3300 
39 5-(3-Hydroxyphenyl)-5-
phenylhydantoin 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.34 1.04 0.3 40%/0.2% 1300 
40 5-(4-Hydroxyphenyl)-5-
phenylhydantoin 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
4.88 
 
1.05 
 
0.3 
 
40%/0.2% 
 
900 
41 5,5-Dimethyl-4-phenyl-2-
oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.08 
 
 
1.14 
 
 
1.5 
 
 
20%/0.5% 
 
 
4800 
42 5-Phenyl-2-(2-
propynylamino)-2-
oxazolin-4-one 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.52 
4.73 
3.15 
1.06 
1.08 
1.25 
0.7 
0.7 
1.5 
15%/0.2% 
15%/0.2% 
35%EtOH/0.2% 
4000 
2400 
1700 
43 Bendro-
flumethiazide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
8.91 
3.90 
1.11 
1.31 
0.8 
1.3 
40%/0.2% 
35%/0.2% 
1200 
800 
44 Benzylphthalide P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.94 
 
 
1.05 
 
 
0.7 
 
 
20%/0.2% 
 
 
5100 
45 Chlorthalidone P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.08 
4.38 
3.79 
5.27 
1.21 
1.09 
1.09 
1.07 
1.5 
0.4 
0.5 
0.6 
40%/0.2% 
40%/0.2% 
40%/0.2% 
30%/0.2% 
1600 
600 
1100 
2000 
46 cis-1-Amino-2-indanol P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
6.38 
 
 
1.10 
 
 
1.3 
 
 
20%/0.2% 
 
 
4400 
47 cis-4,5-Diphenyl-2-
oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.43 
4.51 
3.66 
1.06 
1.06 
1.21 
1.0 
0.9 
1.6 
10%/0.2% 
15%/0.2% 
30%/0.2% 
6700 
6600 
2400 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
48 cis-4-Methyl-5-
phenyl-2-
oxazolidinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.15 
4.94 
3.76 
1.07 
1.08 
1.16 
0.9 
1.0 
1.5 
15%EtOH/0.2% 
10%/0.2% 
25%EtOH/0.2% 
5100 
4600 
3300 
49 Flavanone P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
5.11 
 
 
1.31 
 
 
0.4 
 
 
10%/0.2% 
 
 
 
100 
50 Ketamine (hydrochloride) P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.79 1.05 0.5 10%/0.2% 
 
2300 
51 Lormetazepam P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.79 
 
3.00 
1.15 
 
1.31 
2.0 
 
1.8 
15%/0.2% 
 
40%/0.2% 
5800 
 
1800 
52 Oxazepam P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.43 
3.18 
3.62 
3.32 
1.37 
1.36 
1.34 
1.08 
2.2 
2.5 
1.0 
0.5 
40%/0.2% 
40%/0.2% 
40%/0.2% 
30%/0.2% 
1800 
2600 
400 
1400 
53 N-(α-Methylbenzyl)- 
phthalimide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
4.48 
 
 
1.02 
 
 
0.3 
 
 
10%/0.2% 
 
 
 
4600 
54 Phensuximide P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
6.25 
 
1.11 
 
1.5 
 
1%/0.2% 
 
 
4700 
55 t-Butyl-6-oxo-2,3-
diphenyl-4-morpholine 
carboxylate 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.66 
4.85 
1.04 
1.16 
0.3 
1.5 
5%/0.2% 
5%EtOH/0.2% 
1700 
3000 
56 Thioridazine P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.9 1.09 0.4 15%/0.2% 700 
57 trans-4-Cotinine- 
carboxylic acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.25 
 
4.27 
1.06 
 
1.02 
0.6 
 
0.3 
10%/0.2% 
 
20%/0.2% 
2800 
 
4300 
Chiral acids and amino-acid derivatives   
58 4-((1-(Isopropoxy- 
carbonyl-4- 
methyl)-butyl) amino) 
-benzoic acid                  
.           
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
2.64 
2.22 
3.46 
 
1.28 
1.93 
1.21 
 
1.6 
4.0 
1.6 
 
10%/0.2% 
30%/0.2% 
10%/0.2% 
 
1800 
2200 
2500 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
59 4-Chlorophenyl-alanine 
ethyl ester 
hydrochloride 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.08 1.10 0.7 15%/0.2% 1700 
60 Carbobenzyloxy-alanine P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.44 
3.68 
2.79 
1.07 
1.06 
1.21 
0.9 
0.7 
1.5 
15%EtOH/0.2% 
10%/0.2% 
20%/0.2% 
5300 
5100 
2500 
61 Dansyl-norleucine 
cyclohexylammonium salt 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.08 
 
3.96 
1.08 
 
1.16 
1.0 
 
1.4 
30%/0.2% 
 
30%/0.2% 
5600 
 
2900 
62 Dansyl-phenylalanine 
cyclohexylammonium salt 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
3.81 
3.90 
 
1.09 
1.29 
 
0.5 
1.7 
 
30%/0.2% 
40%/0.2% 
 
 
1000 
1400 
63 N-(3,5-Dinitro-
benzoyl)-leucine 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.17 
2.35 
1.97 
3.74 
1.04 
1.30 
3.14 
1.10 
0.4 
1.6 
4.5 
1.2 
15%/0.2% 
20%/0.2% 
40%/0.2% 
20%/0.2% 
2600 
1900 
1200 
4400 
64 N-(3,5-Dinitro-
benzoyl)-phenyl 
glycine 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.75 
3.94 
3.70 
 
1.19 
1.23 
1.58 
1.4 
1.8 
2.7 
30%/0.2% 
20%/0.2% 
40%/0.2% 
 
3100 
2400 
1300 
65 N-Acetylhomo-cysteine 
thiolactone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
7.36 
4.73 
3.55 
1.06 
1.11 
1.06 
0.9 
1.3 
0.7 
5%/0.2% 
10%/0.2% 
20%/0.2% 
5600 
4600 
4700 
66 N-Benzoyl-valine P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.85 
3.58 
1.11 
1.07 
1.3 
0.7 
15%EtOH/0.2% 
10%/0.2% 
4200 
3800 
67 N-carbobenzoxy-Phenylalanine P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.13 
4.38 
2.04 
1.04 
1.09 
1.35 
0.5 
0.9 
1.5 
15%/0.2% 
15%EtOH/0.2% 
40%/0.2% 
4300 
3000 
1600 
68 2-Phenoxy 
propionic acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.49 
 
 
1.03 
 
 
0.4 
 
 
10%/0.2% 
 
 
5100 
69 2-(3-Chlorophenoxy) 
propionamide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
6.73 
 
1.06 
 
0.9 
 
5%/0.2% 
 
5300 
70 2-(4-Chloro-2-methyl-phenoxy) propionic 
acid 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
4.81 
 
 
 
1.09 
 
 
 
1.1 
 
 
 
5%EtOH/0.2% 
 
 
 
4700 
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Table 1 (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
 
71 
2,3-Dibenzoyl- 
tartaric acid 
 
 
 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
3.80 
4.61 
 
 
1.15 
1.03 
 
 
1.3 
0.3 
 
 
30%/0.2% 
20%/0.2% 
 
 
2700 
2200 
72 2-Bromo-3-methylbutyric acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.02 1.08 0.9 5%/0.2% 4400 
73 Bromosuccinic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.15 
5.90 
1.05 
1.11 
0.6 
1.5 
20%/0.2% 
10%/0.2% 
3100 
5100 
74 Iopanoic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
6.02 
 
 
 
1.13 
 
 
 
1.0 
 
 
 
30%/0.2% 
 
 
 
1600 
75 Iophenoxic acid P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
5.75 
 
 
 
1.12 
 
 
 
0.7 
 
 
 
30%/0.2% 
 
 
 
1000 
Atropoisomerism and miscellaneous chemical functionalities on the asymmetric 
center 
  
76 1,1’-Bi-2-naphthol P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.17 
 
7.96 
1.32 
 
1.04 
2.7 
 
0.3 
40%/0.2% 
 
30%/0.2% 
 
3100 
 
1500 
77 1,1’-Bi-2-naphthol 
bis(trifluoromethane 
sulfonate) 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
5.18 
 
 
 
1.08 
 
 
 
0.9 
 
 
 
5%EtOH/0.2
% 
 
 
 
3200 
78 2,2’-Diamino-1,1’-
binaphthalene 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
6.54 
 
1.08 
 
0.8 
 
20%/0.2% 
 
2800 
79 6-(4-Chlorophenyl)-
4,5-dihydro-2-(2-
hydroxybutyl)-3-
(2H)-pyridazinone 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.65 
11.6 
1.22 
1.06 
2.4 
1.0 
10% 
IPA/0.2% 
5%/0.2% 
3800 
6800 
80 7-(2,3-Dihydroxy-
propyl) theophyline 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
6.08 1.03 0.4 10%/0.2% 3900 
81  Baytan) P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.94 1.20 1.6 10% 
IPA/0.2% 
2500 
82 N,N’-
Dibenzyl- 
tartramide 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
2.60 
3.44 
2.73 
1.46 
1.45 
1.36 
2.5 
2.2 
1.5 
30%/0.2% 
20%/0.2% 
40%/0.2% 
2100 
1300 
1100 
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Table 1. (continued) 
# Compound name and formula CSP t1 min α Rs 
Additive 
MeOH/TFA* 
N 
plates 
83 2-Amino-3-phenyl-
1-propanol 
P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
4.61 
2.90 
1.09 
1.07 
1.3 
0.4 
15%/0.2% 
20%/0.2% 
6000 
1400 
84 Propranolol P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
7.12 
 
 
1.10 
 
 
0.4 
 
 
20%/0.2% 
 
 
400 
85 3-(4-Nitrophenyl) glycidol P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
 
 
 
9.4 
 
 
 
1.07 
 
 
 
0.9 
 
 
 
5%EtOH/0.2
% 
 
 
 
4200 
86 Crufomate (Ruelene)  P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.27 
5.72 
1.06 
1.14 
0.5 
1.7 
5%/0.2% 
5%EtOH/0.2
% 
2700 
4300 
87 Fipronil P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
3.10 
5.54 
1.25 
1.21 
2.1 
1.9 
10%/0.2% 
5%/0.2% 
 
 
88 Omeprazole P-CAP 
P-CAP-DP 
DEABV 
DPEVB 
5.44 
5.04 
1.09 
1.05 
0.9 
0.7 
15%/0.2% 
20%/0.2% 
 
2700 
700 
*The TFA is added to the alcohol modifier.   
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Fig. 1. The monomer of the polymeric chiral stationary phases used. a) P-CAP (trans-1,2-
cyclohexanediyl-bis acrylamide) , b) P-CAP-DP (N,N’-[(1R,2R)]-1,2-diphenyl-1,2-
ethanediyl] bis-2-propenamide), c) DEABV (trans-9,10-dihydro-9,10-ethanoanthracene-
(11S,12S)-11,12-dicarboxylic acid bis-4-vinylphenylamide), d) DPEVB (N,N’-[(1R,2R)-1,2-
diphenyl-1,2-ethanediyl] bis[4-vinylbenzamide]).  
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Fig. 2. Overall results obtained with the four synthetic polymeric chiral stationary phases in 
subcritical mode.  Top diagram: number of separations obtained on each CSPs. Bottom 
diagram: the number of compounds that were separated only by one single CSP or 2 or 3 or 
all 4 CSPs.  The percentages refer to the number of compounds from the 88 compound set 
shown in Table 1. 
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Fig. 3. Enantioseparation of DNB-leucine (3 left chromatograms) and DNB-phenylglycine (3 
right chromatograms on the indicated polymeric chiral stationary phases. Column 250 x 4.6 
mm with 5 μm silica particles bonded by the indicated selector, subcritical mobile phase with 
CO2 + methanol (+ 0.2% v/v TFA) (proportion for DNB-leucine: p-CAP 15%, p-CAP-DP 
20%, Poly-DEABV 40%; proportion for DNB-phenylglycine: p-CAP 30%, p-CAP-DP 20%, 
Poly-DEABV 40%, Compounds 63 and 64), 100 bar, 4 mL min-1, 32oC, UV detection 254 
nm. 
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Fig. 4. Separation of the enantiomers of N-(α-methylbenzyl) phthalic acid monoamide (16) 
on the DEABV CSP.  a: normal phase heptane/EtOH 70%/30% (+0.1% v/v TFA), 1 ml/min, 
α = 1.13, Rs = 1.2;  b: SFC CO2/MeOH 75/25% v/v (+0.2% v/v TFA), 100 bar, 4 ml/min, 
32oC, α = 1.14, Rs = 1.4;  c: SFC CO2/MeOH 70/30% v/v (+0.2% v/v TFA), 100 bar, 4 
ml/min, 32oC, α = 1.12, Rs = 1.3.  Separation of the enantiomers of Furoin (13) on the 
polymeric P-CAP-DP CSP.  d: normal phase mode, mobile phase heptane/IPA 80/20 %v/v 
(with 0.1% TFA), 1 ml/min, α = 1.69, Rs = 3.7;  e: SFC CO2/MeOH 90/10% v/v (+0.2% v/v 
TFA), 100 bar, 4 ml/min, 32oC, α = 1.25, Rs = 2.0, detection UV 254 nm. 
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Fig. 5.  Efficiency variations on the P-CAP-DP chiral stationary phase.  Left: separation of 
the enantiomers of 1,5-dihydroxy-1,2,3,4-tetrahydronaphthalene (28), mobile phase, CO2 + 
15% v/v (MeOH + 0.2% v/v TFA); right: enantioseparation of Chlorthalidone (45), mobile 
phase, CO2 + 40% v/v (MeOH + 0.2% v/v TFA).  Total flow rate 4 mL min-1, 32oC, 100 bar, 
UV detection 254 nm. 
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Chapter 9. General conclusions 
In the first part (chapters 2-4) of the dissertation, the enantiomeric separation of three 
groups of new synthesized racemates: racemic furans, racemic isochromenes, and racemic 
chiral polycycles, was investigated on cyclodextrin based chiral stationary phases. 
Cyclodextrin-based CSPs are effective for separation of these new relatively hydrophobic, 
often neutral racemates in the reverse phase mode. Enantioselective separations for 93%, 
85%, and 100% of the racemic furans, racemic isochromenes and racemic polycycles, 
respectively, were observed on cyclodextrin-based CSPs in the reverse phase mode. Very 
few enantiomeric separations were observed in the normal phase mode or polar organic 
mode. The hydroxypropyl-β-cyclodextrin (Cyclobond RSP) and the 2,3-dimethyl-β-
cyclodextrin (Cyclobond DM) CSPs are the most effective for the separation of all three 
groups of analytes in comparison to other cyclodextrin-based columns. Eighty three percent 
of chiral furans, 60% of chiral isochromenes, and 100% of chiral polycycles were separated 
on either the Cyclobond RSP or DM columns or both. In the reverse phase mode, the pH of 
the buffered mobile phase only showed significant effect on the separation of compounds 
with ionizable groups such as carboxylic acid or amino groups. Increases in the separation 
efficiency and decreases in separation time were observed in the buffered mobile phase for 
these analytes with ionizable groups at appropriate pHs. For the separation of chiral furans, a 
small amount of methyl t-butyl ether in the mobile phase can decrease the retention and 
improve peak efficiency for some of the more strongly retained analytes. Better efficiencies 
were obtained in the separation of polycycles, when acetonitrile was used as organic 
modifier, compared to methanol. The structural features of the analytes affect the 
enantiomeric separations greatly. A small change in the structure of the analytes can result in 
a substantial change in the enantioselectivities on any given CSP. 
The second part (chapters 5-7) of this thesis focuses on the evaluation and development 
of new synthetic polymeric CSPs. P-CAP CSP is prepared with a radical initiated 
polymerization of N,N’-diacryloyl derivative of trans-1,2-diaminocyclohexane. The 
polymeric process begins from the surface of the azo-activated silica support. This CSP 
showed enantioselectivities for many racemates in the normal phase mode and polar organic 
mode. The two mobile phase modes are complementary to each other. For the separation of 
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organic acids, 0.1% trifluoacetic acid in the mobile phase can decrease the retention and 
increase the peak efficiency in both mobile phase modes. More racemates were separated in 
the normal phase mode than in the polar organic mode, while faster separations and higher 
efficiency were obtained in the polar organic mode. The elution order of two enantiomers can 
be easily reversed by use the two CSPs in which the chiral center of the monomer has the 
opposite absolute configuration. The P-CAP CSP showed high sample loading capacity and 
was a promising semi-preparative or preparative CSP. Two new synthetic polymeric CSPs 
based on N,N’-[(1R,2R)]-1,2-diphenyl-1,2-ethanediyl] bis-2-propenamide (commercial name 
= P-CAP-DP), and trans-9,10-dihydro-9,10-ethanoanthracene-(11S,12S)-11,12-dicarboxylic 
acid bis-4-vinylphenylamide (Poly-DEABV) were developed. The P-CAP-DP CSP was 
prepared by a different polymeric method, in which both the monomer and radical initiator 
are dissolved in a suspension of the silica gel derivatized with an acryloyl functional group. 
The polymeric process begins from solution. Poly-DEABV CSP was prepared using a 
method similar to the one used for the P-CAP CSP. Both CSPs showed similar 
enantioseparation abilities compared to the P-CAP CSP. However, these two columns 
provide complementary results to the P-CAP column. Similar to the P-CAP CSP, a small 
amount of TFA in the mobile phase helps the enantioselective separation of the analytes with 
ionizable groups. These columns also showed high sample loading capacity.  
The third part (chapters 8) of this dissertation involves the application of the above three 
synthetic polymeric CSPs and another new synthetic polymeric CSP in SFC. The four tested 
columns showed enantioselectivities for many racemates and high stability in supercritical 
fluid chromatography. The enantiomeric separations obtained in SFC are much faster than 
those obtained in HPLC due to the high flow rate (4 mL/min for SFC vs. 1 mL/min for 
HPLC). Most separations in SFC were done in 5 minutes. Due to the better separation 
efficiency in SFC, better enantiomeric resolutions for some analytes were observed in SFC 
than HPLC. 
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